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SUMMARY
The studies undertaken in this thesis described the biological characteristics 
of defective interfering (DI) particles of West Nile (WN) virus both in vitro and in 
vivo. A reliable and reproducible assay was developed to measure the interfering 
activity of DI virus (the optimum interference assay [OIA]) based on ^ability of DI 
WN virus to cause a reduction in the yield of infectious standard (STD) WN virus. 
The sensitivity of the assay was found to be dependent on several parameters of 
which the cell type used in the assay was the most crucial.
High-multiplicity serial passages of STD WN virus in Vero and LLC-MK2 
cells generated and amplified a large quantity of DI WN virus as measured by the 
OIA and their presence was detected as early as after two serial passages. Propagation 
of pre-formed DI virus in seven cell lines demonstrated that SW13 cells would 
propagate STD WN virus only and no detectable DI virus was propagated in this cell 
line.
Intraperitoneal inoculation of adult mice with DI WN virus protected them 
from a lethal challenge by the neurotropic STD WN virus inoculated by the same 
route. The multiplication of infectious virus in the brains of mice treated with live DI 
virus was greatly reduced compared to mice inoculated with STD virus and infectivity 
was rapidly eliminated. Evidence was produced to show that DI virus was propagated 
in the brain of mice protected by live DI virus. A minority of protected mice sampled 
at 19 days post infection had infectious virus in their brains suggesting that DI virus 
can modulate the acute WN virus infection and cause it to become persistent. Virus 
isolates collected from the protected mice demonstrated three categories of virulence 
for adult mice: as virulent as the parent virus, intermediate virulence and greatly 
attenuated.
DI virus derived from three different strains of WN virus demonstrated 
heterotypic interference both in vitro and in vivo. Interference was limited between 
different members of the WN subgroup of the Flaviviridae and the extent of 
heterotypic interference was found to be consistent with the antigenic classification 
of flaviviruses. Thus, interference by flavivirus DI particles may be useful in the 
classification of flaviviruses.
In conclusion, DI WN virus was generated with properties similar to those of 
DI virus reported for other RNA virus systems. However, the ability of the DI WN 
virus to protect mice was superior to that of any other virus systems described to 
date. Thus, DI WN virus may be an excellent system with which to study the 
biological properties of DI virus.
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CHAPTER 1 
Introduction
I. WEST NILE VIRUS
1.1. History
West Nile (WN) virus was originally isolated from the blood of a woman 
presenting with fever in the West Nile province of Uganda in 1937 revealing WN 
fever one of the earliest recognized arthropod-borne viral diseases of humans 
(Smithbum et a l ,  1940). Between 1940 and 1950 serological surveys of populations 
within East and Central Africa demonstrated that the virus was wide spread in that 
region. In 1950 further isolates of WN virus were made from Sindbis sanitary district 
in Egypt from the blood of three apparently healthy children (Melnick et a l ,  1951).
1.2. Classification
WN virus is a member of the genus flavivirus of the family Flaviviridae 
(Westaway et a l ,  1985).
1.2.1. Flaviviridae
The family Flaviviridae, of which the type species is yellow fever (YF) virus, 
contains a single genus, Flavivirus. Together with the alphavirus genus, flaviviruses 
were originally classified as the members of the family Togaviridae on the basis of 
morphological and serological criteria (Porterfield et a l ,  1978). However, with the 
advent of molecular techniques, it is now clear that the flaviviruses, although
2
generally morphologically similar to alphavinises, differed markedly from the 
alphaviruses in their virion structure, strategy of replication and morphogenesis. 
While flaviviruses have a single envelope protein and do not specify any subgenomic 
messenger RNA (mRNA) (Westaway, 1973; 1987), alphaviruses have at least two, 
sometimes three, envelope proteins and specify a subgenomic 26S mRNA 
corresponding to the 3’ end of the genome which codes for the structural proteins 
(Kaariainen and Soderlund, 1978). In comparison, the structural protein gene of 
flaviviruses are found at the 5' end of the genome. Therefore, in 1984 The 
International Committee on Taxonomy of Viruses (ICTV) approved a proposal by the 
ICTV Togaviridae study group to remove the genus Flavivirus from this family and 
to recognize them as the basis for a new family Flaviviridae (Westaway et al. , 1985).
1.2.2. Antigenic relationship of WN virus with other flaviviruses
Currently, 6 8  viruses have been described in this family (Calisher et a l ,  
1989). All the flaviviruses share a group-specific antigen (Brinton, 1986). Antigens 
presented on the virion surface are reactive in binding assays (immunoflorescence and 
enzyme-linked or radio-immunoassay), haemagglutination-inhibition (HAI) and 
neutralization (N) assays. The flaviviruses were originally grouped on the basis of 
cross-reactivities in the HAI test performed with polyclonal antisera by Casals and 
Brown (1954). The HAI test and binding assays detect the group reactive 
determinants, whereas, N test is relatively type specific. The N test is used to 
distinguish individual viruses in the family and to define subgroups of closely related 
viruses (Monath, 1989).
On the basis of cross-neutralization tests using polyclonal hyperimmune sera, 
deMadrid and Porterfield (1974) classified 36 flaviviruses into seven complexes or 
subgroups, whereas six remaining viruses were antigenically distinct. A more recent 
analysis of 6 6  flaviviruses defined eight antigenic subgroups encompassing 49 viruses. 
WN virus belongs to the antigenic complex comprising 10 viruses including Japanese 
encephalitis (JE), Murry Vally encephalitis (MVE) and Saint Louis encephalitis (SLE) 
viruses. Other antigenic groups include tick-borne encephalitis (12 viruses), Rio 
Bravo ( 6  viruses), Tyuleniy (3 viruses), Ntaya (5 viruses),Uganda S (4 viruses). 
Dengue (DEN) (4 viruses) and Modoc (5 viruses) leaving 17 other viruses 
unclassified (Table 1.1) (Calishergr al., 1989). This antigenic classification conforms 
to major biological and epidemiological characteristics of the flaviviruses.
1.2.3. Strain variation of WN virus
Comparison of 21 WN virus isolates in a kinetic HAI test using immune 
mouse sera revealed two antigenic groups (Hammam et al., 1965). Isolates from 
Congo, Egypt, Israel, and Uganda formed a single homogeneous group termed the 
African-Middle Eastern group. Two strains from South Africa also were placed in 
this group, but one South African isolate was different from all other WN viruses 
tested. The six WN virus isolates from India showed a distinct unilateral differences 
with the African-Middle Eastern group forming an Indian group. Subsequent 
serological studies on isolates from Pakistan, France and the former USSR have 
shown to belong to African-Middle Eastern group (Hammam and Price, 1966; 
Gaidamovich and Sokaey, 1973). Antigenic differences between strains isolated within
Table. 1.1 Antigenic Classification of Flaviviruses
Mosquito-borne
viruses
Antigenic
Group
Tick-borne Antigenic 
viruses Group
Vector-unknown
viruses
Antigenic
Group
Alfuy 3 Karshi 1 Carey 1
Japanese enc. 3 Kyasanur Forest 1 Phnom Penh bat 1
Kedougou 3 I^ngat 1
Kokobera 3(5?) LoupmgiU 1
Koutango 3 Negishi 1 Apoi 2A
Kunjin 3 Omsk 1 Bukalasa bat 2A
Murray Valley 3 Powassan 1 Dakar bat 2A
St. Louis enc. 3 Royal Farm 1 Entebbe bat 2A
Stratford 3 TicK-borne enc. 1 Rio Rravo 2A
Usutu 3 Saboya 2A
West Nile 3
Yaounde (3)*
Sponweni 4 Meaban lA Cowbone Ridge 2B
Zika 4 SaumarezReef lA Jutiapa 2B
Tyuleniy lA Modoc 2B
Bagaza 5 SalVieja 2B
Isreal Turkey 5 SanPerlita 2B
Ntaya 5
Tembusu 5
Yokose 5
Banzi 6
Bouboui 6
Edge Hill 6
Potiskum (6)*
Uganda S 6
Dengue 1 7
Dengue2 7
Dengue3 7
Dengue4 7
Busuquara U Gadgets Gulley U Aroa U
Hheus u Kadam U Batu Cave (U)*
Jugra u Cacipacore U
Naranjal u Montana M.L. U
Rocio u Sokuluk u
Sepik u Tamanabat u
Wesselsbron u
Yellow fever u
Total 36 14 19 = 69
This table was summarized from Calisher etaJ. 1990.
U: unrelated to any other flaviviruses.
*: Batu Cave, Potiskum and Yaounde viruses were not examined in 
their studies but are included for completeness.
the same country can also be detected (Umigar and Pavri, 1977). One study with six 
Indian strains showed differences in adult mouse pathogenicity, Vero cell infectivity, 
and the size of plaques produced in these cells (Umigar and Pavri, 1977a).
1.3.1. Medical and veterinary significance of flaviviruses
Of the 6 8  currently registered flaviviruses, approximately 50% have been 
associated with diseases in humans (Table 1.2) (Karabatsos, 1985). Eight flaviviruses 
have been reported to cause diseases in domesticated or wild animals of economic 
importance (Table 1.3.). Three viruses: dengue (DEN), YF and JE are prevalent 
enough to endanger global or panregional public health concern. Tick-borne 
flaviviruses, such as Powassan (Canada), louping ill (British Isles), Kyasanur Forest 
disease (India), tick-borne encephalitis (TBE) (East Europe, CIS and Scandinavia) 
Russian spring-summer encephalitis (CIS), and Omsk haemorrhagic fever (Siberia) 
viruses induce meningitis or encephalitis in humans with a case fatality ranging 1  to 
30% (Shope, 1980). WN fever (Africa, the Middle East, Europe and Asia), Murrey 
Valley encephalitis (MVE) (Australia), Saint Louis encephalitis (SLE) (USA) and 
Rocio encephalitis occur as intermittently epidemic diseases.
1.3.2. Disease and caused by WN virus
Clinical disease in humans produced by WN virus infection is usually mild. 
Disease occurring in an endemic area of Egypt and during epidemics in Israel has 
been characterized by rapid onset of fever, 38 to 40°C, lasting for 5 to 6  days.
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Malaise, frontal headache, pain associated with eye movement and muscle pain are 
common symptoms. Prominent signs also included enlargement of lymph nodes and 
maculopapular rash and convalescence frequently prolonged, lasting 1  to 2  weeks 
(Goldblum et al., 1954; Marberg et al., 1956). Mild meningeal involvement was 
observed in a few cases during some the early epidemics in Israel, but severe 
meningoencephalomyelitis was reported during a 1957 outbreaks that involved 49 
elderly patients in two nursing homes (Spigland et al., 1958). However, cases of 
meningoencephalomyelitis have been described in younger patients from Israel (Flatau 
et a l ,  1981) and India (Rodrignes et ah, 1985). WN virus has been isolated from 
naturally infected horses with encephalitis in Egypt and France but this is apparently 
a rare occurrence (Rodhain and Hannoun, 1980; Schmidt and Mansoury, 1963).
1.4. Epidemiology
1.4.1. History of epidemics
The first epidemic of WN fever occurred in the summer of 1950 in Israel was 
recognized retrospectively and involved over 500 hospitalized patients. Subsequent 
epidemics were recorded each year from 1951 to 1954 and in 1957. All these 
epidemics occurred around tel Aviv (Klingberg et a l ,  1959). Another epidemics of 
WN fever was reported from the Camargue (Rhone delta), France in 1962 and cases 
were recorded again in 1963 and 1964 (Panther et a l ,  1968; Rodhain and Hannoun, 
1980). The largest epidemics of Wn fever on record occurred in South Africa in 
1974. This epidemics involved an area of about 2500 km^ in the Karoo and south
Cape Province and resulted in thousands of human infections (McIntosh et al. , 1976). 
A smaller outbreaks appear to have occurred during 1983 to 1984 in Pretoria region 
of South Africa. In area where WN fever is endemic, apparently most infections 
occur in early childhood or produce a mild febrile disease (Taylor et al. 1956).
1.4.2. Host and geographical distribution
Virus isolation and antibody surveys indicate that WN virus can infect a wide 
range of vertebrate species in nature. Virus has been isolated most commonly from 
humans and wild birds but isolates also have been recovered from several other 
species including horses, mules, donkeys, goats, water buffalo, sheep, pigs and cattle 
WN virus has been isolated in at least 17 * covering Asia, Africa and Europe
(Figure 1.1.) (Hayes, 1989).
1.4.3. Transmission cycles
Mosquitoes are the principal vector of WN virus. Studies in Egypt, Israel and 
South Africa, have shown Culex mivittatus as the main species transmitting the virus 
in all three countries (Taylor et a l ,  1953; Nir et a l ,  1968; McIntosh and Jupp,
1982). The importance of Culex univittatus as the epidemic vector was shown by the 
very high infection rate found during the 1974 outbreaks in South Africa (McIntosh 
et a l ,  1976). In southwestern Asia, the Culex vishnui complex has been implicated 
as vectors of WN virus. Other than mosquitoes, wild birds are considered to the
1 0
Figure 1.1. Geogrraphical distribution of West Nile virus
In shaded areas West Nile virus is documented.
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second important vector in the transmission cycle of WN virus. Out of 13 different 
species of birds examined in the Egyptian Nile Delta during the year 1950 antibodies 
to WN virus were found in 11 species (Taylor et a l ,  1956). Similar situations were 
also recorded in South Africa, Israel and Pakistan (Hayes, 1989). Many species of 
wild birds are migratory, thus the potential for wide-spread geographic distribution 
of WN virus by this route exists (Hoogstraal et a l ,  1961).
1.4.4. Pathogenesis
Neurotropism and neuromorphic disease expression is a biological common 
denominator linking the flaviviruses. In a natural host, WN virus is usually associated 
with generalized infection and fever and very occasionally causes a neurological 
disease. WN virus is neurotropic in laboratory rodents used for laboratory studies 
(i.e. mice) and even the arthropod vector where the brain and ganglia are major site 
of virus replication.
Flaviviruses produce a wide spectrum of infection and disease, depending on 
the virus-host pairing, virus dose, and multiple factors that influence the host response 
to infection (Figure 1.2.) (Nathanson, 1980). Three patterns of pathogenesis have 
been identified: 1 ) fatal encephalitis usually preceded by early viraemia and extensive 
extraneural replication; 2 ) subclinical encephalitis usually preceded by low viraemia, 
late establishment of brain infection and clearance with minimal destruction of the 
central nervous sytem and 3) inapparent infection, with trace viraemia, limited 
extraneural replication and no neuroinvasion (Monath, 1986).
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In general, neonatal or young animals are more susceptible to lethal 
encephalitis than the older animals (Grossberg and Scherer, 1966). This age-related 
pathogenesis has been exemplified in laboratory studies in mice or hamsters. Neonatal 
animals inoculated by a peripheral route are highly susceptible until 3-4 weeks of age, 
when resistance develops (Nathanson, 1980). In distinct contrast to experimental 
animals, humans exposed during infancy or childhood to WN virus usually experience 
inapparent or mild infections and susceptibility to encephalitis increases with 
advancing age, the elderly being most severely affected (Marberg et ah, 1956).
In natural infections or following experimental intradermal or subcutaneous 
inoculations virus first replicates in the inoculation site and lymph nodes that drain 
the site (Albrecht, 1968). Knowledge of the main sites of flavivirus replication outside 
central nervous system (CNS) derives entirely from tissue titration and 
immunoflurescence studies on experimental animals (Harrison et al. , 1982). Principal 
sites are of meso-, endo-, and ectodermal origin, and include smooth and striated 
muscle, connective tissues, lymphoid and reticuloendothelial cells and peripheral 
somatic and autonomic nerves. Correlations are possible between these experimental 
infection models and the pathogenesis of infection in biological and clinical hosts. 
For example, interstitial myocarditis (Albagai and Chaimoff, 1959) and pancreatitis 
(Perelman and Stem, 1974) in humans have been reported to be associated with WN 
virus infection.
In biological hosts involved in transmission cycles, viraemia is the result of 
vascular uptake of virus released from infected cells in extraneural tissues, and is
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sustained at levels sufficient to infect arthropod vectors. In humans infected with WN 
virus viraemia is frequently detected during the acute phase (Monath, 1986). The 
level of viraemia represents a balance among opposing forces of virus uptake into the 
bloodstream, virus clearance and thermal inactivation.
Studies of experimental flavivirus encephalitis in mice have shown a 
relationship between level of viraemia, development of brain infection (Weiner et al. , 
1970) and wide spread or multisite simultaneous appearance of viral antigen in 
nervous tissue (Albrecht, 1960), supporting the concept of haematogenous spread to 
the central nervous system (CNS) (Johson, 1980). The process by which virus 
particles cross the blood-brain barrier remains uncertain. The ability of the virus to 
replicate in vascular endothelial cells suggests that the virus may infect and pass 
across capillaries in the brain parenchyma (Johnson et al. , 1985). The olfactory tract 
has long been recognized as an alternative pathway to the CNS (Peck and Sabin, 
1947).
Pathological changes occurring in the CNS vary with host and virus strain. In 
monkeys experimentally infected with a number of flaviviruses, including WN virus, 
(Nathanson et al., 1966; Hambleton et al., 1983) and in fatal human cases 
(Haymarker and Sabin, 1947; Rosemberg, 1977; Ryes et al, 1981), lesions are 
distributed throughout the brain and most prominent in grey matter of midbrain, 
thalamus, pons, cerebellum and medulla. WN virus encephalitis in horses is 
characterized by a poliomyelitis-like illness with prominent lesions restricted to the 
spinal cord (Guillon et al., 1968).
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1.5. Molecular biology
1.5.1. Morphology and physicochemical properties
WN virion comprises an isometric RNA core of 30-35nm in diameter which 
is surrounded by a lipid bilayer to yield a total diameter of approximately 45nm. The 
outer surface is covered in a projections that are 5-lOnm in length terminating in a 
2nm diameter knob (Murphy, T' SO). The nucleocapsid core contains one copy of a 
positive sense single stranded RNA molecule surrounded by a capsid protein 
(Westaway, 1980).
Chemical analysis of a representative flavivirus, SLE, gave a composition as 
6% RNA, 6 6 % protein, 17% lipid and 9% carbohydrate (Trent and Neave, 1980). 
However, the lipid content of the virus (both lipid type and overall amount) varies 
depending on the cell line used to propagate the virus (Trent and Neave, 1980). 
Infectious particles possess a sedimentation coefficient in sucrose of 175-218 S 
(Boulton and Westaway, 1972) and buoyant densities of 1.22 g/cm^ and 1.18-1.20 
g/cm^ in CsCl and sucrose respectively (Smith et al., 1970). Infectivity of the 
flavivirus virions is most stable in the range pH 7-9 (Brinton, 1986). Virions are also 
sensitive to ultraviolet light, ionic and nonionic detergents, trypsin digestion and 
temperature with a 50% decrease in infectivity following 10 mins at 50^C (Brinton, 
1986; Porterfield et al., 1978).
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1.5.2. Physical structure of the genome
The flavivirus genome is one single stranded positive sense RNA molecule 
(molecular weight [MW] approximately 4x10^) which is infectious and functions as 
a mRNA for the synthesis of both structural and nonstructural proteins (Strauss and 
Strauss, 1977). Flavivirus genomic RNA has a type 1 cap structure at the 5^  end in 
the form of m^Gppp-Amp (Wengler et al. , 1978) and lacks cap-associated and internal 
base methylated adenine residues (Cleaves and Dubin, 1979). Unlike most other 
mRNA species, flavivirus RNA lacks a 3^  poly (A) tract but has a uridylic acid 
(CUOH) instead (Wengler et al., 1978; Wengler and Wengler, 1981; Duebel et al.,
1983).
Data on complete or partial genome sequences of several flaviviruses including 
WN virus are now available (for review, see Chamber et a l., 1990). These have been 
shown one notable general feature of the flavivirus genome organization that there is 
one open reading frame (ORF) of over 10,000 bases. The ORF for WN virus consists 
of 10,290 bases, and 5^  and 3' non-coding regions consist of 96 and 574 bases 
respectively giving a full length genome of 10,960 bases (Wengler and Wengler, 
1989; Wengler et al., 1987; Castle et al., 1987; Castle et a l ,  1986; Castle et al.,
1985).
Several sequence elements and secondary structures have been found in the 
flavivirus genome that could be important for RNA replication, translation, or 
encapsidation. For example, there are nucleotide sequences in common between the
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3' ends of the plus and minus strand of the virus and these sequences are largely 
conserved between WN and YF viruses (Wengler and Wengler, 1981; Rice et al.,
1986). Although the first two 3'- terminal nucleotides and the heptanucleotides appear 
to be highly conserved in WN virus RNA genome, the intervening nucleotides appear 
not to be conserved. Even two strains of WN virus were found to differ by one 
nucleotide in this region (Wengler and Wengler, 1981; Brinton et al. , 1986). A fairly 
stable complex stem and loop structure appears to be located at 3' end of the genomic 
RNA of WN virus (Brinton et al., 1986). A second heptanucleotide sequence located 
on the descending arm of the stem and aligning with the conserved heptanucleotide 
sequence identified by Wengler and Wengler, 1981) appears to be conserved. This 
3' stem and loop structure may be important in regulating the initiation of minus- 
strand RNA synthesis and could also be involved in genome RNA interactions with 
capsid protein.
1.5.3. Gene order
In recent years, nucleotide and protein sequence data for many flaviviruses 
have accumulated to shape the current view of the flavivirus gene order and viral 
protein synthesis (see reviews by Rice et al., 1986; Westaway, 1987; Chambers et 
al., 1990). The order of proteins encoded in the long ORF is: 5^-C-PrM(M)-E-NSl- 
NS2a-NS2b-NS3-NS4a-NS4b-NS5-3^ (see Figure 1.3.). The structural proteins C 
(capsid, the C precursor is called anchored C), M (membrane, the M precursor is 
called PrM), and E (envelope) encoded in the 5^  quarter of the genome and the genes 
for the nonstructural (NS) proteins are located in the remainder. The NS proteins
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include the large, highly conserved proteins N Sl, NS3 and NS5, and the four small 
hydrophobic proteins NS2a, NS2b, NS4a and NS4b.
1.5.4. Viral proteins
i) Structural protein
All flavivirus virions contain three structural proteins, i.e. the capsid (C) 
protein, the membrane (M) protein and the envelope (E) protein (Brinton, 1986). 
Tryptic peptide maps of the three structural proteins of several flaviviruses indicated 
that each was a unique protein (Wright and Wastaway, 1977).
The C protein present in virions is a small (predicted molecular weight 12-14 
kilodaltons, highly positively charged protein (27% Lys + Arg for YF virus), which 
forms the structural component of the nucleocapsid (Rice et al. , 1986). Flavivirus C 
protein sequence homology is low, except the regions, where hydrophobic and 
hydrophillic amino acids are conserved, including a coterminal hydrophobic region. 
These conserved domains may be involved in protein-protein or specific protein-RNA 
interactions, or both, during nucleocapsid assembly and acquisition of the lipoprotein 
envelope (Mandl et al., 1988). The purified C protein elicited no neutralizing 
antibodies in mice but was found to have group reactive antigenic determinants 
(Brinton, 1986).
The PrM protein is a glycoprotein precursor (predicted molecular weight 18-19
2 0
Kd) modified by addition of carbohydrate to the structural protein M. This precursor 
undergoes a delayed cleavage to form M protein, and the N-terminal PrM segment, 
the fate of which is unclear (Chambers et al. , 1990). The M protein is associated with 
the virion envelope, but is not glycosylated with a MW of 7-9 Kd. The role of the M 
protein in flavivirus replication is currently unknown. However, it was postulated that 
a part of the M protein may be exposed on the surface of flavivirus virions and that 
the M protein may interact with the cell surface based on the interference effect 
observed with Banzi virus infections of cells, which were pretreated with purified 
Banzi virus M protein (Lee and Schlormer, 1981). Neutralizing activity can be 
elicited following incubation of purified M protein into mice (Brinton, 1986).
The E protein (predicted MW 53-54 Kd) is the major structural protein of the 
flavivirus virion. The glycosylated forms are found in most, but not all, flaviviruses. 
Notably WN and Kunjin viruses have non-glycosylated E proteins. This protein 
presumably plays a major role in a number of biological activities including virion 
assembly, receptor binding and membrane fusion, and is the major target for 
neutralizing (N) and haemagglutination inhibiting (HAI) antibodies (Brinton, 1986; 
Heinz, 1986; and all references therein). Comparison of deduced E protein amino 
acid sequences reveals areas of striking homology as well as divergence (Mandl et 
a l ,  1988)
ii) Nonstructural proteins
Processing of the flavivirus polyprotein generates (at least) seven nonstructural
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(NS) proteins, whose cleavage sites are conserved amongst all the flaviviruses 
examined to date (Rice and Strauss, 1991). The NSl protein is a glycosylated protein 
(MW 39-41 Kd) and exists as cell-associated, cell-surface and extracellular nonvirion 
forms (Westaway, 1987; Wengler et ah, 1988). The protein includes 12 strictly 
conserved cysteine residues (except DEN-4) in variant glycosylation sites and 
additional regions of high sequence homology (Rice et al., 1986). Flavivirus 
infections elicit antibodies to NSl with complement fixing (CF) activity and the 
secreted form of this protein has been called the soluble complement fixing (SCF) 
antigen (Smith and Wright, 1985). Type specific, complex specific and group-reactive 
epitopes have been identified for NSl protein and appear to play a role in protective 
immunity (Henchal et al., 1987). Active immunization with NSl or passive 
immunization with anti-NSl protein monoclonal antibodies (MAbs) protects animals 
against challenge with homologous flaviviruses (Bray et a l., 1989; Cane et a l., 1988; 
Gould et û/. ,1986)
The NS3 and NS5 proteins are the two largest flavivirus proteins with MW 
of 68-70 and 103-104 Kd respectively. Both proteins are highly conserved among 
flaviviruses and contain no long hydrophobic stretches (Mandl et al., 1989; Rice et 
al., 1986). A role for NS3 in viral RNA replication has been postulated, and recent 
sequence comparisons suggest that it is probably at least bifunctional, containing both 
a protease activity and possibly a nucleotide triphosphatase/helicase activity (Bazan 
et al., 1989; Gorbalenya et al., 1989). Regions of sequence conservation are 
distributed throughout NS5. A highly conserved domain in NS5 contains the sequence 
motif Gly-Asp-Asp, which is present in NS proteins from a number of positive
2 2
stranded RNA viruses and believed to play a role in RNA-dependent RNA synthesis 
(Rice et a l ,  1986). NS2a, NS2b. NS4a and NS4b are four relatively small non- 
glycosylated proteins with deduced MW of 18 Kd, 14 Kd, 31 Kd and 12 Kd 
respectively (Rice et a l ,  1986). These proteins are poorly conserved among 
flaviviruses, but contain similar structural features consisting predominantly of 
multiple hydrophilic domains. The biological functions of these proteins are currently 
unknown.
1.6. Replication
The early events in flavivirus infection are not well characterized and cellular 
receptors for flaviviruses have not been identified. However, studies on the infection 
of macrophages by WN virus suggested that following binding, the primary mode of 
virus entry is by absorptive endocytosis (Gollins and Porterfield, 1985). Acidification 
of the pre-lysosomal vesicles probably triggers fusion of the virion with the vesicle 
membrane giving way to internalization of the genome after uncoating (Gollins and 
Porterfield, 1986). Viral RNA synthesis can be detected at three to six hours post 
infection with the release of infectious virus beginning at approximately 1 2  hours post 
infection (Chambers et û/. ,1990). Although growth kinetics appear similar in 
vertebrate and arthropod cells, maximal titres in different cell types can vary 
considerably (Mussgay et a l ,  1975).
Picomaviruses and flaviviruses share a similar genome organization but the 
proteins are processed in different ways. Flavivirus RNA synthesis occurs in the
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perinuclear region and involves both replicative intermediate and replicative form 
RNA (Cleaves et ah, 1981; Chu and Westaway, 1985; Westaway, 1987). 
Furthermore, when flavivirus RNA is translated in vitro, only the structural proteins 
or multimers of them are detectable (Wengler et ah, 1979; Svitikin et a l ,  1984).
Incoming viral RNA is translated from a single initiation codon which 
generates a long polyprotein. This polyprotein is cleaved co-translationally and post- 
translationally. Translation events take place in the cytoplasm of the cell with recent 
evidence suggesting that the viral RNA/ribosome complex may require translation at 
various sites within the cell before it is translated completely (Stephenson et ah,
1987). Earlier models of replication proposed multiple initiation sites within the 
flavivirus genome for translation control (Westaway, 1977; 1980; Westaway et ah,
1984). However, data obtained following the sequencing of the YF virus genome 
implied a different strategy (Rice et û/. ,1985). Although discrete polyprotein 
precursors are difficult to define, there are a logical and consistent set of cleavage 
sites along the polyprotein (Figure 1.3.). Following initial rapid processing , two 
series of events take place: (1) the proteins C, pre-M, E and NSl are produced 
utilising a number of hydrophobic segments that act as signal sequences for co- 
translational processing and insertion of the protein into the membrane of the 
endoplasmic reticulum (Rice et ah , 1985; Castle et a h , 1985; Wengler et a l., 1985). 
Cleavage of these proteins is believed to utilise a host encoded signalase. Modification 
of E protein takes place in the form of N-linked glycosylation. The remaining NS 
proteins are produced using a cytoplasmic protease of viral or host origin with a 
specificity for double basic amino acids (Rice et ah, 1985; Castle et ah, 1986).
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Because replication takes place in the cytoplasm, capping of the viral RNA is thought 
to be virus coded. Minus stranded RNAs, for the production of genome length mRNA 
are produced at a ratio of 1:10 (Brinton, 1986).
1.7. Control and prevention
No studies on the control and prevention of endemic or epidemic WN fever 
have been published. Because humans are not the main host for WN virus 
transmission, epidemic activity probably will not be recognized until the infection rate 
in mosquito vectors is very high. The most effective control at that time would be a 
rapid reduction in the density of adult mosquitoes by use of insecticide and avoiding 
exposure to vectors. Genetic studies in Pakistan were undertaken to develop a WN 
virus refractory strain of Cr. Tritaeniorhynchus carrying population regulating genes 
that could be used in a field-release trial to reduce or preferably replace wild vector 
populations as a permanent control measure (Hayes et al. , 1984). Preliminary results 
were not promising (Reisen et al., 1980). No vaccine is available for WN virus 
infection although an formalin-inactivated vaccine is under development (Barrett, 
Personal communication)
n. DEFECTIVE INTERFERING PARTICLES
It has been over 40 years since the concept of interference by "incomplete 
virus particles" was suggested (von Magnus, 1947) and over 20 years since a
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conceptual framework on DI virus properties was proposed by Huang and Baltimore 
(1970). During this period a vast amount of literature has accumulated on DI particles 
of different virus systems and many studies have been shown DI particles to have 
properties unique for that virus group. It is beyond the scope of this thesis to review 
all DI particles that have been reported to date. Over forty excellent reviews have 
already been published which could be consulted about the materials that have not 
been mentioned in this review. For background, Table 1.4. shows a list of current 
reviews and those could also be consulted for information and back referencing. In 
this thesis, a review will be presented which will first introduce the general aspects 
of DI viruses followed by a selective survey of current information on various virus 
systems on which DI viruses have been extensively studied. Emphasis will be placed 
on common properties, significant differences and the phenomena that have been 
uncovered in recent times.
1.1. Historical overview
Henle and Henle (1943) first described the "paradoxical" effect of reduced 
infectivity of influenza virus when inoculated at high multiplicity into mice, compared 
with a dilute (1:1000) inoculation. In 1947 von Magnus reported that non-infectious 
virus was generated following the inoculation of an undiluted influenza virus 
inoculation into embryonated chicken eggs by the allantoic route. In 1951 von 
Magnus used the term "incomplete virus" to describe the non-infectious particles 
produced during serial undiluted passages of influenza virus in embryonated chicken 
eggs. Co-infection of eggs with incomplete virus resulted in interference with the
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Table 1.4. R ecent reviews o f  D I particles from various virus groups
Subject Reference
General reviews
Huang and Baltimore, 1970 
Huang, 1973 
Huang, 1977 
Huang, 1988 
Dimmock,1991 
Holland, 1990 
Roux e t ai., 1991 
Barrett and Dimmock, 1986
RNA viruses
Holland etal., 1981 
Lazzarini^/^A 1981 
Perrault, 1981 
Schlesinger, 1988
Alphaviruses Stollar, 1979,1980 Schlesinger and Weiss, 1986
Poliovirus Cole, 1975
Influenza virus
von Magnus, 1954 
Nayak, 1980 
Nayak etal„\9^5 
Nayak eta/,X9%9
Rhabdoviruses
Reichmann and Schnitzlein, 1979 
Huang, 1982 
Holland, 1987
Arenaviruses
Herpesviruses
Pfau,1977 
Frenkel, 1980
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diluted virus (von Magnus, 1954).
In 1959, Bellett and Cooper first demonstrated the interference phenomenon 
for vesicular stomatitis virus (VSV). From 1959 onwards, a number of studies were 
undertaken on the interference activity of VSV and in 1970 Huang and Baltimore 
coined the term "Defective Interfering (DI) Particles". They gave a rational definition 
of DI particles and postulated their role in modulating acute and persistent virus 
infection in nature. Since then, DI particles have been detected in every viral system 
where they have been sought (Holland, 1990).
1.2. General properties of DI particles and glossary
i) General properties
DI particles of different viruses and even different DI particles isolated from 
a single virus preparation, have been shown to be very different in terms of their 
physical and biological properties. However, all DI particles of animal viruses share 
some common properties. Table 1.5. shows the general properties of DI virus. 
Literature on DI particles has used a variety of terms to describe DI virus such as 
non-infectious, von Magnus, autointerfering, incomplete, defective, interfering, 
deleted or immature virus. Many of these terms are used interchangeably and are 
ambiguous. Therefore, this thesis will use the term defective interfering (DI) virus 
particles exclusively. For infectious virus the terms wild type, standard, ts+ , 
complete, parental, normal, non-defective, competent or helper virus have been used.
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In this thesis the term standard (STD virus will be used,
ii) Glossary
There are a few terms that need to be introduced when discussing defective 
interfering virus systems and these are described briefly as follows:
Standard (STD) virus: STD virus mentioned in this thesis is infectious virus.
Defective interfering virus (DI virus) : It has a portion of the STD virus genome 
deleted and is therefore non-infectious. It requires the STD virus for its propagation 
and interferes with the production of STD virus.
Co-infection: Infection of a cell with both DI and STD virus.
DI virus preparations: Preparations of DI virus grown for use in the experiments 
contain significant amount of STD virus (_^10^ to 10^  pfu).
Serial undiluted passage: This refers to the method for generation and propagation 
of Di viruses. The progeney of one passage is used as the inoculum for the next 
passage while maintaining a high moi (50) by the addition of STD virus as necessary.
Interference: Co-infection of cells with DI and STD virus results in the inhibition of 
multiplication of STD virus. Accordingly, the DI virus replicates at the expense of
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STD virus. This interference is specific for the parental (homologous virus) and 
related viruses (heterologous virus).
Generation: This is the initial event which results in the production of DI virus by 
the deletion of part of the parental virus genome.
Amplification: This is the phenomenon by which DI particles increase in a 
population, usually after serial undiluted passage.
Propagation: This is the phenomenon by which pre-formed DI virus is enriched in 
host cells. In this way, host cells which will only replicate STD virus but not DI virus 
are being identified.
3 0
Table 1.5. Properties of DI virus particles
1.Have a genome generated by deletion from the genome of standard virus
2. Use the structural proteins synthesized by standard virus; hence are antigenically 
identical with standard virus
3. Can not replicate unaided (i.e. are defective)', hence standard virus must co-infect 
the same cells to propagate progeny DI virus
4. Reduce the yield of standard virus from the co-infected cells. Thus, DI virus 
interferes with standard virus multiplication
5. During co-infection the absolute amount of DI virus and its amount relative to 
standard virus are amplified.
6 . Require a functional nucleic acid for interference
3 1
1.3. Generation of DI particles
A number of models have been suggested for the generation of DI particles 
based on DI particle structure. Leppert et al. (1977) and Haung (1977) have proposed 
a "template switching" and a "copy-back" model for DI virus generation in negative 
stranded RNA viruses. Similarly, Nayak et al. (1985) have proposed a "rolling 
polymerase" model for DI influenza virus. While the exact mechanism involved in 
the generation of DI RNA virus has yet to be determined, these two models are 
discussed below (Figure 1.4):
a) Jumping polymerase model: This model, described by Perrault (1981), was 
based on the copy-back model proposed by Huang (1977) and Leppert et al. (1977). 
The basis of this model is that the polymerase detaches from the template whilst the 
nascent strand is still attached, and resumes synthesis at another site on the original 
template or another template. It is the site of resumption of synthesis that determines 
the type of DI particle produced. The detachment/reattachment can occur a number 
of times during the synthesis of a single strand, resulting the formation of simple and 
multiple deletions, or complex internal rearrangements. This model results in the 
production of a large pool of varied molecules (Figure 1.4. A).
b) Rolling polymerase model: This model for DI RNA synthesis involves the 
looping out of the template. In this model, the polymerase does not completely detach 
from the template but rather "rolls" on to a downstream segment of the template 
brought into juxtaposition by the looping out. This model is supported by the flexible
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nature of RNA, and it is possible that transient secondary structures created by 
interaction of the ribonucleoprotein and/or polymerase leads to looping out event. 
This model is proposed on the basis of the structural features of DI influenza virus 
(Nayak et ah, 1985) (Figure 1.4. B).
Generation, amplification and propagation of DI virus is found to be 
quantitatively and sometimes qualitatively dependent on the host cell in the sense that 
ease of generation varies between different cell lines. Different DI genome sequences 
are generated in cells of different species (Kang et al. , 1978; Crumpton et al. , 1981) 
and with some viruses HeLa cells fail to generate any DI virus (Holland et al. , 1976; 
Stark and Kennedy, 1978; Philips et al., 1980). How the cell can influence the 
generation of DI virus genomes is not known. One theory based on the above 
mentioned model of DI virus generation suggests that if the replicase does not fall off, 
no DI virus genomes will be produced (Dimmock, 1991). It follows the rational that 
cells which generate no DI virus genomes have an efficient replicase. The replicase 
holoenzyme probably consists of viral replicase proteins in association with cell 
factors, probably proteins that are unique to the host cells. For example, QB 
bactriophage replicase is composed of one pha e-coded polypeptide and three host- 
coded polypeptides (Blumenthal, 1979). Thus, it has been postulated that the same 
viral replicase protein complexed with proteins from different cell types can form a 
replicase holoenzyme which detaches from the template at a rate determined by the 
cell proteins (Dimmock, 1991). Conversely, there are cell lines (those probably have 
absolutely faithful replicase complex) which will not generate or amplify DI genome 
but will propagate them (Stark and Kennedy, 1978).
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Figure 1.4. Mechanisms of generation of DI virus particles
Figure A and B are the proposed models for the 
generation of DI RNAs from STD viral RNAs.
Shown are negative-strand templates with sequence 
regions a, b, etc. and nascent positive-strand DI 
RNAs with complementary sequence region a ,b^  etc. 
The open circles represent the functioning polymerase 
complex. Generation of DI RNAs could equally occur 
during replication of the positive strand template 
(Nayak 1985).
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1.4. Structures of DI genomes
Based on available sequence information, DI RNAs can be placed into the 
following three classes:
a) Internal deletion: These genomes have also been termed 5^  - 3^  (Nayak et 
a l ,  1985) because both 5^  and 3^  terminal sequences are retained. This type of 
deletion is found in DI RNAs derived from both positive and negative sense RNA 
genomes. These DI molecules may also have additional modifications such as 
repeats, rearrangements or simple changes.
b) 5^  Conserved molecules: These molecules retain the 5% but not the 3' 
terminus of the virion (Perrault and Leavitt, 1977). In all cases so far examined, the 
3^  sequences are the inverted complement of the 5^  terminus. Two types of molecules 
have been identified; stem or panhandle type and snap-back type.
c) 3^  Conserved molecules: These molecules retain their 3' but not the 5^  
terminus of the virion genome. The only naturally occurring DI genomes that fall into 
this category are the DI genomes of Sindbis virus (Schlesinger and Weiss, 1986).
1.5. Interference and DI particles
At least three types of virus interference have been described: interference by 
unconditional defective (DI) particles; conditional defective particles (Younger and 
Quaglina, 1976) or non-defective heterotypic interference (Legault et a l ,  1977). 
Huang (1977) summarized the important features of DI virus-mediated interference 
in animal viruses: a) Interference occurs intracellularly and not at the cell surface
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level, b) Interference is strongest against the STD virus from which the DI virus was 
derived, less strong against related viruses, and nonexistent against unrelated viruses
c) Interference by DI particles is not mediated by interferon. Broadly speaking, these 
features of DI virus mediated interference are applicable to almost all viruses so far 
studied. However, a detailed mechanism of DI virus-mediated interference has yet to 
be determined for any virus system. Furthermore, the mechanism of interference may 
be different for different virus groups and even among different DI particles in the 
same group (Perrault, 1981). Host cell type is a major determinant of the biological 
effects of DI particles. DI particles which strongly interfere in one host cell type may 
interfere weakly or not at all in other cell types (Barrett et al., 1981). In some cases 
this is due to poor replication and amplification of the DI particles but in other cell 
types DI particles may replicate well and amplify well, but exert only weak 
interference with STD virus replication (for review, see Holland, 1987; Kang et 
û/. ,1981; Barrett and Dimmock, 1986)
There are at least six molecular mechanisms that have been postulated on the 
basis of DI virus structures (Dimmock, 1991):
i) Interference by DI RNA' genomes which cannot be transcribed into RNA"^: 
These are represented by copy-back VSV DI genomes which lacks the transcriptase 
recognition site in the 3' terminal section of the RNA strand. These DI viruses also 
have the replicative advantage of having the 3' replicase recognition sequence in both 
DI RNA+ and DI RNA ' (Holland, 1990).
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ii) Interference by DI genomes which are centrally deleted, have the 5^  and 3' 
terminus of the virion and can be transcribed (Schlesinger, 1988).
iii) Interference by DI genomes which have a reiterated sequence. This is 
seen in the RNA DI genome of alphaviruses (Schlesinger and Weiss; 1986) and is 
common in DNA DI genomes of polyoma, SV40 and herpesviruses (Brockman, 1977; 
Fried and Griffin, 1977; Vlazny and Frenkel, 1981).
iv) Interference by DI genomes which have a sequence of enhanced affinity 
for replicating enzymes compared to that of the STD virus genome. This may be 
represented in copy-back VSV DI genomes (Holland, 1990).
v) Interference by DI genomes which are encapsidated more efficiently 
(Deuring et al., 1981).
vi) Indirect interference by DI genomes which are efficient inducers of 
interferon (Marcus and Gaccione, 1989).
1.6. Assay systems
With the exception of rhabdoviruses and picomaviruses, DI particles can not 
be physically separated from the STD virus particles. Therefore, DI particle assays 
tend to measure a biological activity of the DI particles. These assays measure the 
reduction in STD virus yield (Kowal and Stollar, 1980) or the ability of DI particles 
to inhibit infectious centre formation (Johnston et a l., 1975; Janda et a l., 1979). The
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latter assay is based on the finding that cells coinfected with STD and DI particles do 
not produce plaques. It therefore allows statistical determination of the concentration 
of biologically active DI virus in a virus preparation and expressed as defective 
interfering units (DIU). A somewhat different method was employed by Barrett et al.
(1981) to estimate numbers of SFV DI particles. Instead of yield reduction, they 
measured suppression of virus-directed [^H]uridine incorporation into RNA of infected 
cells in the presence of actinomycin D. Incorporation of pH] uridine was depressed 
to approximately the low level of uninfected control cells when large number of DI 
particles were added to infected cell monolayers, but with increasing DI virus 
dilution, it increased sigmoidally to the level of STD virus alone controls. Popescu 
et al. (1976) developed a sensitive technique for the assay and isolation of biologically 
active DI particles of lymphocytic choriomeningitis virus which is known as focus- 
forming assay. This assay based on the protection of individual cells by DI virus. 
However, since the generation of DI virus and their interference varies greatly from 
virus to virus depending on the systems used, identification or development of a 
sensitive assay system is essential precursor for any new virus system to be studied 
to enable characterization of the properties of its DI virus.
1.7. DI particles of flaviviruses
Very little work has been done with the DI particles of flaviviruses. Indeed, 
apart from the work with a persistent infection of cultured mammalian cells with IE 
virus reported by Schmaljohn and Blair (1977) and MVE virus reported by Poidinger 
et al. (1991), all of the work on DI flaviviruses has been reported by Brinton and
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various co-workers (1986) and Smith (1981). Their studies have concerned murine 
genetic resistance to flavivirus infection.
1.7.1. Genetic resistance and DI flavivirus
A gene encoding resistance to flavivirus infection has been identified in mice. 
Genetic resistance to flavivirus infection was first reported by Sawyer and Lloyd 
(1931). This work led eventually to the development of an inbred strain of mice 
resistant to flaviviruses, C3H.RV, which is congenic to the susceptible strain C3H/He 
(Groshel and Koprowski, 1965). The resistance is modulated by other factors, 
including age of the host, route of inoculation and relative virulence of the flavivirus 
strain (Sabin, 1952). In all instances, the flavivirus resistance is inherited as a single 
autosomal dominant gene, recently designated the F/v^ gene (Brinton, 1986; Green,
1981). Although the RV gene does not cause complete disruption of flavivirus 
replication, virus titres from mice that possess the allele are 1 0 0 0  to 1 0 ,0 0 0 -fold 
lower than the titre produced during infection in susceptible mice. Resistant mice also 
suffer a much slower, less virulent infection than susceptible mice (Brinton, 1986).
Early work with murine genetic resistance to flavivirus infection revealed that 
mouse embryo fibroblast cell cultures derived from resistant C3H.RV mice produced 
the same levels of interferon as susceptible cell cultures. However, the C3H.RV 
primary cells were more sensitive to the antiviral effect of administered interferon 
compared to susceptible mouse primary cell culture when infected with flavivirus.
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Similar results were obtained in vivo experiments (Hanson et a l ,  1969). However, 
it was later reported by Brinton et al. (1982) and Smith (1981) that interferon does 
not play an important role in the function of the Fl\^ gene.
Brinton Darnell and Koprowski (1974) first suggested the F/v^ gene-mediated 
resistance to flavivirus infection by increasing the amplification of DI particles. This 
conclusion was based on two observations: a) virus preparations obtained by serial 
passage of undiluted culture fluid from primary cell cultures derived from susceptible 
mice resulted in little or no reduction of STD WN virus when co-infected with 
serially passaged virus; b) culture fluid obtained after three serial passages of WN 
virus in resistant cultures interfered well with the multiplication of STD WN virus in 
co-infected cultures. Thus, they concluded that mice resistant to flavivirus infection 
had the potential to generate and amplify interfering virus. Brinton (1982, 1983) 
further analysed the DI mediated resistance of F l^  gene by characterising the RNA 
molecules taken from the primary cell cultures resistant mice. The author reported 
that virus progeny produced by C3H.RV primary cell cultures contained a major 
population of RNA molecules which were remarkably smaller than the RNA collected 
from the susceptible cell cultures. Four small RNA classes were identified with 
sedimentation coefficients of 8 , 15, 26 and 34S. A preliminary analysis of these 
RNAs by oligonucleotide fingerprinting indicated that the small RNAs were less 
complex than the STD genome RNA, and differed from each other.
A similar conclusion was reached by Smith (1981) who suggested "interfering" 
virus (not defined as DI virus) as being involved in the genetic resistance of mice to
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infection by neurotropic flavivirus Banzi. Smith (1981) found that after intraperitoneal 
inoculation of virus, mice resistant to infection had high levels of interfering virus, 
while a susceptible strain of mice had much lower levels. Surprisingly, interfering 
virus was detected in the spleen and not in the brain, and the amount of interfering 
virus was increased by the presence of cyclophosphamide. On the basis of this results. 
Smith (1981) proposed that interfering virus originated in cells of the 
lymphoreticuloendothelial systems.
1.7.2. Persistence infection and DI flaviviruses
Apart from the above reports, DI flaviviruses have been shown to be 
associated with maintanence of persistent infection in tissue culture. Rabbit kidney 
cells (MA-111) and Vero cells persistently infected with Japanese encephalitis (JE) 
virus continue to produce low levels of infectious virus (Schmaljohn and Blair, 1977). 
Determination of ratios of extracellular physical particles to extracellular infectious 
virus paticles indicated that DI particles were produced by these cultures. Also 
particles from persistently infected cultures interfered with replication of wild-type 
JE virus. In this experiments, the degree of reduction of STD virus yield was 
proportional to the quantity of virus from persistently infected culture added.
WN virus produced by long-term persistenly infected cultures was no longer 
able to plaque on BHK cells (Brinton, 1982). Also, temperature sensitive mutants and 
a replication-efficient mutant of WN virus were isolated from the persistently infected 
cell-cuture fluids (Brinton, 1981, 1982; Brinton et a l ,  1985). Analysis of the WN
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virus progeny collected from the persistently infected cell culture indicated that these 
cultures simulatenously replicated several different mutant virus populations (Brinton, 
1986). Interference with wild-type WN virus was demonstrated with virus produced 
by murine embryo fibroblast cutures persistenly infected with WN virus (Brinton,
1982).
More recently, Poidinger et al. (1991) established a peristent infection in Vero 
cells with Murray Vally encephalitis (MVE) virus and culture fluids collected from 
the persistently infected cells interfered with ho' ologous and heterologous flaviviruses 
but not with unrelated viruses suggsting that DI MVE virus was generated during the 
persistent infection and it has the ability to interfere with homologous and 
serologically related flaviviruses.
Although persistence of flaviviruses in experimental animals has been 
demonstrated none of the reports have claimed that DI virus was associated with these 
persistent infection (for review, see Brinton, 1986). Persistence of tick-borne
f f  Yrxc'j be f v'-i! v- w -i r
encephalitis virus has been observed more oftenj[^(Price, 1966; Zlotnik et al. , 1976; 
Fokina et al., 1982). When animals were sacrificed, virus was isolated from the 
brains and other tissues of the paralysed mice and serum neutralizing antibody could 
not be detected.
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1.8. Animal studies with DI particles
1.8.1. History
DI particles have been extensively studied in vitro whereas their ability to 
modulate viral infections in experimental animal models has also been documented 
but has involved comparatively fewer studies (Barrett and Dimmock, 1986). Some of 
the earliest work on DI influenza virus by von Magnus described the role of 
"incomplete virus" of the A/PR 8  (HINI) strain in ovo and in mice (von Magnus, 
1951). von Magnus experiments in mice demonstrated that diluted "incomplete virus" 
resulted in paralysis and death of mice by intranasal route of inoculation whereas 
using the same route of inoculation, undiluted "incomplete virus" did not cause any 
paralysis or death and the mice survived.
The idea that DI particles could play a role in the expression of naturally viral 
diseases was postulated by Huang and Baltimore (1970), who proposed that DI 
viruses reduced the virulence of acute infections and helped to establish and maintain 
persistent infections. The early studies in vitro on which this hypothesis was based 
have been amply confirmed, but the relevance of this body of work to the more 
complex in vivo situation is still unclear. The speculation that DI virus can be used 
as antiviral or prophylactic agents has been proved in experimental animals with DI 
viruses but there is still no definitive confirmation of there presence and involvement 
in natural diseases of humans and animals. The modulation of infections by DI 
particles in vivo has been reported for a number of viruses and these are described
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below.
1.8.2. Vesicular stomatitis virus (VSV)
Experiments by Doyle and Holland (1973) and Holland and Doyle (1973) first 
showed that purified DI virus derived from VSV could prevent the lethal encephalitis 
in young adult mice caused by intracerebral (i.e.) inoculation of STD VSV virus. 
They found that a large quantities of DI particles (5x10*^ were required to prevent 
death and that this was sufficient to protect death against only low doses ( 1 0 0  pfu) of 
STD virus. With higher doses of STD virus DI virus can only delay the time of 
death. However, the most important observation from these experiments was that the 
otherwise rapidly fatal disease was converted to a more slow progressive infection 
with wasting, hind limb paralysis and death between 7-9 days post infection. Doyle 
and Holland demonstrated that DI virus reduced the multiplication of STD virus in 
the brain but failed to detect DI virus in DI virus-treated mice. Holland and Villarreal 
(1975) extended that the above study to newborn mice and were able to show that DI 
VSV did multiply in the brains of the younger animals. This group concluded that the 
survival of mice after an otherwise lethal dose of STD VSV was due to interference 
mediated by DI virus and distinguished this effect from the presumably 
immunological protection conferred by the administration of DI particles 10 days 
prior to STD virus challenge.
Rabinowitz et al. (1977) used VSV to confirm and extend the studies of 
Holland and co-workers. They followed the i.e. inoculation of 3 to 4 week old mice
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with DI and STD VSV virus and observed a slowly progressive disease of the CNS 
which differed in a number of pathological aspects from that induced by the STD 
VSV alone. Jones and Holland (1980) and Fultz et al. (1982a) demonstrated that 
biologically active DI virus but not UV-inactivated DI or UV-inactivated STD virus, 
protected mice against challenge by STD VSV virus. Hence protection was not due 
to an immune response to virus coat protein and the earlier observation was 
confirmed. However, Crick and Brown (1977) concluded that protection against STD 
VSV virus could be the result of some non-specific host defence response since 
heterologous interference was also observed. These contradictory views could be 
explained by the different preparations of DI virus used.
In comparison to the above studies of infections of central nervous system, 
Fultz et al. (1982a) have reported on VSV infection of Syrian hamsters after 
intraperitoneal (i.p.) inoculation. This route results in pathology of the 
lymphoreticular system with little or no involvement of the CNS. None the less, 
inoculation with biologically active DI VSV protected hamsters against the lethal STD 
virus infection. In contrast to the studies using the i.e. route of inoculation, much 
smaller numbers of DI particles were required to achieve a significant effect. 
Protection resulted in low levels of STD virus in the serum and tissues.. Fultz et al. 
suggested that protection is not only mediated by the interfering ability of DI virus 
but that other factors such as interferon are involved. This results also show the effect 
of DI virus in vivo by different routes of inoculation.
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1.8.3. Rabies vims
Undiluted passages of rabies virus in eggs was found to be apathogenic by the 
i.e. route of inoculation in young adult mice, while dilutions of this virus preparations 
were lethal suggesting that DI rabies virus also has the ability to modulate the lethal 
STD rabies virus infection (Koprowski, 1954). This early observation was confirmed 
by studies upon similar rabies virus preparations (Wiktor et a l ,  1977). However, 
since the latter studies did not have proper controls for the immunogenic effects of 
DI virus, it is uncertain whether or not protection was the result of intrinsic 
interference. Other workers have questioned the relationship between DI virus and 
virulence since Wunner and Clark (1980) found no correlation between virulence of 
different strains of rabies virus and their ability to generate DI virus.
1.8.4. Semliki Forest vims (SFV)
Several studies have demonstrated the protective effect of DI SFV in 
experimental animals. Dimmock and Kennedy (1978) observed that co-inoculation of 
DI and STD SFV by the intranasal route resulted in protection of mice from the lethal 
encephalitis caused by the virulent strain of SFV. Administration of an equivalent 
amount of UV-inactivated STD virus to that of DI virus had no effect on the progress 
or outcome of infection. Mice given DI virus either survived infection without 
showing any clinical signs of STD virus infection or died following the normal pattern 
of SFV disease. Simultaneous inoculation of the DI virus and the STD virus was 
necessary for optimum protection. Inoculation with DI virus two hours (h) before
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infection also gave protection, but inoculation two h after infection had no effect. DI 
SFV reduced the multiplication of STD SFV in the brain by a least ICf’-fold, and DI 
virus was detected in the brain after amplification in tissue culture. Protection was not 
due to the induction of interferon or stimulation of the host immune responses.
Later studies also proved the specificity of protection, as DI SFV did not 
protect mice against infection by heterologous viruses (encephalomyocarditis, WN 
virus or Japanese encephalitis (JE) virus or the LIO strain of SFV (Barrett and 
Dimmock, 1986; Barrett and Dimmock, 1984). Thus, protection did not appear to 
involve the induction of non-specific defence response and all the evidence generated 
by DI SFV in vivo suggested that the protection of the mice was due to the interfering 
properties of DI SFV. Further studies by Crouch et al. (1982) and Barrett and 
Dimmock (1984) have shown that the brains of protected mice have no pathological 
or histological lesions nor any evidence of immune cell infiltration which was 
consistent with the suggestion that DI SFV protects mice by interference rather than 
by stimulation of the host’s immune process.
Other studies on DI SFV virus in mice demonstrated that DI viruses differed 
qualitatively in their biological properties. While some of the of the DI SFV 
preparations protected mice others which had the same interference titre in vitro did 
not (Barrett et al., 1984). Furthermore, DI SFV preparations which protected 
identical numbers of mice differed in the effects they had upon the mouse. Treatment 
with DI SFV p i3 left mice immune to a subsequent lethal challenge with SFV 
whereas mice treated with DI SFV p4 were all susceptible to challenge at 3 weeks
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post infection (Barrett et a l ,  1984). These data are consistent with hypothesis that 
each DI virus passage level contained a mixture of several genetically different DI 
viruses (Kaariainen et a l ,  1981; Barrett et al., 1984).
1.8.5. Influenza virus
After the original work on "incomplete influenza virus" in ovo and in mice by 
von Magnus (1951) and Bemkopf (1950), the next study on DI influenza virus was 
by Holland and Doyle (1973). These workers failed to demonstrate protection of mice 
by DI influenza (HINI) strain A/NWS against a challenge by homologous STD virus 
although onset of clinical signs of infection and reduced infectivity titres in lungs 
were observed. However, Gamboa et al. (1976) demonstrated that inoculation of DI 
WSN together with A/WSN strain (HINI) of influenza virus by the i.e. route 
protected mice from a lethal infection and virus infectivity was diminished, thus 
confirming the earlier studies by Bemkopf (1950). Similar results were also presented 
by Rabinowitz and Huprikar (1979). However, while most of these studies concluded 
that the interfering activity of DI virus was responsible for the amelioration, 
Rabinowitz and Huprikar (1979) were of the opinion that protection was caused by 
augmented humoral immune responses. However, Dimmock et al. (1986) using the 
same mouse model demonstrated that the lethal pulmonary infection of mice by 
A/WSN influenza virus can be prevented in 80% of mice by active DI virus. DI virus 
treated with beta-propiolactone (BPL), which destroys interfering activity as measured 
in vitro but leaves the haemagglutinin and neuraminidase activities unaffected, was 
the control, and this did not alter the course of infection. However, the surprising
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results of these experiments was that although DI virus prevented death it did not 
decrease the multiplication of STD virus in the lungs, as shown by assay of 
infectivity, total HA antigen and neuroaminidase activity, or distribution of viral 
antigens in lung tissues. Such mice became ill and developed the same type of cellular 
infiltration in the lung as those with the lethal infection, but consolidation was 
delayed, less extensive and resolved in due course. Since the pathology in the mouse 
is immune (T cell) mediated and there was no effect on virus multiplication the 
authors suggested that DI virus appeared to inhibiting the deleterious effect of T cell 
response. This unique way of exerting DI virus affects in mice demonstrates the 
diversities by which DI virus acts in vivo. This issue will be expanded later.
1.8.6. Rift Valley Fever virus
One of the early studies DI virus in experimental animals was demonstrated 
by Rift Valley fever DI virus (Mims 1956). This experiment used a intravenous route 
of inoculation of incomplete Rift Valley fever virus in mice and i.e. inoculation of the 
STD virus. It demonstrated that incomplete virus delayed the incubation period of the 
disease and reduced infectivity titres in mice. The incomplete virus was also shown 
to be capable of immunizing mice since high titres of neutralizing antibody were 
obtained after administration.
1.8.7. Arenaviruses
Welsh et al. (1977) have shown that i.e. inoculation of DI lymphocytic
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choriomeningitis virus (LCMV) prevented death and CNS disease caused by the STD 
virus in 2-day-old rats. The synthesis of STD virus and antigens was reduced, but no 
interferon or host immune responses appear to have been involved in protection. 
Since the disease caused by STD virus is immune-mediated, it was suggested that 
protection correlates with the ability of DI LCMV to inhibit the expression of LCMV 
surface antigens in infected cells (Welsh and Oldstone, 1977). Help and Coto (1980) 
have shown that DI virus was generated in newborn mice infected with another 
arenavirus, Junin, and propose that DI virus is responsible for the delay in death and 
reduced yield of STD virus in co-infected animals. These studies are particularly 
interesting as arenaviruses naturally persistent in their hosts. Popescu and Lehmann- 
Grube (1977) observed that DI virus was present in both acute and persistent 
infections of mice with LCMV.
1.8.8. Reovinis
Spandidos and Graham (1976) demonstrated that the generation, replication 
and in vivo interfering ability of DI reovirus in newborn rats after i.e. and 
subcutaneous inoculation. They claimed that DI virus was generated during the acute 
phase of disease and such DI virus was generated from the Lj segment only. 
Surviving rats were runted and chronically infected, and DI virus present in these 
brains contained virus segments with multiple deletions. All but two of the 
chronically infected rats also contained virus which was identical to that in the 
inoculum. The claim that DI virus was generated de novo is difficult to substantiate 
as it cannot be proved that the inoculum was free of DI virus. Thus, the question of
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in vivo generation of DI virus in this system remains unanswered.
1.8.9. Runde virus
Traavik (1978) has reported persistent infections of mice after intracerebral 
inoculation of the coronavirus Runde virus into suckling mice. It was suggested that 
this persistence was due to DI virus.
1.8.10. Paramyxovirus
Ruttkay-Nedecka et a l  (1986) have used DI Sendai virus in newborn mice as 
a model for the possible role of DI virus of paramyxoviruses in several chronic 
degenerative diseases of the CNS (Ruttkay-Nedecka et al., 1986). The dynamics of 
STD virus multiplication and distribution in CNS of mice infected with STD, DI . 
both virus as well as histological changes and the clinical symptoms were evaluated 
for up to 112 days post infection. In all virus-infected mice, infectious virus could be 
detected . 5 h and day 2 post infection but infectivity titres were low in the mice
treated with DI virus alone or mice treated with DI virus plus STD virus compared 
to mice treated with STD virus alone. The authors suggested that the role of DI virus 
in maintaining a persistent infection even after 3 months post infection was evident.
1.9. Persistent infection
One of the original hypothesis of Huang and Baltimore (1970) was that DI
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viruses were involved in the establishment and maintenance of persistent infections. 
Persistent infections of both tissue culture cells and the whole animal have been 
described for a number of viruses including RNA viruses (Holland et ah, 1980; 
Huang, 1988; Roux et a l ,  1991). For a persistent infection to be established an 
individual host cell or a proportion of the population must survive infection, i.e. there 
is a balance between virus multiplication and death of cells. In tissue culture models 
the cells often undergo through a period of "crisis" where most cells die, but a few 
survive to continue growing. Because DI particles often interfere strongly with 
replication, it can be anticipated that they might frequently exhibit a direct cell- 
sparing effect in addition to indirect protective effects such as induction of interferon 
other cytokines, alteration of immune responses, reduction of early virus yield etc.
VSV DI particles have been shown to establish persistent infections in cell 
culture (Wagner et a l ,  1963; Holland and Villereal, 1974). At high levels of 
interference, DI particles are able to cause the establishment of persistent infections 
in permissive cell line in which viral replication is normally cytocidal. At low levels 
of interference, infectious cycle was merely prolonged with a 6 -8 hour delay of DI 
particle release (Khan and Lazzarini, 1977). DI particles have been shown to co- 
evolve with the STD virus in persistent infections. DI particles isolated at various 
times during the course of a persistent infection always interfered most strongly with 
virus isolated a number of passages prior to that of the DI particles. Virus mutants 
isolated from the later passages showed increasing resistance to interference from 
these early DI particles, however, new DI particles were then generated from the 
mutant genomes, which were able to interfere with STD virus replication (Depolo et
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al. , 1987; Horodyski and Holland, 1980). Similar persistence in cell culture has been 
documented for many viruses including alphaviruses (Schlesinger and Weiss, 1986) 
and influenza virus (Nayak, 1980). During the maintenance of persistent infection 
virus co-evolved and accumulated a variety of mutants such temperature sensitive (ts) 
mutant, or small plaque mutants (O’Hara et al., 1984; Giachetti and Holland, 1988). 
Bangham and Kirkwood (1990) have presented a simple mathematical model to 
explain virus-DI cycling effects on the replication and persistence. This type of 
cycling can derive rapid virus evolution and lead to unpredictable periodic emergence 
of new virus and DI virus genomes (O’Hara et a l., 1984).
The role of DI particles in establishing and maintaining persistent infection 
in vivo was first reported by Spandidos and Graham (1976) who showed that i.e. 
infection of newbron rats with DI and STD reovirus resulted in survival of the rats, 
which then developed a runting syndrome. DI virus was isolated using an 
amplification method from brains of runted rats at 30 days post infection, but its 
interfering properties were not investigated. Popescu and Lehmann-Grube (1977) 
inoculated newborn mice with STD LCMV together with DI LCMV, which resulted 
in the generation and persistence of DI and infectious LCMV. Both were present at 
83 days post infection but defective virus in particular was at a very low level. 
Another study by Welsh et al. (1977) showed that i.e. co-inoculation of 2-day-old rats 
with DI and STD LCMV resulted in protection, but without persistent infection in the 
animal. The isolation of a STD LCMV from persistently infected mice which were 
resistant to interference by DI LCMV can now be explained in the light of the result 
observed in cell culture system that STD virus co-evolved during maintenance of a
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persistent infection (Horodyski and Holland, 1984).
Fultz et al. (1982a) have demonstrated that the acute infection caused by VSV 
in hamsters can become persistent following i.p. inoculation of DI VSV. 
However,persistence could also be initiated by administration of polylrpolyC, and 
may be driven by interferon. Further studies with this system have shown that a 
persistent infection reduced the life expectancy of the hamsters (Fultz et al. , 1984).
SFV is a virus which in mammals becomes persistent only when the host is 
immunologically compromised (Atkins et al. , 1985). However, while the majority of 
mice which survived the lethal dose of virus STD SFV treatment of DI virus were 
free of detectable infectious virus, a minority (16%) contained up to 1 0  ^ pfu/brain. 
These viruses can be plaqued, and they were not temperature sensitive or plaque 
mutants. A particularly surprising observation was that about one-third of these 
isolates were as virulent as the parent virus initially used to inoculate the mice and 
some mice had the equivalent of 1 0 0  LD5 0  virus in the persistently infected brain. 
How the mice survived with such a large amount of virulent virus in their brain is not 
understood (Atkinson et al., 1986).
1.10. Significance of animal studies
Table 1.6. shows that in different virus systems DI virus can alter the normal 
expression of disease resulting in modulation of infection either with complete
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protection or delay in death. The major focus of DI virus work on experimental 
animals has been on the inhibition of STD virus replication and has led to the 
expectation of a direct correlation between the amount of DI virus in an inoculum and 
the degree of attenuation of the disease process. The interaction of DI virus with host 
and infectious virus appear to be more complex; they involve a dynamic fluctuating 
interaction between STD virus and its variants, including DI virus. They also involve 
the interaction of each of the virus populations with non-specific and specific host 
defences. Natural killer cells, interferons and lymphocytes are all implicated to 
respond differentially to the presence of DI virus in a virus population. For example, 
it has been hypothesised that influenza virus interacts with T lymphocytes in such a 
way that a lethal immunopathology results (Morgan and Dimmock, 1992) They 
suggested that DI virus could be acting at two levels: 1) restricting recruitment of T 
cells into the lungs or 2) reducing the immunopathological effects of T cells. The 
overall supression of the activity of the T cells in vivo in the lungs by STD virus as 
measured by their response to mitogen, is reversed by the presence of DI virus to the 
evident benefit of the host. On the other hand, DI SFV or DI VSV modulated the 
STD virus infection in vivo by inhibiting the multiplication of STD virus. Since SFV 
and VSV are neurotropic in mice, it has been suggested that DI virus may play role 
in changing the functions of brain neurotransmittors to cause a pathology and disease 
pattern different from those normally seen with the STD virus (Barrett and Dimmock, 
1986)
Interpretation of some studies is difficult due to the immunogenic load of the 
DI virus used in the inoculum, but other studies have shown that this need not be a
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problem if proper controls are used. It is unfortunate that many of the studies that 
have demonstrated the modulation of STD virus effects in vivo have used the 
i:_. _ . route of inoculation as this route break the blood brain barrier (Mims, 
1964).
The quantités of DI viruses inoculated into anmals to achieve protection 
against STD virus tend to be large. For example, Jones and Holland (1980) quoted 
that approximately 10* DI particles were required to protect against a lethal infection 
caused by i.e. inoculation of 100 pfu virus. This is expected as DI virus is not self- 
replicating, and is required to enter the same cell as STD virus to exert interference. 
What is surprising is that with so many cells available for infection that co-infection 
of cells with DI and STD virus should occur at all.
The DI virus-modulated infection may be more complex than what appears at 
first sight, it seems that DI viruses are not the only variants which can alter the 
pattern of disease: in particular temperature sensitive mutants have also this property 
in vivo (Haspel et a l ,  1975; Clark and Ohanti; 1976). The possibilty that DI viruses 
themselves are also temperature sensitive must also be considered. Serial undiluted 
passages which are used to generate DI virus also results in the accumulation of 
various STD virus mutants including temperature sensitive mutants and Holland et al.
(1982) have reported the evolution of both DI and STD virus during persistent 
infections in tissue culture. These points must all be borne in mind in any discussion 
of modulation of virus infections.
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1.11. DI viruses and natural infections
All viruses examined produce DI particles in cell culture and some of them 
also have been shown to modulate infections in in vivo. However, despite this large 
body of information from cell culture and experimental animal infections, there is still 
no definitive confirmation nor refutation of their presence and involvement in natural 
diseases of humans and animals. This may be because of difficulties in isolating DI 
viruses from natural infections since it has been proved to be difficult to isolate DI 
virus from the experimental infections where they have been deliberately introduced.
Involvement of DI particles in natural infection has been supported by 
Northern blot analysis of RNAs extracted from specimens (faeces and blood) of 
humans suffering from hepatitis A virus (HAV) infections. The presence of 
subgenomic viral RNA molecules was observed (Nuesch et ah, 1989). Interestingly, 
the identification of the deletion end points in these RNAs by RNAase protection 
experiments, is compatible with two of the three deletions identified in RNAs of HAV 
particles grown in vitro and shown to interfere with STD virus replication (Nuesch 
et al., 1989). These HAV DI RNAs have been identified in all HAV-infected cell 
culture systems reported to date. The propensity of most of the in vitro infection 
systems to readily evolve to persistent infections, the extended incubation period of 
HAV in vivo and the detection of DI RNAs in both situations might be related 
phenomena.
Another step forward was the isolation of an influenza virus (influenza
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A/chicken/pennsylvania/1/83) (H5N2) from a natural infection which contained 
primarily defective interfering particles (Chambers and Webster, 1987). In chickens, 
coinoculation of this virus together with the closely related but highly virulent 
influenza A/chicken/Pennsylvania/1370/83 virus results in reduced mortality 
compared to virulent virus infection alone (Bean et ah, 1985). The biological basis 
of this protective effect has also been recently reported (Chambers and Webster, 
1991). Protective activity required ^  100-fold excess input of protecting virus over 
virulent virus, functioned effectively during the first generation of virulent virus 
multiplication, and also functioned against an antigenically heterologous (H7N7) 
virulent influenza virus. Protection was with the complete inhibition of
virulent virus spread to the brain of infected chickens. Plaque purification of this 
virus depleted the DI particles and beta-propiolactone-inacivated virus, had no 
protective effect. These characteristcs are consistent with the hypothesis that 
protection was the result of DI particle-mediated interference with virulent virus 
multiplication within the repiratory tract of the chicken (Chambers and Webster, 
1991).
Rotavirus isolated from two chronically infected immunodefient children have 
an unusual genome structure, which is compatible with their being DI virus (Pedley 
et al. , 1984). Genomic rearrangements found in these rotaviruses were derived from 
several of the eleven segments which comprise the genome of STD rotavirus. 
Although they carried substantial deletions they were unusual in being larger than the 
segment from which they were derived. It appears that regions of the genome have 
repeated several times, as found for example with SFV (Lehtovaara et al. , 1981) and
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Sindbis virus (Monroe and Schlesinger, 1984). Unfortunately, these clinical isolates 
cannot be shown to have interfering activity as they cannot be propagated in tissue 
cuture.
Attenuated viral vaccines have classically been produced by serially passaging 
virus in nonnatural host cells. Recently, attenuated measles vaccine preparations have 
been shown to contain DI paticles and/or subgenomic viral RNAa as well (Calain and 
Roux, 1988; Bellocq et al., 1990). From time to time, it has been suggested that 
measles virus infection is modulated to subacute sclerosing panencephalitis by DI 
particles, however, this is still at the level of speculation (Cemesa and Sordi, 1980).
The possibility that DI viruses exist in nature has been strengthened by recent 
studies with influenza, rota and HAV virus but for an unequivocal conclusion it 
essential to demonstrate that these have the eponymous property of interfemce and 
their biological role in vivo.
6 0
Aims of the thesis
Although a large body of information has accumulated on the biological 
properties of defective interfering (DI) particles of different RNA viruses, very little 
is known about the nature of DI particles of any of the flaviviruses. Therefore, the 
primary aims of this thesis was to generate data on the biological properties of DI 
particles of West Nile (WN) virus, a member of the Flaviviridae, both in vitro and 
in vivo.
Since there is no published assay to measure the interfering activity of DI 
flavivirus, the initial aim of this thesis was to develop a reliable and reproducible 
assay system to measure the interfering activity of DI WN virus in vitro. Then it was 
intended to utilize this assay to charaterize the generation and propagation of DI 
viruses using different strains of standard (STD) WN virus in different cell lines; and 
to characterize the interfering property of the DI viruses against homologous and 
heterologous STD viruses.
Furthermore, it was also intended to use the DI viruses generated in tissue 
culture to modulate the effect of lethal STD WN virus infections in mice. Finally, as 
it has been postulated that DI virus may play role in establishing persistent infection, 
this thesis also aimed to investigate the role DI WN virus to initiate and maintain a 
persistent infection in mice protected by DI WN virus.
6 1
CHAPTER 2 
Materials and Methods
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2.1. Cell culture
2.1.1. Growth and maintenance of cells
All the cell cultures used in this project were obtained from the stock stored 
in liquid nitrogen in the Flavivirus Research Laboratory, University of Surrey, and 
were grown and maintained for various assays including the propagation of viruses. 
The designation and the origin of the cells are shown in Table 2.1.
Cells were grown and maintained in Eagle’s minimal essential medium 
(EMEM, Flow Laboratories, U.K.) supplemented with L-glutamine (2mM, Flow 
Laboratories, U.K.) and nonessential amino acids (ImM, Flow Laboratories, U.K.). 
In addition, the medium was also supplemented with sodium bicarbonate (20mM, 
Flow Laboratories, U.K.), 100 units of penicillin G (Sigma), 0.1 mg/ml streptomycin 
sulphate (Sigma) and 5% (v/v) foetal calf serum (FCS) (Flow Laboratories, U.K.) for 
growth of cells respectively. Cells were incubated at 37®C (except for the C6-36 
which were grown at 28°C) under the condition of 5% carbondioxide (CO2 ).
Cells were sub-cultured by trypsinization of the confluent cell monolayers 
prior to seeding into a fresh tissue culture flask (Nunc). Trypsin was prepared with 
2.5% (w/v) Hanks salts (Flow Laboratories, U.K.) and 0.05% (w/v) EDTA in 
phosphate buffer saline (PBS). Cells were normally amplified at a split ratio of 1:5. 
The mosquito cells C6-36 were sub-cultured and amplified by trituration to remove 
the cells from the surface of tissue culture flask prior to seeding into a new tissue
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Table 2.1 D esignation  o f  cell cultures used in the present project
Cell cultures Abbreviations Source
African green monkey undifferentiated Vero 
kidney cell line
Flow Laboratories (U.K.)
Rhesus monkey undifferentiated 
kidney cell
LLC-MK2 Flow Laboratories (U.K)
Human adenocarcinoma cell line SW13 Flow Laboratories (U.K)
Human cervical carcinoma cell line HeLa Flow Laboratories (U.K.)
A edesalbopictus larvae cell line C6-36 CAMR, Porton Down (U.K)
Baby hamsters undifferentiated 
kidney cell line
BHK-21 Flow Laboratories (U.K)
Mouse fibroblast cell line '929 Department of Biological 
Sciences, University of 
Warwick, U.K
(A
culture flask.
2.1.2. Storage and preservation of cells
Sub-confluent (80-90%) cell monolayers were detached from tissue culture 
flasks following the same procedure adopted in the cell sub-culture. Cells were 
pelleted at 2000 revolution per minute (rpm) for 5 minutes (mins) and then 
resuspended in the cell growth medium supplemented with 7.5% dimethyl sulphoxide 
(DMSO, BDH Anal R grade). The cells were aliquoted into liquid nitrogen ampoules 
(Nunc) and stored at -70°C overnight, following this period, the ampoules were stored 
in liquid nitrogen (-196°C).
2.1.3. Resuscitation of preserved cells
When required, ampoules of the desired cell cultures were removed from the 
liquid nitrogen and thawed in a 37°C water bath. The cells were pelleted and the 
supernatant was removed. The cell pellet were resuspended in 1ml of cell growth 
medium and transferred into a tissue culture flask. Flasks were incubated at 37^C in 
a 5 % CO2  atmosphere and grown to confluence before further sub-culture.
2.2. Viruses
The designation, abbreviations and origins of viruses used in this project are 
included in Table 2.2. All viruses were obtained as freeze-dried preparations. These
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Table 2.2
Designation of viruses used in the present project
Viruses
West Nile virus:
EgyptlOl 
Sarawak 
IndiaIG2266 
Smithbum(Uganda) B956
Madagascar
abbreviations ongins
WN
ElOl
S
I
U
M
London School of Hygiene and Tropical 
St. Thomas Hospital, London
CDQFor Collins, U.S. A  
J. S. Porterfield, Oxford
Institute Pasture, France
medicine
Japanese encephalitis-Wild type
Sarawak
G8924
782219
JE London School of Hygiene and Tropical medicine
GDC, Fort Collins, U.S.A.
CDC, Fort Collins, U.S.A.
Japanese encephalitis vaccine strains: 
SA-14-5-3 CDC, Fort Collins, U.S.A.
Murray Valley encephalitis 
strain original
MVE CDC, Fort Collins U.S.A.
Saint Louis Encephalitis virus SLE CDC, Fort Collins, U.S. A
Continued on next page.
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Table 2.2 continued from the previous page
Viruses abbreviations origins
Tick-borne encephalitis:
Turkish tick-borne encephalitis
TBE
TTE J.Stephenson, PHLS, CAMR
LangatTP21 LGT-21 H. Webb, St. Thomas 
Fîospital,UK
Yellow fever virus: YF
17DD Brazil LSTMH
None-vector borne flavivirus:
Dakar bat DB CDC, Fort Collins, U.S. A
Non-flaviviruses 
Semliki Forest virus 
strain TS-H
SFV Depatment of Biological Sciences 
University of Warick
*: Arbovirus Reference Branch, Division of Vector-borne Viral Diseases, 
Centers for Disease Control, Fort Collins, USA
LSTMH: London School of Tropical Medicine and Hygine, London, UK.
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were reconstituted in sterile deionized distilled water and used to prepare seed stocks 
by infection of cell cultures.
Sub-confluent (80-90%) cell monolayers were used to grow all viruses. Before 
infecting with viruses, cell monolayers were washed once with PBS (Oxoid) and 
subsequently the virus inoculum was allowed to absorb to the monolayers for 30 to 
45 minutes at room temperature. Maintenance (EMEM supplemented with 1 % FCS) 
was added to the flask and then incubated at 37®C (except C6-36 cells which were 
incubated at 28°C) under maintenance medium. Viruses were harvested as cell culture 
supernatants when 80-90% cytopathic effect (cpe) was clearly evident. Cell debris 
were removed from the supernatant by centrifugation at 2(XX) rpm for 5 mins. Then 
the supernatant was aliquoted into cryotubes (Nunc) and stored at -7(fC.
2.3. Plaque purification of virus
All standard (STD) viruses used in this project were propagated at a 
multiplicity of infection (moi) 1 to 0.1 plaque forming unit (pfu). In addition, the 
West Nile (WN) virus strain Sarawak was plaque purified by titrating a virus by the 
plaque assay method described in the section 2.4, and individual well isolated plaques 
were selected from the plaque assay plates and picked-up with sterile pasture pipette 
and then suspended in maintenance medium prior to amplification in sub-confluent 
Vero cell monolayers.
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2.4. Virus infectivity titration
Virus infectivities were titrated by plaque assays in either LLC-MK2 or Vero 
cell monolayers seeded in six well tissue culture dishes (Nunc). Ten-fold dilutions of 
virus were prepared in PBS and lOOul samples of appropriate dilutions were 
inoculated onto the cell monolayers which had been previously washed with PBS. 
Following incubation for 30 mins at room temperature the cell monolayers were 
overlaid with 5ml of a mixture of 2% agar (w/v) (Sigma) and double strength 
maintenance medium supplemented with 0.05% DEAE (w/v) (Sigma). After 3-7 days 
incubation (depending upon the type of virus and cells used) at 37^C in 5% CO2  
atmosphere a second overlay of 2 ml of medium as above containing 0.008% (w/v) 
neutral red (Gibco)was added to each of the wells. Following overnight incubation in 
the dark at 37°C, virus plaques were recorded via the use of a light box (Genetic 
Research Instrument) and the virus titre was determined as logio of the amount of 
plaque forming unit (pfu) per ml, i.e.logjo pfu/ml.
2.5. Temperature sensitivity (ts) assay
Virus infectivity was titrated by the plaque assay in Vero cells as described in 
the preceding section at both 37°C and 39.5°C. A virus was determined as 
temperature (ts) if a ^ 2 1 ogio reduction in the virus infectivity titre was observed at 
39.5°C compared to that at 37°C. In addition, the efficiency of plating (e.o.p.) was 
also calculated to determine the relative ability of viruses to replicate at the 
supraoptimal temperature.
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2.6. DI virus preparations
DI virus preparations of isolates of WN virus from Malaysia (Sarawak), India 
(G-2266) and were derived by serial passages at a high moi (50 pfu per cell). 
Monolayer cells were propagated in 80 cm^ tissue culture flask (Nunc) and washed 
with PBS prior to infecting with virus. After 30 to 45 mins incubation at room 
temperature the inoculum was removed, the cells washed with PBS and maintenance 
medium was added before incubating at 37°C (except C6/36 cells which were 
incubated at 28°C) under 5 % CO2  atmosphere. Cell culture supernatant was harvested 
at 48 hours post infection and 5ml of the supernatant was used to infect fresh cell 
monolayers and the remaining supernatant was aliquoted and stored at -l(fC  for the 
determination of virus infectivity and interference activity. STD virus was added as 
and when required to maintain the high moi in each serial passage. DI virus 
preparations are all designated by passage numbers (pi to plO) WN virus strain Egypt 
101 were derived from DI virus p7 generated by Barrett (personal communication).
2.7. Interference assay
The ability of the DI virus (generated by high moi serial passage) to interfere 
with the multiplication of STD virus was determined by an "optimised interference 
assay" (01 A) modified from the yield reduction assay (YRA) described by Barrett et 
al. (1984) for SFV. The detailed methodology will be described in Chapter 3.
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2.8. Preparation of mouse ascitic fluid with monoclonal antibody (MAb)
MAbs already prepared against wild-type strain G8924 (K series) of Japanese 
encephalitis (JE) virus were used in this study (Sil et al., 1992). In order to obtain 
higher concentration of MAb, mouse ascitic fluids were prepared following the 
procedure described below.
An ampoule of the required hybridoma line was removed from the liquid 
nitrogen and thawed rapidly in a water bath at 37®C. The ampoule was then 
centrifuged at 2(XX) rpm for 5 mins to pellet the hybridoma cells. The supernatant 
containing DMSO was removed by pipette and the hybridoma cells resuspended in 
Leibowitz (L-15) medium (Flow-U.K.) supplemented with 10% FCS and placed at 
25cm^ tissue culture flask (Nunc). When confluent growth was observed cells were 
detached from the surface of the flask by agitation and seeded in 175cm^ tissue 
culture flask (Nunc). After this amplification, hybridoma cells were removed from 
the surface of the flask by agitation and collected the cell pellet as described above. 
The cell pellet was resuspended in 1ml of PBS to yield approximately 10* cells per 
ml. Balb/C mice (Olac U.K.) of six weeks old which had been pretreated with 0.5ml 
of pristane (2,6,10,14-tetra methyl pentadecane. Sigma, U.K.) were inoculated 
intraperitoneally with 0.3ml of hybridoma cells. Two to four weeks later the 
peritoneal cavity of the mouse was aspirated for ascitic fluid using a needle and the 
fluid collected in a suitable sterile vessel. The ascitic fluid was centrifuged at 2000 
rpm for 5 mins to remove cell debris and stored at -20°C.
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2.9. Properties of the MAbs used in this project
MAbs used in this project were characterized against various viruses using a 
number of biological assays (Sil et al., 1992). Table 2.3 shows the specificities of 
MAbs.
2.10. Preparation of polyclonal antibody
Polyclonal antibodies against required viruses were prepared in TO female 
outbred white mice (Olac, U.K.). Three to four weeks old mice were inoculated 
intraperitoneally with lOOul of either inactivated (see section 2.10.) or live viruses. 
At 21 days post infection blood samples were collected directly from the heart and 
the red blood cells (RBC) were removed by centrifugation at 20(X) rpm for 5 mins. 
Sera were collected and stored at -20°C prior to use for assays.
2.11.1. Haemagglutination (HA) assay
Gander red blood cells (RBC) (Tissue Culture Services, Slough) and viruses 
harvested from the tissue culture fluids were used in HA assays. HA was performed 
according to Clarke and Casals (1958) and modified for use with plastic disposable 
plates by Sever et al. (1964). The V bottomed 96-well plates (Nunc) were used.
Fifty microlitre (50ul) of viral antigens was diluted in two-fold steps in borate 
buffered saline (50mM boric acid, 120 mM sodium chloride, 0.4% (w/v) bovine
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Table 2.3
Properties of monoclonal antibodies (MAbs) used in the present project
MAbs reactivity pattern
biological activities 
N HÂT
Series K
(immunogt 
virus JE G
en
8924)
K1 group common - +
K2 JEsubgroup common + +
K3 flavivirus intermediate - +
K4 flavivirus intermediate - -
K5 flavivirus intermediate - +
K7 flavivirus intermediate - +
K8 JEsubgroup - +
K9 group common - -
KIO JE type - +
K ll flavivirus intermediate + +
K12 JEsubgroup + +
K13 JE type - +
K14 JEsubgroup - -
K15 JE type + +
K16 group common - +
K17 JEsubgroup - +
K18 group common - -
K19 flavivirus intermediate - -
K20 JE type + +
K21 flavivirus intermediate - -
K23 JEsubgroup - +
K24 flavivirus intermediate - +
K25 group common - +
K26 JE type - +
K27 group common - +
K28 flavivirus intermediate - -
K29 groupcommon - +
K30 JEsubgroup - +
K32 JEsubgroup - -
K33 JE type + -
K36 groupcommon - -
K37 flavivirus intermediate - -
K38 flavivirus intermediate - -
K39 JE type - -
K40 JEsubgroup - +
K41 flavivirus intermediate - +
K42 flavivirus intermediate - +
K43 JE type - +
K44 JEsubgroup - +
K45 flavivirus intermediate - +
N.B. 1) All the MAbs are specifically reactive with the virus E protein.
2) The gamma-globulin concentration in the ascities were used 
between 2 mg and 5 mg per ml.
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albumin, pH 9.0). The standardized gander RBCs (as described in section 2.12.2) 
were diluted 1:220 in the appropriate pH buffer (monobasic [150mM NaCl, 200mM 
monobasic sodium phosphate] and dibasic [150mM NaCl, 200mM dibasic sodium 
phosphate] sodium phosphate solutions mixed in predetermined proportions to produce 
the desired final pH value). Fifty microlitres of the gander RBC suspension was 
added to each virus dilutions, shaken briefly and incubated at room temperature for 
90 mins. The HA titre of the virus was determined as the highest virus dilution at 
which haemagglutination occurred. The amount of virus (in 50ul) at this dilution was 
determined as 1 HA unit (HAU).
2.11.2. Standardization of goose red blood cells
On arrival of goose {Anser cinereus) RBCs in the laboratory they were washed 
three times in dextrose gelatin veronal (DGV) buffer (0.058% [w/v] veronal 
barbitone, 0.038% [w/v] sodium barbitone, 0.06% gelatine, 0.14mM calcium 
chloride, 0.49 mM magnesium chloride, 55.6 mM D-glucose, pH 7.4) and 
centrifuged at 12(X) rpm for 5 mins. After a final wash the RBCs were stored as 8 % 
stock suspension in DGV solution until used. The final concentration of RBC was 
made by suspending the cells to an optical density (OD) of 0.75 as determined using 
a Pye Unicam model PU 2280 spectrophotometer at 490nm.
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2.11.3. Haemagglutination inhibition (HAI) assay
MAI assay was based on the HA assay. Two fold serial dilutions of 25ul of 
antibody was performed in V-bottomed 96-well plates. Four HAU of virus in 25ul 
of borate buffered saline was added to each dilutions of antibody. Then, the plates 
was shaken briefly and incubated for two hours(h) at room temperature. Following 
this, 50ul of gander RBC (in appropriate pH buffer)was added to each well and 
incubated for further 90 mins. HAI titre of antibodies were determined as the 
reciprocal of the highest dilution, which completely inhibited the HA activity of 4 
HAU virus.
2.12. Virus neutralization assay
The test was performed using 100 pfu of virus. The virus infectivity titre was 
determined by the plaque assay method described earlier. Confluent Vero cell 
monolayers were grown in 6 -well tissue culture plates. The virus under study was 
diluted to give 100 pfu per lOOul of PBS and mixed with an equal volume of 1/10 
dilution of antibody (final dilution 1 / 2 0 ) or one of a series of 2 -fold dilution of the 
antibody and incubated at room temperature for 45 mins. Following incubation, 200ul 
of the virus/antibody mixture was pipetted into the cell monolayers grown in 6 -well 
plates which were washed with PBS prior to the inoculation. Both virus and PBS 
control were included in each plate. Following incubation for 30-45 mins at room 
temperature, the wells were overlaid with 5ml of a mixture of 2% Noble agar (Sigma)
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and double strength growth medium as described in plaque assay method. After 
incubation at 37®C for the requisite number of days plaques were visualized by the 
addition of 1 % crystal violet or 2 ml of second overlay medium containing 0.008% 
neutral red as mentioned in the plaque assay method. The neutralization (N) titre of 
the antibody preparation was determined as the reciprocal of the dilution of the serum 
which neutralized 50% of the virus infectivity.
2.13. Inactivation of virus with betapropiolactone (BPL)
Several studies have demonstrated that BPL destroys viral infectivity and 
interference ability of DI virus of a number of viruses by interaction with their 
nucleic acid without affecting the physical and biological properties of their protein 
(Barrett et û/. ,1984; Morgan and Dimmock, 1992; Chambers and Westaway, 1991, 
McLain et a l  1989). In this project BPL-inactivated DI viruses were used in DI- 
mediated mouse protection studies as a control in order to the determine the 
difference between the immunogenic and non-immunogenic protection.
Virus inactivation with BPL (Sigma) was performed following the method 
described by Barrett et al. (1984a). Briefly aliquots of virus were mixed with 0.01 % 
BPL and buffered with 50mM Tris (Sigma) and incubated overnight at room 
temperature. The following day virus samples were stored in -lOPC before being used. 
Each inactivated virus preparation was examined for residual infectivity in a 
plaqueassay toensure that no infectivity was present in the inactivated material.
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2.14. Pathogenicity studies
Female outbred (strain TO) white mice (Olac, U.K.) of 4 to 5 weeks of age 
and weighing 25-30g were used to investigate the pathogenesis of the virus. They 
were diluted in PBS and administered by one of the following two routes: 
intracerebrally (i.e.) by inoculating 2 0 ul of virus preparations into a partially 
anaethesized mouse and by inoculating lOOul of virus dilution intraperitoneally (i.p.). 
The inoculated mice were observed for a period of up to 21 days post infection and 
then average survival time (AST) and pfu/LD^o were calculated using the methods 
shown in the appendix.
2.15. Protection studies
All protection studies with DI WN virus in this thesis were conducted by the 
i.p. route of inoculation. Female outbred TO white mice (Olac, U.K.) of 4 to 5 
weeks of age and weighing 25 to 30g were also used in protection studies. Mice were 
treated with undiluted DI virus preparations unless stated. Challenge dose of STD 
WN virus had the same infectivity titre as that of the DI virus preparations except 
where stated. Control mice were inoculated in exactly the same with BPL-inactivated 
DI virus replacing live DI virus in order to control for possible immunogenic effects 
and to demonstrate that the mere presence of WN virus antigen did not prevent 
infection (see Chapter 5). Other controls received STD virus only or DI virus only. 
Mice were observed for 21 days unless otherwise stated.
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2.16. Brain tissue sampling
When brain tissues were required, mice were killed with ether. Whole brain 
were dissected out and dispersed in viral growth medium by passing tissue through 
a 19 gauge syringe needle and the supernatant was stored at -lOPC.
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CHAPTER 3 
Development of an assay to measure DI WN virus
79
3.1. INTRODUCTION
To date, five types of biological assay have been described for measuring DI 
virus: a) reduction in yield of STD virus (first described for VSV; Bellett and 
Cooper, 1959); b) inhibition of infectious centre formation first reported by Welsh 
et al. (1972) for lymphocytic choriomeningitis virus; c) a focus-forming assay which 
measures the ability of DI virus to allow individual cells to survive and proliferate 
(first described for DI lymphocytic choriomeningitis virus; Popescu et al. , 1976); d) 
a colorimetric assay based on neutral red dye uptake by DI particle-protected cells 
described by Treuhaft (1983) for respiratory syncytial virus and e) RNA synthesis 
inhibition assay based on the ability of DI SFV to inhibit synthesis of virus-specified 
RNAs (Barrett et al., 1981).
A few reports have appeared on the quantitation of DI flavivirus. Studies on 
WN (Brinton-Damell and Koprwaski, 1974) and Banzi (Smith, 1981) viruses have 
only demonstrated that interfering viruses could be preferentially propagated in the 
murine primary cell culture and this charateristic was attributed to murine genetic 
resistance to flaviviruses. The other two studies on IE (Schmaljohn and Blair, 1977) 
and MVE (Poidinger et ah, 1991) viruses have shown that DI virus derived from 
these viruses could contribute to maintenance persistent infection in cell culture. None 
of these studies have optimised any of the available assays to dectect and quantify DI 
viruses nor developed any methods particularly applicable to DI flaviviruses. 
Accordingly, in this chapter, a sensitive, reliable and reproducible assay based on the 
interfering property of DI WN virus has been developed.
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3.2. RESULTS
3.2.1. Interference assay
Many workers have reported that DI virus interferes with the multiplication 
of STD virus. This interference results in the reduction of yield of infectious progeny 
viruses (for review, see Holland, 1987). Accordingly, an assay was developed to 
measure DI WN virus-mediated interference by quantifying the reduction of infectious 
progeny virus. It follows the basic design of a yield reduction assay (YRA) described 
by Bellett and Cooper (1959) which was subsequently adapted by Barrett et al. (1984) 
for SFV. Prior to use of the optimised YRA for DI WN virus the methodology, 
optimisation of various parameters, reproducibility and sensitivity were examined. In 
addition, evidence that interference measured in this assay was indeed due to DI virus 
was also determined.
3.2.2. Methodology
DI virus used was generated by ten high-multiplicity serial passages of STD 
WN virus strain Sarawak in Vero cells and passage (p) 10 was used except where 
otherwise mentioned for the development of the assay. Generation of DI WN virus 
in tissue culture will be described in detail in Chapter 4. The final optimised assay 
procedure is described in Figure 3.1. This will be refered to as the "optimised 
interference assay" (01 A) for DI WN virus.
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3.2.3. Measurement of interference using the optimised interference assay
The quantity of DI virus in a virus preparation was measured on the basis of 
the difference between the yield of infectious progeny virus from cells coinfected with 
DI and STD viruses, and STD virus alone. Figure 3.2. shows that the decrease in 
progeny virus was proportional to the concentration of DI virus. The interference titre 
of DI WN virus is defined as the reciprocal of the dilution which causes a 70% 
reduction in the yield of infectious progeny compared with cultures infected with STD 
virus alone, and expressed in defective interfering units or DIUs. Thus DI WN virus 
strain Sarawak titrated in Figure 3.2. has a titre of 1 in 32 or 10'^°^/250ul (the 
volume of the assay) or 10^  ^DIU/ml.
Assuming that at least one DI particle per cell is necessary to completely 
inhibit STD virus synthesis by that cell, the minimum number of DI particles 
detectable by the assay can be found from the Poisson distribution (see below) since 
infection of a cell by a DI particle is a random event.
P  ( r )  = e - ’^  *  —
r\
Where P(r) = the fraction of cells in the 24-well tissue culture plates receiving r 
DI particles where the average ratio of DI particle: cell, i.e. the moi is m.
Therefore, when there is a 70% reduction in STD virus synthesis P(r)=  0.7 and
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Figure 3.2. The optimised interference assay (OIA) measuring 
the decrease in yield of infectious progeny 
brought about by DI WN virus.
The assay is describedin Figure 3.1.. STD virus control 
represent cultures infected with STD virus only. Error 
bars show + 1  standard error of mean.
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P(r) that cells are not infected by a DI particle is r= o .
Therefore, P(r)= 0.p)= e “ . m°/0 
m = , / .y 5
As a result, on average f ' of the cells must be infected by one DI particle. The 
minimum number of DI particles detectable is . t  /  ^ of cells in a 24-well plate = 
x2xlO\ Therefore the assay will detect a minimum ofÿ } {10  ^DI particles. Hence 
the interference titre calculated from Figure 3.2. is 1(P^ DIU/ml and this represent 
a minimum of 10^  DI particles /ml.
3.2.4. Optimization of the assay
i) Influence of STD virus upon assay
Use of the assay on a routine basis would depend upon the influence of STD 
virus within a given sample. DI virus stocks used in this project regularly contained 
_> lOVml pfu of STD virus. The assay performed using these stocks showed that the 
amount of STD virus present in the DI virus stock although increased the moi by 1 
(moi of 5 due to added STD virus plus moi of 1 due to STD virus present in DI virus 
stock would add-up to maximum moi of 6 ) did not affect the assay.
To determine the effect of the moi of STD virus upon the sensitivity of assay, three 
different moi of STD virus were added in the assay. Table 3.1. shows that maximum 
interference was obtained using a moi of 5, and that interference was reduced 100-
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Table 3.1: Interference titres of DI WN virus(strain Sarawak) 
passage 10 using different multiplicities of infection of STD virus
Multiplicity of Interference
Infection titre*
0.5 0.6
5.0 2.6
50.0 0.3
Interference titres expressed  as log^  ^DIU/ml
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to 200-fold at a mois of 0.5 and 50 respectively, suggesting a competitive nature of 
interference between STD and DI viruses.
ii) Selection of optimum cell type for interference assay
It is known that interference by DI virus is expressed to different extents in 
different cell types (Dimmock, 1991). Interference by DI WN virus was investigated 
using different cell types in order to obtain the most sensitive cell system for the 
assay.
Table 3.2 shows that cell types displayed a gradient of sensitivity to 
interference by DI virus. LLC-MK2 cells gave the highest interference titre while in 
BHK-21 and SW13 cells no detectable interference could be demonstrated. Results 
also showed that cells originated from same species exhibited markedly differing 
sensitivities. For example, the interference titre in HeLa cells was 10' DIU/ml while 
no detectable interference occurred in SW13 cells ahhough both cells are originated 
from human carcinoma cells. Furthermore, Vero and LLC-MK2 cells originated from 
African and Rhesus monkey kidney cells respectively but Vero cells gave an 
interference titre 100-fold less than that in LLC-MK2 cells. Table 3.3. shows a 
selection of characteristics of different cell types studied and there was no apparent 
correlation between the properties of the cells and interference. However, as far as 
sensitivity is concerned, LLC-MK2 cells appeared to be most sensitive cell line to 
measure interference among the cell types examined.
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Table 3.2: Interference titres of DI WN virus strain 
Sarawak passage 10 in Vero cells by the optimum interference 
asay in different cell types$
Cell Line Interference titre *
LLC -MK2 2G
*"929 1.6
HeLa 1.4
Vero 0.6
SW13 <.0.3
BHK-21 < 0.3
Interference titre expressed as log^o DIU/ml
$Assays were performed as described in the methods 
section, except that different cell types were used
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iii) Multiplication of STD virus in different cell types
The ability of different cell types to support the multiplication of STD virus varies 
considerably. Therefore, it was necessary to examine whether or not there was any 
correlation between the above and sensitivity of interference by DI virus. Table 3.4. 
shows that virus grown in cells which had been used for interference assay exhibited
different infectivity titres in the progeny when virus was inoculated at a moi of 1  and  ^ ;
cL* tK'
>' '  i / O T O l  /V ^  t-
harvested when there was 80 to 90% cytopathic effect (cpe).jThe incubation time 
varied from 24 to 48 hours post infection. However, this variation did not correlate 
with the sensitivity of interference suggesting that permissibility of cell types to 
multiply STD virus was not related to supporting interference by the cells.
iv) Interference as a function of time
In an attempt to increase the sensitivity of the assay it was decided to 
determine whether or not there was any effect of addition of DI virus in the assay at 
different times relative to STD virus. Therefore, assays were undertaken in which 
cells were infected with DI virus either 1, 2 or 4 hours (h) after or before infection 
with STD virus; cells were also infected with STD and DI viruses simultaneously 
(Table 3.5.). Maximum interference was observed with simultaneous infection. 
Interference was also observed in cells which were infected with DI virus 1 h before 
or after infection with STD virus. No interference was detected when cells were 
infected with DI virus 2 h before or after STD virus, suggesting that interference was 
an early event in the replication cycle of WN virus.
90
Table 3.4 Multiplication of STD WN virus strain Sarawak in different cell lines 
following inoculation of STD virus at a moi of 1 and harvesting at 24 h post infection
Cell line
Infectivity titre 
(log^^pfu/ml)
Mean of the infectivity 
titre in indiviual cell line
Mean of the infectivity 
titre of all cell lines used
Vero
8.5
8.1
8.6
8.4+ 0.26
LLC-MK2
73
8.0
8.0
7.8 +0.4
BHK-21
&8
83
8.0
8.4+ 0.4
SW13
7.0 
7.5
8.0
7.5+0.5
8.0+0.4
HeLa
15
7.8
82
7.8 +0.35
^ 2 9
8.0
8.5
8.4
8.3+0.26
C6/36
15
8.0
83
7.9+0.4
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Table 3.5: Interference titres of DI WN virus (strain Sarawak) p assage 10 in the OIA 
following addition of DI virus at different times relative to standard hom ologous virus
Addition ofDlvirus Interference titre *
Time (h)
- 4 < 0 . 3
- 2 < 0 . 3
- 1 1.7
2.6
+ 1 0.6
+ 2 < 0 . 3
+  4 < 0 . 3
Assays were performed in LLC-MK2 cells 
* Interference titres expressed as log^^DIU/ml
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3.2.5. Reproducibility of the assay
Interference by a number of DI WN virus preparations were determined by 
the OIA (Figure 3.1. and Debnath et a l ,  1991). Assays using LLC-MK2 cells, the 
same number of cells, DI (DI WN virus strain Sarawak passage [p] 10 derived from 
LLC-MK2 cells) and STD (WN virus strain Sarawak) virus inocula were performed 
so that the reproducibility of the assay could be directly compared. All assays 
generated similar sigmoidal curves demonstrating that magnitudes of reductions in the 
yield of infectious virus progeny and calculated interference titres were similar (data 
not shown). Taking together with other assays performed under same conditions, the 
mean and standard errors of the measurements of these interference titres of DI WN 
virus strain Sarawak plO are shown in Table 3.6. In statistical analyses it is usual to 
look at the standard error (see Appendix), thus the reliability of a sample mean in 
indicating the true mean of the whole population can be described. It is also useful 
to attach confidence limits at a certain level of probability (usually 95%, see 
appendix). Therefore, in Table 3.6. the mean interference titre lies between 232.7 to 
301.9 DIU/ml with a level of confidence of 95%. Thus, the assay proved to 
reproducible.
3.2.6. Verification that the assay measured DI virus
Since several different mechanisms can be responsible for the phenomenon of 
interference, it was necessary to demonstrate that the interference seen in this assay 
was indeed mediated by DI virus rather than some other mechanism.
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Table 3.6 Reproducibility of interference titres of DI WN virus obtained by 
the optimum interference assay
Interference titres (DIU/ml) from eight 
independent experiments
220
225
240
250
276.2
277.8
322
328
Mean of the titres 267.3
Standard deviation 41.3
Standard error of the mean (SEM)
Confidence limit (95%)
+ 14.6 
2327-301.9
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i) Addition of DI virus in the assay after infection with STD virus
In order to determine if interference was intracellular or operated at the level 
of attachment, absorption or penetration, interference between DI virus added 1 h 
before infection with STD virus or simultaneously was compared (see Table 3.5.). 
Simultaneous infection gave higher interference than that obtained by adding DI virus 
1 h before infection with STD virus. Thus, the observed interference was not due to 
interference at the cell surface due to reduced uptake of STD virus into cells because 
of the presence of DI virus.
ii) Evidence that interferon was not involved in the interference
Since STD virus was inoculated at high moi in the assay and generating DI 
virus, induction of interferon which has a non-specific inhibitory effect on virus 
replication can not be ruled-out. It was, therefore, pertinent to show that interference 
demonstrated in this assay was not due to interferon. The possibility that interferon 
was involved in the assay was unlikely for several reasons:
a) The assay was performed in the presence or absence of actinomycin D 
(AMD). AMD has the property of inhibiting the cellular DNA dependent RNA 
synthesis which plays the principal role for inducing interferon. Interference assays 
performed in the presence of AMD (10^^ DIU/ml) did not differ significantly from 
the assays performed in absence of AMD (10^^ DIU/ml.) suggesting that interferon 
was not involved in the interference demonstrated in the assay, b) DI virus used in
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the development of this assay was derived from Vero cells which has been shown to 
be defective of interferon production (Desmyter et al. , 1968). c) An assay conducted 
using the alphavirus SFV as the STD virus demonstrated no interference. This result 
indicated that interference was specific to WN virus. This point will be examined 
further in a later Chapter (Chapter 7).
iii) Evidence that interference was not due to temperature sensitive mutant
It has been shown that temperature sensitive (ts) mutants accumulate during 
serial high-multiplicity passages (Ahmed et al. , 1980) and were reported to be capable 
of interfering with replication of STD virus (Karanen, 1977). It was therefore relevant 
to determine if the interference phenomenon observed was due to ts mutants present 
in the STD virus or STD virus present in the DI virus stocks. Infectivity titration 
(Table 3.7.) shows that both STD virus and the infectious virus present in the DI 
virus preparations exhibited similar plaquing efficiency at 37°C and 39.5°C and ts 
mutants had not been generated during serial passage.
3.2.7. Haemagglutination (HA) activity of seially passaged virus preparations
The HA activity of the STD WN virus used for serial passage was determined 
as 1 HAU/3.9xlO' pfu/ml virus. Subsequently, between passage 1 (pi) and p4 there 
was a deacrease to 1 HAU/1.25x10^ pfu virus (Table 3.8). Thus, the HAUtpfu ratio 
of WN virus strain Sarawak in Vero cells decreased three-fold between pO and p4, 
whereas the infectivity titre decreased 10'  ^ or 16-fold. This would indicate that non-
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Table 3.7 Infectivity titrations o f  W N virus strain Sarawak at different tem perature
Infectivity titre (logopfu/m l)
Efficiency of plaquing
37 C 39.5 C 3 9 .^ C /3 'P c
8.0 7.9 0.8
STD WN virus 7.8 8.2 S ' ^ t c ^ Z I  2.5
strain Sarawak
(grown in Vero cell) 7.8 7.8 i.o
7.0 6.9 0.8
DI WN virus plO 74 73 gg
(derived from
Vero cells) 73 73 g.8
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Table 3.8. H A  activities and infectivity titres o f  the STD  and D I W N  virus strain Sarawak
derived from V ero cells
Passage no. logj)fu/ml log^^pfu/lHAU
0* 85
1 7.0
4.6
4.6
2 8.3 4.1
3 7.9 4.1
4 to 10 7.3 to 7.0 :^4.1
"Passage 0 is the STD WN virus strain Sarawak used for high-multiplicity serial passages
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infectious virus with HA activity was present in the WN virus p4 preparation.
3.3. DISCUSSION
Results presented in this chapter have described the development of an assay 
which can reliably measure the interference property of DI WN virus. Although 
various assays have been developed for different viruses to study the biological 
activities of their DI viruses (Holland, 1987), variability between viruses and the 
assays precluded the opportunity to use one standard assay for studying DI viruses of 
all virus systems. Therefore, any attempt to study the biological activities of DI virus 
for a new virus system, it is quite justifiable to develop or identify a sensitive assay 
system that will measure the biological property of DI virus (interference) derived 
from that virus system. Since no such information has been available for DI WN 
virus, an optimised assay was developed to measure the interference property of DI 
WN virus which was refered to as the "optimised interference assay" (OIA).
The assay followed the basic design of YRA described by Bellett and Cooper 
(1959) who measured biological activity of DI VSV and employed Poisson 
distribution analysis of the decrease in virus yields with increasing DI virus input to 
show an all-or-none effect on virus yields. This approach, or variations of it , have 
been employed extensively in a number of virus-cell systems to measure biologically 
active DI virus in sensitive cells (Kowal and Stollar, 1980; Fuller and Marcus, 1980; 
Treuhaft and Beem, 1982; Barrett et a l ,  (1984). This assay developed for DI WN
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virus is a variation of the original YRA. It has been shown that the assay is simple, 
sensitive and reproducible.
Various experiments have shown that the interference measured has the 
property of DI virus interference as described in Chapter 1 and the possibility that it 
was caused by some other form of interference have been excluded. The assay has 
been optimised by examining various parameters. Since the assay measures 
interference, it detects only biologically active DI virus rather than physical particles. 
The sensitivity of the assay has been improved by modifying the moi of STD virus, 
time of addition of DI virus and using the most sensitive cell line to measure 
interference. However, its sensitivity is limited by the number of cells on the tissue 
culture plates, since the number of DI particles is calculated from the proportion of 
cells that do not yield STD virus. The calculation also makes the assumption that one 
DI particle causes the cell to be resistant to superinfection with STD virus. Therefore, 
the minimum number of DI particles that can be detected by this assay is 1.4x10^ DI 
particles. As far as sensitivity is concerned, this assay can be favourably compared 
with the focus-forming assay (Popescu et al. , 1976) and optimised YRA of Barrett 
et al. (1984).
Figure 3.2. shows a sigmoidal relationship between serial dilutions of DI virus 
preparations and the yield of infectious virus progeny in the assay demonstrating that 
increasing the input moi of DI virus led to a progressive decrease in yield of 
infectious progeny virus. At a high concentration of DI virus, yield of infectious virus 
was reduced by 95 to 99% indicating that an "all-or-none effect" of DI virus is
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operative involving STD virus and their homologous DI virus. The same response has 
been reported for DI SFV (Barrett et al. , 1981), influenza virus (McLain et al. , 1988) 
and VSV (Sehellick and Marcus, 1980).
Interference by DI particles of WN virus was also found dependent on the moi 
of STD virus used in the assay and the time of addition of DI virus relative to STD 
virus. A moi of 5 pfu of STD virus provided optimum interference in the assay and 
interference was greatly reduced either by increasing or decreasing the moi of STD 
virus. This is presumably due to a moi of 4 of STD virus needed to infect every cell 
in the culture (by Posion distribution). Thus, lowereing the moi of STD virus will 
mean that all cells are not co-infected and so DI virus can not replicate whereas a 
high moi of STD virus will result in STD virus out-competing DI virus during 
replication. The growth of virus inoculated at very low multiplicity is a two-step 
process. In the first cycle, only a very small fraction of cells are infected with STD 
virus and few cells will be co-infected with DI and STD viruses. Consequently, 
interference at single cell level is likely to be minimal. On the other hand, a higher 
multiplicity of STD (moi 5) relative to DI virus would likely to favour enrichment of 
DI virus. Evidence that very greatly increased numbers of STD virus (moi 50) over 
DI virus could reverse the DI particle-mediated interference (Haung and Wagner, 
1966) supports the suggestion that in the process of interference the mois of both DI 
and STD virus are critical factors for successful interference. Similarly, infection of 
cells with DI and STD viruses simultaneously, or infection with DI virus 1 h before 
or after STD virus induced interference. This suggests that the induction of 
interference occurs at an early stage in the replication cycle of WN virus and does not
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take place at cell surface, in agreement with the observations of Huang and Wagner 
(1966) and Johnston et al. (1974). Also, use of the alphavirus SFV as the STD virus 
showed that STD WN virus was required for interference. Similarly, HA assays 
showed that DI virus preparations contain non-infectious HA acivity. Thus, the acivity 
generated during serial undiluted passage fits the criteria of being DI particles.
LLC-MK2 cells were found to be the most effective cell line examined for 
assaying interference mediated by DI WN viruses. Recent data (Poidinger et al., 
1991) on low level interference by DI particles of MVE virus may also be attributed 
to cell factors associated with measuring interference because Vero cells were used 
to assay interference. In this study, low level interference has been also observed in 
Vero cells; this was nearly 100-fold less than that detected when LLC-MK2 cells 
were used in the OIA (Table 3.4.).
Identification of a cell type which can readily show the interference activity 
of DI virus would have great value in understanding the role of DI virus in flavivirus 
pathogenesis and to use DI particles as a tool for the study of flavivirus RNA 
replication. In this part of the study, it has been shown that a large quantity of DI 
particles can be measured by this assay using LLC-MK2. Barrett et al. (1981) 
reported that interference by SFV DI particles varies depending upon the host cell 
line used for assay. VSV DI particles are neither generated nor propagated in HeLa 
cells but demonstrated interference when assay was performed in this cell line 
(Holland et a l., 1976). In this study it has been shown that HeLa cells would support 
DI WN virus-mediated interference. Thus the host cell variations observed for
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interference with this flavivirus in this study were different to those in the other virus 
systems, but supported the general proposition that DI virus replication or interference 
or both vary greatly depending upon the host cell type used.
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CHAPTER 4
Generation and characterization of defective interfering particles of WN virus in 
cell culture.
1 0 4
4.1. INTRODUCTION
STD virus repeatedly passaged at high multiplicity enriches DI particles which 
interfere with viral replication. Whilst this property of DI particles has been 
demonstrated for almost all virus systems examined (Perrault, 1981; Roux et a l ,  
1991; Dimmock, 1991), factors affecting their generation, amplification, propagation 
and interfering properties appear to be diverse. Several parameters contribute to these 
DI particle-associated events.
The effects of the host cell on the generation and propagation of DI virus 
during repeated passage of virus was first documented by Choppin (1969) using 
influenza virus. They demonstrated that the von Magnus phenomenon (as discussed 
in chapter 1) occurred in Madin-Darby bovine kidney (MDBK) cells to a much lower 
degree than in other cells. Subsequently, a number of different cell lines have been 
shown to influence the type of DI particle generated and propagated (Huang and 
Baltimore, 1970; Kang and Allen, 1978; Stark and Kennedy, 1978; Barrett et a l ,  
1981; Holland, 1987). In one particular case, one dominant host gene has been shown 
to favour a high degree of interference by WN virus DI particles (Brinton-Damell and 
Koprowski, 1974).
In addition to the influence of the host cell, other parameters that have been 
shown to be important for DI virus generation including interactions between DI virus 
and STD virus and also the strain of virus studied (McClure et a l , 1980; Barrett et 
a l ,  1984). Therefore, any attempt to characterise the DI particle of a new virus
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system involves charaterization of different parameters that may influence the 
generation and propagation of DI virus.
Although a substantial amount of information on DI particles of different 
positive and negative-sense RNA viruses has accumulated over recent years, relatively 
little is known about DI particles of flaviviruses. Several reports have described the 
induction of homologous interference by DI particles of the flaviviruses WN (Brinton- 
Damell and Koprwaski, 1974, Brinton, 1981,1982, 1983) and MVE (Poidinger et al. , 
1991). However, none of these studies have examined the in vitro parameters in any 
detail. Therefore, it was decided to examine the process of WN virus DI particle 
generation and propagation in seven cell lines of different genetic background and 
identify important factors that influence both generation of DI particles and their 
interference abilities.
4.2. EXPERIMENTAL PROTOCOL
4.2.1. High moi serial passage of WN virus strain Sarawak and India in cell 
culture
STD virus stocks of WN virus strains Sarawak and India were prepared from 
the seed stock (Table 2.2.) in Vero cell monolayers at a multiplicity of infection (moi) 
of 0.01-0.1 pfu. STD WN virus strain Sarawak was serially passaged in slightly 
subconfluent Vero and LLC-MK2 cell monolayers at a moi of 50 pfu. Cell culture 
fluid was harvested at 48 hours post infection and 5ml of the cell culture supernatant
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was used as the inoculum for the next serial passage. The remainder of the 
supernatant was aliquoted and stored at -70^C until required. Ten serial passages were 
performed (passages one to 10 [pi to plO]). STD virus was added, as required, 
during serial passage to maintain high moi. The same procedure was followed for 
WN virus strain India except that only LLC-MK2 cells were used for serial passages.
4.2.2. Propagation of DI virus in different cell lines
In order to propagate DI virus in different cell lines, Vero derived plO of WN 
virus strain Sarawak was passaged in Vero, LLC-MK2, L9 2 9 , HeLa, BHK-21, SW13 
and C6/36 cell lines maintaining the high moi.
4.3. RESULTS
4.3.1. Generation and amplification of DI virus by serial passage
4.3.1.1. High-multiplicity serial passage of WN virus strain Sarawak in Vero 
cells
After 10 high moi (50) serial passages of WN virus strain Sarawak in Vero 
cells, individual serially passaged virus preparations were assayed for infectivity and 
interference activities. Table 4.1. shows that there was a 35-fold reduction in 
infectivity after 10 serial passages of virus compared to cultures infected with STD 
virus alone, suggesting that DI virus had been generated. In order to demonstrate
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Table 4 . 1 . 1 nfectivity and interference titres of serially passaged  WN virus 
stran Sarawak in Vero cells
Passage number Infectivity titre* Infectivity reduction+ Interference titre$
0 8.5 0 jcOS
1 7.0 1.5 j^ .3
2 8.3 0.2 0.5
3 7.9 0.6 2.4
4 7.3 1.2 2.4
5 7.5 1.0 0.5
6 7.3 1.2 1.6
7 7.2 1.3 1.3
8 7.4 1.1 1.4
9 7.0 1.5 2.5
10 7.0 1.5 2.6
* Infectivity titre expressed as loq^fu/ml
Kduction in infectivity titre expressed as log pfi
10
$ Interference titre expressed as log  ^DIU/ml
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their interference abilities, the optimised interference assay (OIA) (Figure 3.1) was 
conducted in LLC-MK2 cells with the serially passaged virus preparations. LLC-MK2 
cells were chosen in the OIA on the basis that this particular ce711 line demonstrated 
the highest level of interference among the six cell lines examined (for details, see 
chapter 3). Table 4.1. shows that interference against homologous STD virus could 
be demonstrated as early as after two serial passages of STD virus and the highest 
interference titre of 10^  ^DIU/ml was demonstrated by p9. Although the reduction of 
infectivity after one passage was over 90%, during subsequent passages it did not 
exceed this value. It was also noteworthy that the levels of interference caused by 
different serially passaged virus preparations did not show any significant correlation 
with the reduction in infectivity. Also, a large amount of infectious progeny virus 
(^10^ pfu/ml) was present in almost all serially passaged virus preparations 
suggesting that a large amount of DI virus could be generated in Vero cells without 
a concomitant reduction in infectivity.
4.3.1.2. High-multiplicity serial passages of WN virus stain Sarawak in LLC- 
MK2 cells
Previously (Chapter 3), it was found that LLC-MK2 cells were the best cell 
line for measuring interference among the six cell lines examined. Therefore, WN 
virus strain Sarawak was serially passaged 10 times in LLC-MK2 cells in order to 
examine whether this particular cell line also had greater ability to generate DI virus 
than Vero cells. Table 4.2. shows the infectivity and interference titres of WN virus 
strain Sarawak that had been serially passaged ten times in LLC-MK2 cells. The
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Table 4.2. Infectivity and interference titres of serially passaged  
WN virus strain Sarawak in LLC-MK2 cells
Passage number Infectivity titre* Infectivity reduction+ Interference titre$
0 7.5 0 :<&3
1 6.3 1.2 0.4
2 6.6 0.9 1.7
3 5.5 2..0 0.6
4 5.5 2.0 1.4
5 5.9 1.6 1.4
6 5.6 1.9 1.5
7 4.1 3.4 2.4
8 4.5 3.0 2.5
9 4.1 3.4 2.6
10 4.6 2.9 2.6
* Infectivity titre expressed as log^pfu/ml 
+ Reduction in infectivity expressed as log,pfu/ml 
$ Interference titre expressed as log^ DIU/ml
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progeny virus harvested from LLC-MK2 cells showed that infectivity of the virus 
decreased over 90% after one passage as had been observed in Vero cells (Table 4.1). 
However, 10 passages in LLC-MK2 cells resulted in a 10^^- or 800-fold reduction 
in infectivity. Interference was detected after one serial passage (10® DIU/ml) and 
after 10 passages interference increased to 400 DIU/ml, although there were 
variations both in infectivity and interference between virus preparations derived from 
different passages.
4.3.1.3. Comparison between the process of DI virus generation conducted in 
Vero and LLC-MK2 cells
A comparison between the generation of DI WN virus strain Sarawak in LLC- 
MK2 and Vero cells indicated that while infectivity of the progeny virus harvested 
from these two cell lines demonstrated a significant difference, the interfering abilities 
of serially passaged viruses derived from both cell lines did not show great variation 
(Figure 4.1 and Tables 4.1 and 4.2). For example, while the infectivity of the virus 
progeny decreased over 90% after one passage in either of the cell lines, 10 passages 
in LLC-MK2 cells resulted in a 800-fold reduction in infectivity whereas 10 passages 
in Vero cells only resulted in a 35-fold reduction. Interference was detected after one 
passage in LLC-MK2 cells and after two passages in Vero cells. Although the 
interference titre varied depending upon the passage levels of virus in both the cell 
lines, reduction in infectivities in each passage level were always greater in LLC- 
MK2 cells than Vero cells. The amount of DI virus in both cell lines, as measured 
by the OIA did not show any significant difference. Thus, despite similar quantities
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Figure 4.1. Infectivity and interference patterns in serially passaged 
virus preparations.
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of DI virus, as detected in the OIA, being generated and enriched there was less 
interference with the replication of STD virus in Vero cells.
Figure 4.1. shows the infectivity and interference patterns of serially passaged 
virus preparations derived from LLC-MK2 and Vero cells with WN virus strain 
Sarawak. While both infectivity and interference titres of serially passaged viruses 
derived from the LLC-MK2 cell line demonstrated a "rise and fall" pattern between 
passages, they did not show a classical cyclic pattern (Huang and Palma, 1974) 
whereby a reduction of infectious virus in the progeny could be directly correlated 
with the increase in yield of DI virus, as measured by the OIA. However, it was 
observed that at certain passage levels, where interference titres were higher, there 
was a greater reduction in the quantity of infectivity suggesting that the existence of 
DI and STD viruses in the virus preparation was competitive in nature.
4.3.1.4. Propagation of DI virus in seven different cell lines
Propagation is defined here as the enrichment of DI virus once it has been 
generated. It may be closely related to amplification but is distinct experimentally 
since it can be distinguished from generation by inoculating cells with pre-formed DI 
virus. In this way cell lines could be identified which permit multiplication of STD 
virus but not propagation of DI virus.
In order to propagate DI virus, a constant amount of Vero cell-derived WN 
virus strain Sarawak plO was passaged in seven different cell lines maintaining a moi
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of 50 pfu of STD virus. The progeny virus was assayed for interference by the OIA 
using LLC-MK2 cells. It was found that LLC-MK2 and L9 2 9  cell lines gave maximum 
propagation of DI virus and the greatest reduction in the infectivity of the progeny 
(Table 4.3.). There was no detectable DI virus in the progeny from SW13 cells as 
measured in the OIA, nor any reduction in the infectivity of the progeny. The results 
for BHK-21 cells were noteworthy in that the DI virus was propagated without any 
decrease in the infectivity of the progeny. Interestingly, DI virus was propagated 
efficiently in Vero cells with little reduction of infectivity in the progeny.
4.3.2. High-multiplicity serial passage of WN virus straiu ludia iu LLC-MK2 
cells
In order to determine whether or not different strains of WN virus can 
influence the generation of DI virus, STD WN virus strain India was serially 
passaged ten times in LLC-MK2 cells at a high moi (50). Table 4.4. shows that WN 
virus strain India was more efficient in generating DI virus than the WN virus strain 
Sarawak (Table 4.2). For example, although both WN virus strains Sarawak and India 
demonstrated similar interference after one serial passage, at other passage levels, the 
interference titres varied significantly between the two strains. WN virus strain India 
p2 showed 10°^-fold higher interference than the p2 of WN virus strain Sarawak 
(Tables 4.2 and 4.4). More significantly, interference by serially passaged viruses 
derived from WN virus strain India did not fall below 10^  ^ DIU/ml after two serial 
passages and the highest interference titre demonstrated by plO of WN virus strain 
India, was 10^  "^ DIU/ml. In comparison, the highest interference titre derived from
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Table 4.3: Interference titres of DI WN Sarawak p11 following
propagation of DI WN Sarawak p10 (grown in Vero cells) 
in different cell types $
Cell lines Infectivity titres#
Standard
virus
Passage
11
Infectivity Interference* 
reduction titres
LLC-MK2 7.9 5.8 2.1 2.6
L929 8.1 6.3 1.8 2.6
Vero 8.3 8.1 0.2 2.3
HeLa 7.3 6.5 0.8 2.2
BHK-21 8.3 8.3 2.2
06-36 6.9 6.2 0.7 1.6
SW13 7.0 7.0 <0.3
* Interference titre expressed as logo DIU/ml 
$
A ssays were conducted in LLC-MK2 cells 
Infectivity titre expressed in logic pfu/ml
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Table 4.4. Infectivity and interference titres of serially p assaged  
WN virus strain India in LLC-MK2 cells
Passage number Infectivity titre* Infectivity reduction + Interference titre$
0 8.5 0 :<0.3
1 7.0 1.5 0.6
2 6.7 1.8 2.3
3 6.5 2.0 2.4
4 5.6 2.9 2.4
5 5.7 2.8 2.6
6 5.7 2.8 2.7
7 5.3 3.1 2.8
8 5.8 2.1 3.0
9 5.0 3.5 3.1
10 5.9 2.6 3.4
*lnfectivity titre expressed as log,(pfu/ml 
+ Reduction in infectivity expressed as log^^fu 
$lnterference titre expressed as lo% DIU/ml
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WN virus strain Sarawak in LLC-MK2 cells was l(f   ^DIU/ml at plO. These results 
suggest that genetic make-up of WN virus strain India might have influenced its 
higher ability to generate DI virus.
4.4. DISCUSSION
Little information has been available on DI particles of flaviviruses. The only 
published studies are on WN (Brinton-Damell and Koprowski, 1974; Brinton, 1981, 
1982, 1983), Banzi (Smith, 1981), MVE (Poidinger et al. , 1991) and JE (Schmaljohn 
and Blair, 1977) viruses. These studies have investigated only two specific aspects of 
flavivirus DI particles: generation of DI particles of WN and Banzi viruses had been 
shown to be associated with a resistance gene in the murine host while MVE and JE 
virus DI particles were found to be involved in maintaining persistent infection. None 
of these studies have examined in detail the in vitro parameters involved in generating 
DI particles.
Marked influence of host cells on the generation and/or propagation of DI 
virus has been demonstrated in different virus systems and there is no uniform 
evidence that one single cell line exerted a similar influence on different virus systems 
examined (Holland et a l ,  1976; Stark and kennedy, 1978; Nayak et a l ,  1985). 
Therefore, it was pertinent to examine to what extent the host cell influenced the 
generation and/or propagation of DI WN virus. As is common with many other 
animal viruses, serial passaging of WN virus at a high-multiplicity generated large
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quantities of DI virus, as measured by the OIA, in LLC-MK2 and Vero cells. Their 
appearance could be demonstrated as early as after two serial passages. Such an early 
generation and subsequent amplification of large quantities of DI virus in sensitive 
host cells has also been demonstrated for influenza virus (Janda et a l ,  1979; Nayak 
et a l ,  1985) VSV (Holland et a l ,  1976) and SFV (Stark and Kennedy, 1978). 
Against this general conclusion several other findings associated with the process of 
generation and propagation of DI WN virus have emerged.
First of all, although high-multiplicity serial passages of WN virus strain 
Sarawak generated large quantities of DI virus in both Vero and LLC-MK2 cells 
without showing great variation between two the host cells, significant differences 
between these cell lines were evident when the reduction in infectivity of infectious 
virus was considered. After 10 passages, the reduction in infectivity of WN virus 
strain Sarawak in LLC-MK2 cells was 800-fold in comparison to that of STD virus 
grown alone, whereas in Vero cells the reduction of infectivity was only 35-fold. The 
autointerference phenomenon observed during the process of DI virus generation and 
amplification in other virus systems has shown that as the yield of DI virus increases 
there was a great reduction in the yield of infectious virus (Von Magnus, 1954; 
Choppin et a l , 1969; Huang and Baltimore, 1970; Holland et a l , 1976). In the case 
of the generation of DI WN virus, this phenomenon was not so marked in Vero cells 
as in LLC-MK2 cells. It is also important to remember that Vero cells have shown 
to be poorly sensitive to interference when the OIA was performed in this cell line 
(see chapter 3) whereas LLC-MK2 cells appeared to be the most sensitive cell line 
for measuring interference among the cell lines examined. When this observation was
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extended to the propagation of DI WN virus strain Sarawak in different host cells, a 
similar phenomenon could be demonstrated with BHK-21 cells. That is, although 
BHK-21 cells propagated large quantities of DI virus, they neither showed any 
autointerfering ability nor supported interference when the OIA was performed in 
BHK-21 cells (see chapter 3) suggesting that BHK-21 cells are also a low interfering 
cell line but has the ability to propagate DI WN virus. These results, taken together 
with the findings of cell-sensitivity for the interference assay, suggest that "low 
interference" host cells allow DI virus generation/ amplification to proceed with only 
marginal interference with the replication of STD virus. Two conclusions can be 
drawn from these specific findings: a) low interference by DI WN virus in Vero cells 
compared to high interference by LLC-MK2 cells does not reflect the relative abilities 
of these host cells to generate DI virus, but rather is related to a host effect on 
simultaneous generation of STD and DI WN virus; b) the mechanism commonly 
proposed for interference that there is a competition between DI and STD viruses for 
viral functions (Huang and Mander, 1972; Perrault, 1981; Dimmock, 1991 ) does not 
seem to take place for DI WN virus generated or propagated in Vero and BHK-21 
cells. An alternative mechanism involving a change in relative affinities of RNA 
replicase for DI and virion ribonucleocapsid (RNC) template as affected by host 
factor(s) (Perrault and Holland, 1972; Holland et al., 1976) might take place.
In contrast to the above phenomenon, SW13 cells displayed an unique feature 
which is worthy of note; when DI WN virus was propagated in SW13 cells there was 
no reduction in infectivity nor was it possible to detect any DI virus by the OIA using 
the sensitive LLC-MK2 cell line. In the previous chapter, it has been shown that
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SW13 cells do not support interference when assays were performed in this cell line. 
Thus, SW13 cells would appear to be optimum cell line to propagate STD WN virus 
lacking DI virus. The factor(s) responsible for inhibiting interference or propagation 
of DI virus in this particular cell line is not known. However, the host factor 
controlling DI WN virus replication has been shown in another host system. Brinton- 
Damell and Koprowski (1974) suggested that generation of DI particles of WN vims 
is controlled by a host factor that encodes resistance to flavivims infection.
Variation in infectivity and interference of serially passaged vims preparations 
derived from WN vims strain Sarawak in LLC-MK2 cells (as depicted in Figure 4.1.) 
signifies a process of interaction between STD and DI vimses present in the vims 
preparations since cells must be coinfected with STD vims to propagate DI vims. The 
interpretation could be that whenever the yield of DI vims was sufficient to infect 
most cells, the yield of infectious vims dropped; subsequently there was insufficient 
STD vims to support significant DI particle replication resulting in less DI particles 
and more infectious vims replication. Evidence for such cycling has been observed 
in other vims systems (Kawai et a l , 1975; Grabau and Holland, 1982: Roux and 
Holland, 1980). Often this cycling is not very regular (Kawai et al. , 1975; Palma and 
Huang, 1974) which is consistent with the findings presented here. Recently a simple 
mathematical model has been presented to explain vims-DI cycling effects on 
replication and vims persistence (Bangham and Kirkwood, 1990).
In addition to the influence of host cells on the generation of DI WN vims it 
has been shown that the rate of generation of DI WN vims is also dependent upon the
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strain of the virus. WN virus strain India appears to be more efficient in generating 
DI virus than strain Sarawak (Tables 4.2. and 4.3.). Similar strain variation in 
generating DI particles has also been reported for SFV (Barrett and Dimmock, 1984). 
Simlarly, one out of four isolates of polio virus type 1 examined did not generate 
detectable DI virus in HeLa cells (McClure et al. , 1980). Others have reported that 
single VSV clones have a genetic capacity to regularly generate the same DI virus in 
a given cell type (Kang et a l ,  1978) These findings together with the evidence 
presented here argue that the genetic make-up of a STD virus might also influence 
the generation of DI virus.
In conclusion, host cells that will readily generate and propagate DI WN virus 
have been identified including identification of a cell type (SW13) that will only 
propagate STD virus but not DI virus. The host cell variations observed for 
generation of DI virus and their interference with WN virus in this study were 
different to those in other virus systems, but supported the general proposition that 
DI virus replication, or interference, or both, vary greatly depending upon the host 
cell type used. Barrett et al. (1981) reported that interference by SFV DI particles 
varies depending upon the host cell line used for assay. Stark and Kennedy (1978) 
could not generate demonstrable DI SFV in HeLa cells even after 200 serial passages. 
VSV DI particles are neither generated nor propagated in HeLa cells but 
demonstrated interference when assay was performed in this cell line (Holland et al. , 
1976). In this study it has been shown that HeLa cells will propagate DI particles of 
WN virus. Huang and Baltimore (1970) reported that MDBK cells were much less 
sensitive to VSV autointerference than Chinese hamster ovary cells. DI Sendai virus
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was more readily generated in ovo than in chick embryo lung cells (Kingsbury and 
Portner, 1970). The present study demonstrates that WN virus exhibits various 
degrees of interference in a variety of cell lines. Furthermore, the low level of 
interference in some hosts has been shown to be due to the relative insensitivity of 
STD virus to interference by DI virus in these cells, and not to an inability of these 
hosts to generate DI WN virus. This study also demonstrates that the generation of 
DI WN virus is a complex process involving host cell, STD virus and DI virus 
interaction.
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CHAPTER 5 
Protection of mice by DI WN virus strain Sarawak
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5.1. INTRODUCTION
A large body of information has accumulated on DI particles of different 
viruses, with the majority of studies examining their interfering properties in cell 
culture (Holland, 1987) or their use as a tool to examine the replication mechanism 
of a particular virus system (Perrault, 1981). Relatively few studies have dealt with 
the effect of DI particles in vivo despite the suggestion that DI viruses have the 
potential to act as modulators of infection and disease (Huang and Baltimore, 1970; 
Barrett and Dimmock, 1986; Dimmock, 1991). Some of the earliest work on DI 
particles was performed with "incomplete virus" of A/PR / 8  strain of influenza virus, 
which later appeared to have the same properties as of DI particles, in ovo and in 
mice suggesting that incomplete viruses had protective abilities (Bemkopt, 1950; von 
Magnus, 1951). These early observations have been confirmed with DI particles from 
VSV (Doyle and Holland, 1973; Robinowtiz et ah, 1977; Fultz et a l ,  1982), 
reovirus (Spandidos and Graham, 1976), lymphotypic choriomeningitis virus (Welsh 
et al, 1977), influenza virus (Dimmock et a l., 1986), Sendai virus (Ruttkay-Nedecka 
et al., 1987) and SFV (Barrett et a l., 1984), showing that mice can be protected from 
an acute virus infection by administering respective DI viruses.
While some of these studies suggested that protection was due to interference 
by DI particles (Doyle and Holland, 1973; Barrett and Dimmock, 1984; Dimmock 
and Kennedy, 1978), others concluded that the protection observed was due to 
activation of the host-immune system and not interference by DI VSV (Crick and
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Brown, 1977). In the influenza virus system it has been shown that although DI virus 
prevented death, it did not affect the multiplication of virus in the lungs (Dimmock 
et al. , 1986). Since the pathology in the mouse is immune-mediated and there was no 
effect on virus multiplication, the authors suggested that DI virus appeared to be 
inhibiting the deleterious effect of T cell response. In addition to these contrasting 
views, it has been shown that not all DI viruses are able to protect animals in vivo, 
even though they apparently have strong interference activity in vitro (Jones and 
Holland, 1980: Fultz et al. 1981; Barrett and Dimmock, 1984,1986). This is not 
surprising since the in vitro situation can be manipulated so that the majority of cells 
are co-infected by STD and DI viruses and interference thus can be maximised. In 
vivo, there are a large number of cells present in an animal and the chance of co- 
infection would appear remote, especially following intraperitoneal and intracerebral 
inoculation. However, mice are protected by DI virus and evidence for DI virus- 
mediated interference in vivo has also been demonstrated (Fultz et al., 1982; 
Dimmock and Kennedy, 1978).
In the previous chapter, in vitro generation and characterization of DI WN 
virus was examined. In this chapter, the effects of DI WN virus on an otherwise 
lethal WN virus infection in mice were investigated. The outcome of STD WN virus 
infection in mice was compared with the administration of biologically active DI virus 
and BPL-inactivated DI virus and the factors associated with the DI virus effects in 
mice were identified.
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5.2. RESULTS
5.2.1. Determination of a LDgg of STD WN virus strain Sarawak in mice by the 
intraperitoneal route of inoculation
In order to investigate the modulation of STD WN virus (Sarawak) infection 
in mice by DI WN virus strain Sarawak, it was necessary to determine a LD5 0  of 
STD WN virus strain Sarawak. Although it is known that STD WN virus produced 
neurotropic disease leading to death in adult mice, virulence of STD WN virus varies 
from strain to strain and also depends on the passage history of the virus preparation 
(Hayes, 1988). In the protection experiments presented in this chapter STD WN virus 
strain Sarawak virus was used as a reference virus. Consequently, preliminary 
experiments were carried out to determine the required dose of STD WN virus strain 
Sarawak (in pfu) to kill adult mice (3-4 weeks of age) by the intraperitoneal (i.p.) 
route of inoculation. Following the protocol of the pathogenicity study described in 
Chapter 2, groups of 15 mice were inoculated with 10-fold dilutions of STD WN 
virus strain Sarawak and were observed daily up to 21 days post infection to record 
their health status. The LD 5 0  was calculated according to the procedure described in 
Appendix. From these experiments it was found that 200 pfu of STD WN virus strain 
Sarawak were required to kill 50% of the mice following i.p. inoculation of mice. 
The average survival time (AST) was calculated (see Appendix) to be 10.14^0.5 days.
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5.2.2. Protocol for protection experiments
In the previous chapter (Chapter 4), it has been shown that DI WN virus strain 
Sarawak derived from LLC-MK2 cells had different interference titres depending on 
the passage level in cell culture. Four of these serially passaged virus preparations 
were used in these protection experiments due to their differences in interfering 
abilities in vitro (Table 5.1.). For example, p3 and p6 showed low to moderate 
interference titres as measured by the OIA, while p8 and plO showed a ten-fold 
higher interference titre than DI virus p6. Table 5.1 shows the in vitro properties of 
different DI virus preparations used in the protection experiments. Experiments were 
complicated by the presence of large quantities of STD virus in the DI virus 
preparations (Table 5.1) and the low pfu/LDjo (200 pfu i.p.) of the STD WN virus 
strain Sarawak. This problem was overcome by challenging mice with STD virus of 
the same infectivity titre as that of the DI virus preparations. Also, it was possible 
that the large quantity of WN virus antigen present in the virus preparations might 
contribute to the protective effect of the DI virus preparations. Therefore, preliminary 
experiments were carried out using DI-WN plO virus preparations to determine the 
immunogenic load present in the inoculum used to protect mice. The effect of WN 
virus antigen present in the inoculum was controlled by administering beta- 
propiolactone (BPL)-inactivated DI virus to mice challenged with STD WN virus 
strain Sarawak according to the methods described by Barrett et al. (1984) (see 
Chapter 2). Previously, BPL treatment had been demonstrated not to affect the 
antigenicity of the flaviviruses (Wills, 1991).
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The disease patterns observed in mice after inoculating with STD WN virus 
alone, BPL-treated DI virus plus STD virus or live DI virus plus STD are shown in 
Figures 5.1, 5.2. and 5.3. respectively and summerized in Table 5.2. The clinical 
signs induced in adult mice with STD WN virus strain Sarawak are shown in Figure 
5.2. Mice remained apparently healthy until 4-5 days post infection when they showed 
signs of malaise indicated by ruffled fur and inactivity (sick). The first signs of 
central nervous system involvement were behavioral changes. These included "vertical 
walking" against the side of their cage and "continuous aimless walking" when they 
walked over, rather than around, litter mates. Such alterations in the pattern of 
normal behaviour varied between individual mice. Malaise was succeeded by partial 
paralysis (half paralysis), usually of the hind limbs and this was followed by complete 
paralysis and death generally by 10 to 11 days post infection.
Figure 5 ?  ’. shows that the disease induced in adult mice inoculated i.p. with 
STD WN virus strain Sarawak plus BPL-inactivated DI virus preparations. It followed 
a reproducible pattern as observed with mice infected with STD WN virus strain 
Sarawak alone (Figure 5.1). However, mortality of mice treated with BPL-inactivated 
DI virus and • with STD WN virus (Sarawak) was lower than that of mice
infected with STD virus alone (Table 5.1.) indicating that BPL-inactivated DI virus 
was immunogenic. For example, 25 % of mice receiving BPL-treated DI virus plus 
STD WN virus survived in contrast to no survivors among the mice infected with 
STD virus alone (Table 5 1.). Although it was possible that BPL-treated DI virus 
could block attachment of STD virus to cells, it was more likely that mice inoculated 
with BPL-treated DI virus plus STD virus survived due to the quantity of antigen
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Figure 5.1. The disease patterns observed in mice after inoculating 
the STD WN virus strain Sarawak by the intraperitoneal 
route of inoculation.
Figure shows the death and clinical signs on each day 
and STD virus dose was 10^  pfu.
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Figure 5.2. The disease patterns observed in mice after
inoculating the BPL-treated DI virus plus STD 
WN virus .
Figure shows the death and clinical signs on 
each day.
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Figure 5.3. The disease patterns observed in mice after 
inoculating live DI virus plus STD WN virus 
strain Sarawak.
Figure shows the clinical signs of mice on 
each day.
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present in the inoculum which elicited a protective effect. In comparison, all mice 
receiving live DI virus alone survived infection without showing any disease 
symptoms and out of eight mice receiving live DI virus plus STD virus only one 
mouse succumbed to death during the observation period (Table 5%: and Figure 5.’5). 
These results, therefore, suggest that compared to BPL-inactivated DI virus, the 
significantly higher survival rates achieved by DI-WN virus plO plus STD virus was 
due to live DI virus. Since a small number of mice treated with BPL-inactivated DI 
virus survived the challenge by STD WN virus, a working definition of live DI virus- 
mediated protection was proposed by which protection rate could be calculated from 
the difference between survival rates of mice receiving live DI virus plus STD virus 
and BPL-inactivated DI virus plus STD virus. Thus, in Table 5.2 protection rate 
achieved by DI virus was 62.5%. In all protection experiments presented in this 
chapter the protection rate is quoted on the basis of the above definition.
5.2.3. Reproducibility of protection
The reproducibility of the protection experiments is shown in Table 5.3. While 
the mean percentage protection by different DI viruses was variable, the results are 
reproducible for individual DI virus preparations. Calculation of the 95% confidence 
limits (see Appendix) shows that there is little variation in the results.
134
T able 5.3. Reproducibility of protection of mice treated withi STD WN virus 
strain Sarawak plus DI virus p3 or p10
STD + DI virus p3 STD 4- DIviruspIO
75 62.5
70 56.2
Protection
rates (%) from 87.5 62.5
six independent
70experiments 68
75 68
75 68
Mean 75.4 ± 6 .4$ 64.2 ±1.7
SEM* ± 2 .6 ± 1 .9
95% confidence Bmit 68.7 to 82.1 59.24 to 69.3
*SEM: Standard error mean 
$ Standard deviation
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5.2.4. Protection of mice by different DI virus preparations of WN virus strain 
Sarawak
To investigate the protective effects of DI WN virus (Sarawak) preparations 
on the challenge of mice with homologous STD virus, mice were infected with either 
STD virus alone, DI virus plus STD virus, BPL-inactivated DI virus plus STD virus 
or DI virus alone. Table 5.4. shows the protection of mice by administration of 
different DI WN virus preparations against challenge by homologous STD WN virus. 
The survival rates of mice receiving live DI virus plus STD virus (75 to 98.5%) 
were significantly higher than those of the mice infected either with STD virus alone 
or BPL-treated DI virus plus STD virus (25 to 37.5%), indicating that live DI virus 
was responsible for protection of the mice from the lethal infection of STD WN 
virus. However, 25 to 37.5% of the mice receiving BPL-inactivated DI virus plus 
STD virus survived infection in contrast to no survivors among the mice inoculated 
with STD virus alone. Presumably, this is due to the quantity of antigen present in 
the DI virus inoculum. However, there was no significant delay in death between the 
mice receiving STD virus alone and BPL-inactivated DI virus plus STD virus as 
shown in Table 5.4. by calculating the AST.
Although all the DI virus preparations used in this study showed protective 
abilities, protection rates were variable depending on the DI virus preparation used. 
DI-p3 WN virus demonstrated the highest protective ability (75 %) among the DI virus 
preparations examined. In comparison, DI-p6 WN virus achieved the lowest
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Table 5.4: Protection of mice by four different p assa g es of DI WN virus 
strain Sarawak against a lethal challenge with hom ologous STD virus
Inoculum
Challenge No. survivors Survivors + Protections AST*
( % ) ( % ) (Days)
(iSEM)
STD-WN virus (Sarawak) 4.5 0/24 N.A 11.64-0.5
DI virus-p3-WN-Sarawak:
STD -4- BPL-DI virus 4.5
STD-h DI virus 4.8
DI virus only 4.5
DI virus-p6-WN-Sarawak:
STD -4- BPL-DI virus 4.6
STD 4- DI virus 4.9
DI virus only 4.6
Dlvirus-p8-WN-Sarawak:
STD 4- BPL- DI virus 3.5
STD 4- DI virus 3.8
DI virus only 3.5
DIvirus-pl 0-WN-Sarawak:
STD 4- BPL-DI virus 3.6
STD 4- DI virus 3.9
DI virus only 3.6
5/24
23/24
21/21
3/8
6/8
8/8
3/8
7/8
8/8
3/16
13/15
13/13
20.8
95.8 
100
37.5 
75
100
37.5
87.5 
100
18.8
86.7
100
11.S4-0.9
75
37.5
50
67.9
10. ^ 0.2
12.54-0.4
10.24-0.6
10.74-0.5
N.A: not applicable
* AST and SEM : Average survival time and standard error mean 
^Survivors refers tothose mice which survived infection with virus
$ Protection refers to those mice which survived infection due to the administration 
of DI virus and calculated from the difference between survival rates of mice receiving 
DI virus plus STD virus, and BPL-treated DI virus plus STD virus.
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protection rate (37.5%) and DI-p8  and plO WN virus preparations demonstrated 
intermediate protection (50-68%). It was also noteworthy that administration of DI 
virus preparation alone, which contained potentially lethal doses of STD WN virus 
( 1 0  ^* to 1 0 ^  ^ pfu infectious virus), neither caused any death nor produced disease 
symptoms in the DI virus only infected mice (Table 5.4.). As the pfu/LD^o of STD 
WN virus strain Sarawak was 200 pfu, it would indicate that DI viruses used in this 
study were able to protect mice against a challenge of 40 (DI virus plO) to 400 (DI 
virus p 6 ) LD5 0  of STD WN virus strain Sarawak. Clearly, there is no correlation 
between the challenge dose of STD virus and the relative protection of mice by 
different DI virus preparations.
As indicated in summary results of the protection study (Table 5.5.) there was 
no correlation between the ability of DI viruses to protect mice and their passage 
history. For example, DI virus p3 gave the highest protection (75%) but when this 
preparation was passaged to produce serially passaged DI virus p6 , the level of 
protection decreased by 2-fold. On the other hand, p 8  and plO derived from the same 
series of serial passage gained its protective ability by achieving a protection rate of 
50 and 67.9% respectively.
5.2.5. Comparison between protection in vivo and interference titre in vitro by 
DI WN virus preparations
There was no correlation between the ability of DI virus to protect mice and
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Table 5.5. Summary of the protection experiments carried out by four 
different DI viruses derived from WN virus strain Sarawak
Passage no Protection rate
of DI virus (%)
p3 75
p6 37.5
p8 50
plO 67.9
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their interference titres in cell culture measured by the OIA (Table 5.6). For example, 
DI-p3 WN virus preparation which had shown the lowest interference ability in the 
in vitro assay (10°^ DIU/ml) showed strong in vivo protection ability among the DI 
virus preparations used in the protection experiments. In comparison, DI-p6  WN 
virus preparation which showed moderate interference in vitro (10'^ DIU/ml) 
achieved the lowest protection rate (37.5 %) and DI-p8  and DI-plO of the same series, 
which showed the highest in vitro interference titres (10^^ DIU/ml), demonstrated 
moderate protection (50 to 6 8 %). Therefore, this would indicate that interference 
measured by the OIA was no guide to the ability of the DI virus preparation to 
protect mice and DI virus which protected mice was qualitatively different from the 
DI virus which interferes in the in vitro assays.
5.2.6. Challenge of DI-WN virus protected mice by STD WN virus strain 
Sarawak at 21 days after initial infection
Mice which had been protected by DI virus from a lethal WN virus infection 
were challenged at 21 days post infection with IOOLD5 0  of STD WN virus strain 
Sarawak i.p. to determine if they had developed a protective immune response. After 
this second inoculation mice were observed for 2 1  days and none of the mice showed 
any clinical signs of WN virus infection. However, the control group of mice which 
were matched with the protected group of mice by age and dose of STD virus 
infection did not show any significant difference in the survival rate from the DI 
virus-protected mice (data not shown). Although 30% of mice from the control group 
died after 12 days post infection it was surprising that 70% of the mice survived even
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though they were infected with IOOLD5 0  of STD WN virus. This experiment was 
repeated and produced similar results. One possibility could be that mice used for 
second inoculation were 9 weeks old and older mice may become resistant to WN 
virus infection (Hayes, 1988). Therefore, no conclusion could be drawn on the 
protective immune response of the protected mice.
5.2.7. Neutralizing and haemagglutination-inhibiting (HAI) antibody induced 
in protected mice
In order to investigate the immune status of mice protected by DI WN virus, 
sera were collected from the mice receiving either DI virus plO only, DI virus plO 
plus STD virus or BPL-treated DI virus plO plus STD WN virus at 19 days post 
infection. The immune response was examined by measuring neutralizing (N) and 
haemagglutination-inhibiting (HAI) antibody present in serum against STD WN virus 
strain Sarawak.
The results in Table 5.7. show that N antibody response to the DI plO virus 
alone, DI plO virus plus STD virus or BPL-treated DI virus plus STD virus could be 
detected in all the samples examined. However, N titre varied little between 
individual mice of the same group or between the mice of the different groups. For 
example, while N antibody titre in mice receiving DI virus alone varied between 20 
to 40, in mice receiving either DI virus plus STD virus or BPL-inactivated DI virus 
STD virus varied between 40 to 80. These results indicated that the ability of both 
live or inactivated DI virus to initiate an immune response was not reflected by the
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Table 5.7: Neutralizing and haemagglutination-inhibiting antibody in the serum of protected mice
against STD WN virus strain Sarawak
Virus inoculum 
used in mice
DIWN
(p10)
Virus
only
(Sarawak)
DIWN virus 
(p10)+
STD virus 
(Sarawak)
BPL-DI WN
(p1(^
STD WN virus 
(Sarawak)
N titre"
40
40
40
20
80
40
40
80
80
80
80
80
80
80
40
HAI titre$
160
160
160
160
160
160
160
160
320
320
320
320
320
320
320
* N titre: The titres are expressed as the reciprocal of the dilution of the antibody 
inhibiting 100 pfu (N test) of STD WN virus strain Sarawak by 50%.
$ HAI titre: The titres are expressed as the reciprocal of the dilutions of the antibody 
inhibiting 4 HAD (HAI test) of STD WN virus strain Sarawak.
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serum N antibody titre. By comparison, the HAI antibody level was 2 to 16-fold 
higher than the N antibody titre but HAI titres varied little between individual mice 
(160 to 320 HAI titres) (Table 5.7.)
5.2.8. Effect of concentration of DI and STD virus upon protection by DI WN 
virus
To determine whether or not the protective effect of DI virus in mice was 
dependent on the quantity of DI virus or STD virus administered, groups of mice 
were infected with a constant amount of STD virus together with different 
concentrations of DI virus (DI virus p3 and plO) and with undiluted DI virus (p3) 
plus 10 times higher concentration of STD virus (Table 5.8). The results in Table 5.8 
show that with both the DI viruses examined the concentration of DI virus was 
critical for the protection of mice since a ten-fold dilution of DI virus greatly reduced 
the level of protection. For example, while undiluted DI virus p3 induced 75% 
protection, ten-fold dilution of the same DI virus reduced the level of protection 
against a challenge of homologous STD virus by 6 -fold. Similarly, undiluted plO DI 
virus induced 62.5% protection; 10-fold dilution of plO DI virus reduced the 
protection by 2.5-fold. Furthermore, it was determined if protection depended upon 
the absolute amount of DI virus inoculated per mouse or the ratio of DI virus:STD 
virus. Table 5.8 also shows that increasing the quantity of STD virus by 10-times 
protection was completely abrogated suggesting that the ratio of DI virus to STD 
virus was also critical for protection.
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T able 5.8: Dose dependence of protection by DI preparations derived from WN virus strain Sarawak
Cfiallengedose 
Inoculum of STD virus 
(logiopfu)
No. Survivors 
No. Inoculated
Survivors
(%)
Protection
(%)
STD + BPL DI virus-pS 4.5 2/8 25
STD + DI virus-pS 4.8 8/8 100 75.0
STD + 1/10 DI virus-p3 4.5 3/8 37.5 12.5
10x STD + DI virus-p3 5.5 2/8 25 0
STD virus only 4.5 0/8 0
DI virus only 4.5 8/8 100
STD + BPL DI virus-pl 0 3.6 2/8 25
STD +  DI virus-pl 0 3.9 7/8 87.5 62.5
STD -k 1/1ODI virus-pl 0 3.6 4/8 50 25.0
STD virus only 3.6 0/8 0
DI virus only 3.6 5/5 100
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5.2.9. Effect of time of DI virus inoculation relative to STD virus
The effect of time of administration of DI-p3 virus at different times relative 
to challenge with STD virus was investigated. Controls were mice co-inoculated with 
DI virus and STD virus or BPL-treated DI virus and STD virus. DI virus was 
inoculated either 1 h before or after STD virus infection and also either or 1 day 
before or after STD virus infection. Internal control groups of mice were infected 
either with STD virus alone or DI virus alone. Table 5.9 shows that although 75% 
of mice survived an inoculation of DI virus at one day prior to STD virus, only a low 
level of protection (25%) could be achieved as BPL-treated DI virus plus STD virus 
given one day before STD virus infection also increased the number of survivors 
(50%). There was no significant reduction in protection by DI virus when it was 
administered either 1 h earlier or later than the STD virus (56.2%). Simultaneous 
infection provided the highest protection (62.5%).
5.2.10. Effect of DI WN virus on multiplication of STD virus in mouse brain
Mice infected with STD WN virus (Sarawak) plus either DI virus p3 or BPL- 
inactivated DI virus p3 plus STD virus were sacrificed at 7 days post infection and 
individual mouse brain homogenates assayed for infectivity. Table 5.10 shows that 
the brains of all mice given BPL-inactivated DI virus plus STD WN virus contained 
1 0 0 - 1 0 ,0 0 0 -fold higher levels of virus infectivity (lO^^-lO*^ pfu/brain) than those of 
mice given live DI virus plus STD virus (10^^ to 10^  ^pfu/brain). Thus, live DI virus 
inhibited the multiplication of STD virus in the mouse brain. At the time the brain
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T able 5.9: Time dependence of protection by Dl-p3 WN virus (Sarawak) against homologous STD virus
Virus inoculum Time of inoculation of DI virus
No. Survivors _
— — —  -------  Survivors
No. inoculated (%)
Protection
STD +  BPL DI virus _1 day
STD + DI virus -1 day
STD 4- DI virus -1hour
STD + BPL DI virus Ohour
STD 4- DI virus Ohour
STD virus only Ohour
DI virus only Ohour
STD 4- DI virus 4-1 hour
STD 4- DI virus 4-1 day
4/8
12/16
7/8
5/16
15/16
0/16
5/5
7/8
3/8
50
75
87.5
31.3
93.8
100
87.5
37.5
25.0
56.2
62.5
56.2
6.2
4 .5
* DI virus is DI virus p3 and the STD virus challenge was 10 pfu
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Table 5.10: Infectivity titres of brain tissues collected from the mice
infected with DI virus-p3-i- STD WN virus and BPL-DI virus- p3 + STD WN virus strain Sarawak
at 7 days post infection
BPL- DI virusp3 4- STD virus  ^
(lo^^fu/^rafn) Health status*
Dlvirus-p34- STD virus 
Infectivity titre
(log^^pfu/ brain) Health status
8.0 Hind limb paralysis 4.3 Sick
7.6 Sick 3.8 Well
7.5 Sick 3.7 Well
6.8 Sick 3.7 Well
6.6 Sick 3.5 Well
6.5 Well 3.5 Well
6.3 Well 3.3 Well
3.3 Well
Normal refers to mice showing no clinical signs of infection 
The STD virus challenge contained 1 cf ^ pfu
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samples were collected three out of eight mice infected with BPL-inactivated DI virus 
plus STD virus were apparently healthy, four were sick and one was half paralysed. 
Although there was no correlation between health status and virus infectivity titre in 
the brain, only one mouse was sick among the eight mice given DI virus plus STD 
virus. In parallel experiments 25 % of mice survived infection with BPL-inactivated 
DI virus plus STD virus while 100% survived infection by DI virus plus STD WN 
virus.
5.3. DISCUSSION
The results of the protection studies presented in this chapter provide evidence 
that intraperitoneal administration of DI WN virus can protect adult mice from an 
otherwise lethal infection by STD WN virus. Several parameters associated with the 
effectiveness of protection by DI WN virus in mice were examined including its 
dependence on passage history of DI virus, dose, time of inoculation, immunogenic 
load of the inoculum and reduction of virus infectivity in brains.
Studies in mice with different DI WN virus (Sarawak) preparations (Table 5.4) 
indicate that DI virus generated by WN virus in cell culture are able to protect mice 
against a challenge by the homologous STD virus. In contrast, mice infected with 
STD virus succumbed to death by 10 to 12 days post infection. Due to the presence 
of large quantities of infectious virus in the DI virus preparations it was necessary to 
challenge mice with very large doses of STD virus. The LD 5 0  of WN virus strain 
Sarawak has been determined to be 200 pfu following the intraperitoneal route of
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inoculation. Thus, in protection experiments mice were challenged with 40 to 400 
LD 5 0  of STD virus. Even though such large doses were used, DI virus was still 
capable of eliciting protection. Accordingly, the protection studies reported in this 
chapter compare very favourably against previous studies where DI virus mediated 
lower protection rates and lower challenge doses were used (Barrett et al., 1984; 
Dimmock and Kennedy, 1978; Jones and Holland, 1980; Dimmock et al., 1986). 
Also, challenge of mice by the intraperitoneal route is a severe test of protection 
against a neurotropic virus, yet good protection rates were observed. Again this 
compares very favourably with previous studies (Barrett and Dimmock, 1984).
Evidence has been presented that DI WN virus preparations are heterogeneous 
in their ability to protect mice. Some DI WN virus preparation provided strong 
protection (DI virus-p3), others were either moderate or weak in protecting mice 
against challenge with STD virus (plO, p 8  and p 6 ) (Table 5.6). Thus protection 
varied independently of passage history. This variability of DI WN virus in vivo was 
not consistent with the interfering properties of these DI viruses in vitro. For 
example, DI virus-p3 which appeared to have the strongest protective ability (75%) 
showed poor interfering activities in vitro as measured by the OlA {IQP ^  DlU/ml). On 
the other hand, DI virus-p6  which showed moderate interfering activities in vitro 
showed the lowest protection ability among the DI viruses used in this study. Thus, 
the interfering ability shown by the DI viruses can not be used to predict which DI 
virus preparations modulate WN virus infection in vivo. The finding that in vitro 
interference does not correlate with in vivo protection has been reported previously 
for DI SFV (Barrett et a l ,  1984) and supports the suggestion that only some DI
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viruses are able to interfere effectively in vivo (Barrett and Dimmock, 1986).
The induction of protection described above can either be due to the DI virus 
mediated protection by interference with replication of STD viruses or to the 
production of specific or non-specific immune response by the DI or STD virus. In 
protection experiments along with treating mice with live DI virus mice were also 
treated with BPL-inactivated DI virus plus STD virus in order to determine the 
immunogenic role of the antigen present in the inoculum. Although survival of mice 
receiving live DI virus plus STD varied between 100 to 80% in contrast to no 
survivors against infection with STD virus alone, a small proportion of mice (25%) 
receiving BPL-inactivated DI virus plus STD virus survived infection. These results 
suggest that some protective immunity might have been stimulated in the mice. This 
hypothesis was examined by measuring the serum N and HI antibody of the mice 
either protected by live DI or BPL-inactivated DI virus mice. Surprisingly, the 
immune response was not great as reflected by the serum N antibody (N antibody titre 
varied between 20 to 80) (Table 5.7). By comparison, HAI antibody titre was 2 to 
16-fold higher than the N antibody. It is not known whether serum antibody consists 
of HAI- reactive-non-neutralizing antibody (which recognises antigenic site different 
from those which result in neutralization (Caton et a l ,  1982)Jhas any role in the 
protection process or these data are indicative of an overall low avidity neutralizing 
antibody. If DI viruses stimulate a weak adaptive immune response, it is difficult to 
envisage this process contributing greatly to recovery from the STD WN virus 
infection. Therefore, other factors must be involved in the protection mechanism. It 
could be that protection is entirely mediated through DI virus interfering property as
151
with DI lymphocytic choriomeningities virus (Welsh et a l ,  1977) or DI virus 
stimulates non-adaptive immune response such as interferon, macrophages or natural 
killer cells as suggested for DI VSV in hamsters (Fultz et a l ,  1982).
Although the possibility of involvement of DI virus-mediated interference in 
the protection process has been examined in the following chapter (Chapter 6), 
evidence that a 10^  to ICf-fold reduction of infectious virus at 7 day post infection in 
the brains of mice receiving DI virus plus STD virus strongly suggests that live DI 
virus inhibits the multiplication of infectious virus in the brains of infected mice. 
While the majority of the mice treated with DI virus were protected there were a few 
which succumbed. However, the time of death and amount of virus present showed 
that DI virus did not ameliorate the disease to a noticeable extent.
The findings that protection is dependent on the dose and time of inoculation 
of DI or STD virus are consistent with results obtained with SFV (Barrett and 
Dimmock, 1984; Dimmock and Kennedy, 1978). Thus there is a limited time period 
following STD virus infection during which the protective effect of DI virus is to be 
initiated. Similarly, protection can be abrogated either by increasing the concentration 
of STD virus or by decreasing the concentration of DI virus suggesting that the ratio 
of DI virus to infectivity is a critical factor in protection process. Taken together with 
the evidence of inhibition of STD virus in the brain of infected mice the above results 
agree with the general opinion that DI virus has the potential to modulate the effect 
of lethal virus infection in vivo (Huang, 1977; Barrett and Dimmock, 1986; 
Dimmock, 1991).
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The majority of studies of DI viruses in animals have involved infections of 
the central nervous system after either intracerebral or intranasal inoculation. There 
have been only four reports on the protection effects of DI virus inoculated by other 
routes. Early studies on Rift Valley fever virus in mice showed that intravenous 
inoculation of "incomplete” virus protected mice against intracerebral inoculation of 
STD virus (Mims, 1959). Later on, hamsters were shown to be protected by DI VSV 
through i.p. inoculation. However, there has been heterologous interference by DI 
particles of the New Jersey serotype of VSV and induction of interferon by DI virus 
in mice suggesting that protection was not due to the intrinsic interfering ability of 
DI virus. DI SFV has been demonstrated to have the ability to modulate systemic 
infection, converting an otherwise lethal into a subclinical infection (Barrett and 
Dimmock, 1984). Only a report on the flavivirus Banzi has suggested that interfering 
virus is involved in the genetic resistance of mice to that virus since after i.p. 
inoculation, mice which are resistant to infection has high levels of interfering 
viruses. In comparison with the above studies, the results presented here indicate that 
modulation of a systemic virus infection by DI WN virus is more effective than the 
other virus systems.
Over the years the important features of the modulation of RNA virus 
infection by DI virus in vivo have been uncovered by using VSV, SFV and influenza 
virus as prototype systems for study (Barrett and Dimmock, 1986; Huang, 1988; 
Nayak et ah, 1989; Dimmock, 1991). Several conclusions can be drawn by 
extrapolating the results presented here with WN virus and three other virus systems. 
Firstly, this findings establish that the protective ability of DI WN virus is greater
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than that reported for the other three virus systems. Secondly, DI WN virus decreased 
the overall virus multiplication in the brains of infected mice by a similar magnitude 
as reported for DI VSV (Jones and Holland, 1980) and DI SFV (Barrett et al. , 1984). 
Thirdly, although modulation of systemic infection by DI VSV and SFV has been 
reported (Fultz et al., 1982; Barrett and Dimmock, 1984), unlike WN virus system, 
both viruses either led to persistent infection or provided a low level of protection and 
only delayed death. Finally, in contrast to DI VSV, SFV and WN virus, DI influenza 
virus has no effect on the production of progeny virions of the lungs but interferes 
with the abortive infection of lymphocytes which otherwise results in the immune 
pathology (Dimmock, 1991; Morgan and Dimmock, 1992). On the basis of these 
differences and similarities of DI virus effects in vivo it is tempting to postulate that 
since WN, VSV and SFV are neurotropic in mice, the mechanism(s) of DI virus- 
mediated protection against these viruses may be similar.
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CHAPTER 6
Characterization of virus isolates derived from the brains of mice protected by 
DI WN virus
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6.1. INTRODUCTION
In the past, investigations on DI virus-mediated protection in experimental 
animals have suggested that it is the activity of the DI virus which is responsible for 
protection rather than the immune response to the DI virus. This hypothesis is 
supported by the evidence that DI virus inhibits the multiplication of STD virus in 
target tissues of the protected host (Fultz et al., 1982; Jones and Holland, 1980; 
Welsh et al., 1977; Barrett et al., 1984). While this suggestion agrees with the DI 
virus property of interference, findings that infectivity titres in tissues of protected 
mice are either undetectable (Doyle and Holland, 1973; Spandidos and Graham, 
1976; Barrett et al., 1984), reduced (Holland and Doyle, 1973; Rabinowitz et a l ,  
1977; Dimmock and Kennedy, 1978) or indistinguishable (Dimmock et a l ,  1986) 
from the titres in animals infected with STD virus only, may reflect the diversity of 
mechanism(s) by which DI virus acts in vivo.
Modulation of an otherwise lethal infection by DI virus in vivo ranges from 
conversion to a subclinical condition and complete recovery, to the production of a 
atypical chronic/persistent infection or only a delay in the onset of death (Doyle and 
Holland, 1973; Fultz et a l ,  1982; Atkinson et al., 1986). Classical persistent viral 
diseases are usually characterised by a lack of massive virus-induced destruction of 
cells and by an immune response unable to completely eradicate the viral infection. 
Little is known about the dynamic nature of persistent virus infections in vivo, but cell 
culture models indicate that alterations in the nature of viruses during persistent 
infections may be associated with the generation of DI virus (Brinton, 1986).
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Therefore, it has been speculated that DI virus might play an important role in 
chronic diseases (Huang and Baltimore, 1970).
In the preceding chapter it has been shown that DI WN virus can modulate an 
otherwise lethal infection of STD WN virus in mice. Therefore, it was decided to 
investigate virus multiplication within the mouse. In addition, protected mice were 
examined for the presence of infectious virus and DI virus at different days post 
infection in order to investigate potential persistent infections. Pathogenicity of the 
virus isolates derived from the protected mice were also studied to determine any 
changes in their virulence in comparison to their parent virus.
6.2 EXPERIMENTAL PROTOCOL
6.2.1. Isolation of virus from the mouse brain
Whole brains were harvested from mice infected either with BPL-treated DI 
virus plus STD virus, DI virus plus STD virus or DI virus only at 7 or 19 days post 
infection according to the procedures described in Chapter 2. Supernatant from the 
brain homogenate was examined by a plaque assay procedure following the methods 
outlined in Chapter 2 to determine the virus infectivity titre present in the brain 
samples. In order to obtain a homogeneous virus population distinct and isolated 
plaques were collected from tissue culture plates in which assays were performed 
according to the methods described for virus plaque purification in Chapter 2. 
Purified plaques were amplified in cell culture and extracellular progeny virus was
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harvested following the protocol described in Chapter 2.
6.2.2. Interference assay with virus samples derived from the mouse brains
Mouse brain virus samples collected at different days post infection were 
examined for the presence of interfering virus. Interference activity of the mouse 
brain-derived virus samples were measured by the OIA as described in Chapter 3 
using LLC-MK2 cells and interference titres were expressed in DIU/brain.
6.3. RESULTS
6.3.1. Presence of infectious virus in mouse brains
In the previous chapter (Chapter 5) it was demonstrated that live DI virus 
greatly inhibited the multiplication of STD WN virus in mouse brain (see Table 
5.10). In order to investigate the nature of virus in protected mice the study was 
extended by measuring the virus present in the brains of protected mice on day 7, 19 
and 90 post infection.
Table 6.1 shows the virus infectivity titres present in the brain of mice 
receiving live or BPL-inactivated DI virus p3 on 7 and 19 days post infection. 
Comparison of infectivity titres in the brains of mice receiving STD WN virus plus 
DI WN virus p3 to those found in mice inoculated with STD WN virus plus BPL- 
inactivated DI virus at 7 and 19 days post infection revealed two catagories. a) Those
158
D
%
o3
* <
%
+
a
|A
Û0
r o  CO CO 
Li. CO In
o^
œ
cn
(O (O
00
- o
5
■ 5
+
D
|A
CO
■5
+
o
DO“Dr-
6
■5
I
C O C O C O C O C O C O C O - U  
CO CO I n  c n  ^  ^  b o  CO
_o> p  p  O )  >1 >1 p o  
CO c n  b )  b o  c n  b î  o
p
ro
5 0
00 -nI
8 8
CO
I Ic
<g
s>.
3
cn
I
3
&
I
I t
3  CD
Q a
io
p
Ï
3
cn
I
I
TlI
CD
<
W
■§ I
| s  I
CD
i
CL
O O’
i ' 5
I
■o
c
cn
O
<
a
O '
Ë .Ic 
m  
-Q  cn 
CO o
I
&
TJ
O
3 
S
CD
3 
o
CO CD
I I
159
receiving live DI virus had titres of infectious virus reduced by several order of 
magnitude at 7 days post infection but each brain was found to contain infectious 
virus. Although the majority of the brains examined showed no detectable infectious 
virus at 19 days post infection, 37.5% of the mice contained a low level of infectious 
virus (2.1 to 3.5 logio pfu/brain) in their brains, b) Those receiving BPL-inactivated 
DI virus p3 plus STD WN virus had high virus infectivity titres in their brains (6.3 
to 8.4 logio pfu/brain) at 7 days post infection and those that survived infection from 
this group showed no detectable infectious virus (_^1.3 logio pfu/brain) in their brains 
on 19 days post infection. Thus, these results indicate that although live DI virus was 
able to eliminate detectable quantities of infectious virus by 19 days post infection in 
the majority of mice, a small proportion of mice contained infectious virus that 
persisted in their brains without any clinical signs of infection. On the other hand, 
those receiving BPL-treated DI virus plus STD virus which would have died had the 
disease followed its normal course had no detectable infectious virus in their brains. 
Presumably, in this case, an host immune response was able to eliminate the virus 
infection.
The above experiments were extended to investigate the presence of infectious 
virus in the brains of mice protected by other DI virus preparations (p6, p8, plO). 
The results in Table 6.2 show that all six mice receiving BPL-inactivated DI virus 
plus STD virus which had survived challenge infection contained no detectable 
infectious virus in their brains at 19 days post infection whereas 19% (4/21) of the 
mice receiving DI virus (either p6, p8 or plO) plus STD virus contained 10^  ^ to 10^  ^
pfu/brain. Also, 15 mice examined from the groups of mice given DI virus alone
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(Tables 6.1 and 6.2) showed no detectable virus infectivity in their brains although 
DI virus administered contained _< 10^  pfu STD virus.
In order to determine the duration of persistence, groups of protected mice 
receiving either DI virus plO plus STD virus or DI virus plO alone were observed 
until 90 days post infection. None of the mice showed any clinical signs of infection 
during this period and all 11 brains examined (5 from mice given DI virus only and 
6 from mice given DI virus plus STD virus) showed no detectable infectious virus in 
them suggesting that infectious virus did not persist in these mice at 90 days post 
infection.
6.3.2. Propagation of DI virus in mouse brain
In order to postulate that the mice survived a potentially lethal WN virus 
infection through the interfering property of DI WN virus it was necessary to 
demonstrate that DI WN virus was propagated in the brain. In an attempt to do so, 
the OIA was used to measure the interfering ability of the mouse brain-derived virus 
samples collected at 7, 19 and 90 days post infection. Samples collected from mice 
receiving DI virus plus STD virus, DI virus only and BPL-treated DI virus plus STD 
virus were used.
Table 6.3. shows that 28.6% (2/7) of the samples collected at 19 days post 
infection from the mice given DI virus plO plus STD virus interfered with 
homologous STD WN virus strain Sarawak in vitro with interference titre as
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measured by the OIA varied between 220 to 240 DIU/brain. No measurable 
interference was observed from the samples collected at 19 days post infection from 
the mice receiving BPL-treated DI virus plO plus STD virus or DI virus plO alone. 
Of the 9 samples examined from the mice observed up to 90 days post receiving 
either DI virus plO alone (0/4) or DI virus plO plus STD virus (0/5) none showed 
any detectable interference against homologous STD WN virus strain Sarawak.
Similarly, out of 14 samples collected at 19 days post infection from mice 
given either DI virus p6 or p8 plus STD virus, two (one from each group) (14.2%) 
demonstrated detectable interference against STD WN virus strain Sarawak. Samples 
from mice receiving DI virus alone or BPL-treated DI virus plus STD virus were also 
examined and none contained detectable interference (Table 6.4.)
The results in Table 6.5 shows that 25% of the samples collected at 7 days 
post infection from the mice receiving DI WN virus p3 plus STD virus interfered 
efficiently against STD WN virus in the OIA and their interference titres were 2 to 
3-fold higher than those observed for the virus samples collected at 19 days post 
infection from the mice receiving any of the DI virus preparations used, including DI 
virus p3. For example, one sample collected from the mice given DI virus p3 plus 
STD virus at 19 days post infection demonstrated an interference titre of 280 
DIU/brain whereas the interference titre for the positive samples collected on day 7 
post infection varied between 600 to 640 DIU/brain. As observed with other DI virus 
preparations, none of the samples collected from the mice receiving DI virus p3 alone 
or BPL-treated DI virus p3 plus STD virus showed any interference activity against
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STD WN virus in the OIA. The results obtained from the interference assay 
demonstrated two specific patterns (Table 6.6.): a) Only samples collected either at
7 or 19 days post infection were found to be able to interfere against homologous
J f K « A
STD virus, b) All the samples found to demonstrate interference/were collected from 
the mice receiving live DI virus plus STD virus
6.3.3. Properties of the infectious viruses derived from mouse brains treated 
with different DI virus preparations plus STD WN virus strain Sarawak
Viruses isolated on day 7 and 19 post infection from the brains of mice treated 
with different DI virus preparations plus STD WN virus strain Sarawak (see Tables 
6.1 and 6.2) were examined to determine their properties. Although infectivity titres 
of individual mouse brain preparations were determined directly from the supernatant 
of the brain homogenate, samples found positive for infectious virus were given one 
passage in Vero cells at a moi of 0.01 pfu to obtain a working virus stock. Single 
plaques were picked from each virus preparation propagated in Vero cells and 
amplified by one more passage in that cell line. Thus, a homogeneous virus 
population was obtained for each virus isolates under study and their infectivity titres 
are shown in Table 6.7. As a control for this study, three plaque picks were made 
from STD WN virus strain Sarawak using the procedure described above. Since a 
number of workers have shown that infectious virus isolated from persistent infections 
has altered properties, such as temperature sensitivity and virulence (see review by 
Holland et û/.,1980), the virus isolates shown in Table 6.7. were compared for any
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Table 6.7. Infectivity titre o f  the m ouse brain-derived virus isolates (plaque pick virus)
Inoculum used 
to infect mice
Plaque pick(pp) 
no. *
Infectivity titre
(logio
(7 days post infection) 
DI virus-p3 -I-STD WN
(19 days post infection)
DIvirus-p6-t- STD WN 
(19 days post infection)
pp-1
pp-2
pp-3
pp-4
pp-5
pp-1
pp-2
8.0
7.8
7.8 
73 
73
73
7.8
DIvirus-p8+STD WN 
(19 days post infection)
DIvirus-plO-kSTD WN 
(19 days post infection)
STD WN virus (Sarawak)
pp-1
pp-1
pp-2
pp-1
pp-2
pp-3
7.5
15
7.1
7.0
7.4
73
* Virus was harvested at 72 h post infection and single plaque picks 
were used as inocula
169
changes from the properties of the parental WN virus used in the inoculum given to 
the mice
Plaque formation by the viruses isolated from the mouse brains and shown in 
Table 6.7. were neutralized by mouse antisera against STD WN virus strain Sarawak 
showing that the virus isolates were indeed WN virus. These isolates had plaquing 
characteristics in Vero cells similar to STD WN virus. Plaque size, time to produce 
plaques and morphology did not differ from that of STD WN virus (data not shown).
6.3.4. Temperature sensitivity (ts) of the virus isolates derived from the mouse 
brains
Temperature sensitivity (ts) of plaque formation by the mouse brain-derived 
virus samples was investigated to observe if the virus had changed by multiplication 
in mice. Both STD WN virus strain Sarawak and mouse brain-derived virus samples 
in plaque assays were incubated at 37^C and 39.5°C. The results in Table 6.8 show 
that both STD WN virus and the mouse brain-derived virus isolates were not ts as the 
viruses exhibited a similar infectivity titre at the optimal temperature 37®C as well as 
the supraoptimal temperature 39.5°C. Thus, the viruses had not been become into ts 
mutants during multiplication in mice.
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6.3.5. Pathogenicity of virus isolates derived from the brains of mice treated 
with DI virus p3 plus STD WN virus
The virulence of viruses isolated from the brain of mice was determined in 
terms of pfu/LD^o and kinetics of killing adult mice by intraperitoneal (i.p.) and 
intracerebral (i.e.) route of inoculations and compared to that of the parent virus. 
Table 6.9 shows the comparative virulence of the STD WN virus strain Sarawak and 
the virus isolates derived from brain of mice treated with different DI viruses plus 
STD WN virus at 7 and 19 days post infection. The results shown in Table 6.9 
indicate that the mouse brain isolates used in this study showed a variable degree of 
virulence depending on which DI viruses were used to treat the mice. For example, 
pfu/LD^o ratios of the virus isolates collected at 7 days post infection from the mice 
treated with DI virus p3 were 6.3x10^ to 10^  by the i.p. and 1.3x10^ to 7x10^ by the 
i.c routes of inoculation. In contrast, for STD WN virus strain Sarawak the pfu/LD^o 
ratios were 200 and 2 for i.p. and i.c. routes of inoculation respectively. Similarly, 
isolates collected at 19 days post infection were also attenuated and the pfu/LD^o 
ratios for these isolates were 2x10^ and 4x10^ for i.p. and i.c. routes of inoculation. 
Thus, the virus isolates collected from the mice treated with DI virus p3 plus STD 
virus were attenuated at least by 4000-fold compared to STD WN virus strain 
Sarawak. To examine the nature of the viral populations present in each virus isolate 
collected either at 7 or 19 days post infection more than one plaque picked virus was 
examined for each virus isolate in the virulence studies. Clearly, the results shown 
in Table 6.9 indicate that the virus populations obtained by plaque purification 
demonstrated a uniform property of attenuation of the isolates collected at 7 and 19
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days post infection suggesting that virus populations used in this study did not contain 
a heterogeneous mixture of viruses in terms of their virulence.
6.3.6. Pathogenicity of the other virus isolates collected at 19 days post infection 
from the mice receiving different DI virus preparations (p6, p8, plO) plus STD 
virus
The virulence of virus isolates derived from the brains of mice treated with 
DI virus preparations p6, p8 and plO were also examined in adult mice. All the 
isolates collected from the mice treated with the above mentioned DI viruses were 
obtained at 19 days post infection. Table 6.9a. shows the comparative virulence of 
the isolates and that of the STD WN virus. Isolates showed a range of pfu/LD^o 
values and the average survival times of mice. For example, isolates derived from 
the mice treated with DI virus p6 plus STD virus had the same pattern of virulence 
as STD WN virus (death at 9.14:0.1 days post infection) but the pfu/LD^g ratio was 
20 to 23 by the i.c. route which was 10-fold higher than that of STD WN virus strain 
Sarawak (2 pfu). In contrast, the same virus isolates showed a marked attenuation 
(2x10^ pfu/LD^o) when the virus was inoculated i.p. suggesting that this particular 
virus isolate might have lost the ability to cross the blood-brain barrier to cause a 
neurotropic disease in mice. On the other hand, an isolate collected from the mice 
treated with DI virus p8 showed an identical disease pattern as with STD WN virus 
(death at 11.2 ± 0 .0  days post infection) and in terms of pfu/LD^g ratio this isolate 
was as virulent as STD WN virus. Furthermore, a virus isolate collected from the 
mice given DI virus plO showed intermediate virulence in comparison with its parent.
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For example, AST for the virus isolate collected from the mice given DI virus plO 
was 15.14: 0.8 days whereas for the parent virus it was 10.24: 0.3 days. Similarly 
the i.p. pfu/LD^o for the mouse brain isolate (DI virus plO) was 2.5x10^ which was 
12.5-fold higher than the parent virus suggesting that this virus, although not as 
virulent as the parent virus, had been less attenuated than the virus isolates collected 
from the mice receiving DI virus p3.
6.3.7. Comparison of the virulence of the mouse brain-derived virus isolates
While some of the virus isolates derived from the mice receiving DI virus 
preparations showed a marked attenuation compared to their parent virus, other 
isolates were either less attenuated or as virulent as the parent virus (Table 6.10). On 
the basis of their virulence and attenuation virus properties in mice isolates can be 
divided in to three groups. Firstly, isolates collected from the mice receiving DI virus 
p3 plus STD virus were more attenuated than the isolates collected from other mice 
irrespective of their time of collection.
Secondly, the virulence of one isolate (collected from the mice treated with 
DI virus p6) was dependent on route of inoculation, i.e. while the virus was virulent 
as the parent virus by the i.e. route, it was greatly attenuated when the i.p. route of 
inoculation was used (2x10^ pfu/LD^o).
Thirdly, the isolates collected from the mice receiving DI virus plO were less 
attenuated than the other attenuated isolates but less virulent than its parent virus.
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Finally, isolates from mice receiving DI virus p8 was as virulent as the parent virus. 
Interestingly, this pattern of virulence and attenuation correlates partially with the 
level of protection achieved by the individual DI virus preparations against a 
challenge of STD WN virus (Table 6.10 and see Chapter 5). For example, DI virus 
p3 virus demonstrated the greatest protection among the DI virus preparations used 
in protection studies and DI viruses p6 and p8 showed the lowest protection abilities. 
Therefore, these results suggest that modulation of STD virus disease in mice by DI 
viruses could be related to the property of individual DI virus preparations and that 
changes may have been brought about by genetic change(s) of the STD virus.
6.4. DISCUSSION
In order to provide information for understanding the mechanism by which DI 
virus acts in vivo, three types of data were generated in this chapter:
a) The ability of DI WN virus either to eliminate infectious virus from the 
brains of mice resulting in complete recovery from the disease or to initiate a 
persistent infection resulting in chronic or subacute disease.
b) Inhibition of STD virus multiplication in protected mice was related to the 
propagation of DI virus in mouse brain.
c) Infectious viruses isolated from the brains of protected mice were examined 
to identify any alteration in their biological properties from those of their parent 
virus.
In order to postulate that treatment with DI virus prevented the elimination of
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infectious virus from the mouse, brains of mice treated with different DI viruses were 
examined at 7, 19 and 90 days post infection. Although the presence of infectious 
virus in all DI virus plus STD virus treated mice examined early infection (7 days 
post infection) is not an indication of initiating a persistent infection, it does, 
however, demonstrate the process of elimination of STD virus in DI virus-protected 
mice when compared with the pattern of virus infectivity at later stages of infection. 
Twenty four percent of the mouse brain samples collected from the mice treated with 
different DI virus preparations at 19 days post infection contained a low level of 
infectious virus indicating that infectious virus has not been completely eliminated 
from the mice. Whether or not this is a "persistent infection" depends on how it is 
defined. Protected mice were clinically healthy throughout all experiments and a 
group of 11 mice protected by DI WN virus plO have been observed up to 90 days 
post infection and have remained healthy throughout this period. Although isolations 
were made at a comparatively short time (7-19 days post infection) after infection, 
there is no doubt that the virus is persisting relative to the mice receiving BPL-treated 
DI virus plus STD virus which showed no detectable virus in their brains at 19 days 
post infection. Since infectious virus could be directly isolated from protected mice, 
a co-cultivation technique such as required by Fultz et al. (1982) to detect VSV under 
similar experimental conditions were not used. Thus it is possible that co-cultivation 
may reveal that infectious virus is present in a higher proportion of protected mice.
In addition to infectious virus, DI virus was demontrated at 7 and 19 days post 
infection in the brains of a minority of protected mice. Experiments to show the 
presence of DI virus in protected mice by the OIA revealed that 23 % of the mouse
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brain samples examined receiving DI virus plus STD virus contained detectable levels 
of DI virus and their interference titres varied between 200 to 640 DIU/brain. In 
contrast, samples collected from the mice receiving BPL-treated DI virus plus STD 
virus demonstrated no interference suggesting that inactivated DI virus is not capable 
of propagating DI virus in mice. Although nearly 100% DI virus-treated mice 
survived a lethal virus infection, it was surprising that only 23% of the mice showed 
the presence of DI virus in their brains. This could be due to insufficient sensitivity 
of the assay to detect DI virus present in the samples. Moreover, it has already been 
demonstrated that the in vitro assay was no guide to assess the in vivo situation. A 
similar problem of detecting DI virus in vivo has been described for DI VSV (Holland 
and Villareal, 1975) and DI SFV (Barrett et ah, 1984). However, one difference 
between these two systems and that of the WN virus was that at least 23% of the 
mice treated with DI WN virus did demonstrate measurable interference in contrast 
to complete failure to detect any DI SFV in the brains of protected mice (Barrett et 
ah, 1984). Evidence that DI VSV and DI SFV had been propagated in mouse brain 
was revealed after an amplification step (Holland and Villareal, 1975; Dimmock and 
Kennedy, 1978). The above results would indicate the propagation of DI virus in the 
mouse brain and inhibition of multiplication of STD virus. Thus, viral interference 
seems the most plausible explanation for the protection effect.
The infectious virus isolated from brains of protected mice was neutralized by 
mouse anti-sera against STD WN virus strain Sarawak suggesting that the isolates 
were indeed WN virus. Secondly, studies on temperature sensitivity, plaque size and 
morphology demonstrated that mouse brain-derived virus isolates did not differ from
1 8 0
the parent virus in these respects. Therefore, these results contrast with the results of 
Fultz et al. (1982) who found that the virus isolated from DI VSV-protected hamsters 
were temperature sensitive, small plaque mutants. Thirdly, the virulence of virus 
isolates derived from the mouse brains was measured in terms of pfu/LD^o and 
kinetics of killing adult mice (Tables 6.9 and 6.10). It should be noted that virus 
isolates from protected mice were passaged in cell culture no more than twice, so the 
question of losing virulence by cell culture adaptation was minimal. The results of the 
virulence studies demonstrated that ability of the virus isolates to kill adult mice 
varied depending on from which group of mice they were collected. The variations 
in virulence of the virus isolates can be summarized as follows:
a) Isolates collected from the mice treated with DI virus p3 were at least 4000- 
fold less virulent by both i.p. (10  ^ to 10^  pfu/LD^o) and i.e .(10  ^ to 10^  pfu/LD^o) 
routes of inoculation than their parent virus (200 pfu/LD^g [i.p.] and 2 pfu/LD^o 
[i.e.]).(Table 6.9).
b) Virulence of the isolate collected from the mice treated with DI WN virus 
p6 was the same as the parent virus by the i.e. route but by the i.p. route the isolate 
was avirulent compared to its parent virus (Table 6.9a.).
c) A 12.5-fold decrease in virulence compared to the parent virus was 
demonstrated by the isolate collected from the mice receiving DI WN virus plO 
(Table 6.9a.).
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d) A virus isolate collected from the mice treated with DI WN virus p8 was 
as virulent as the parent virus (Table 6.9a).
The above results clearly demonstrate that attenuation of virulence of the virus 
isolates derived from the mice protected by DI virus was related to which DI viruses 
were used to treat the mice. Thus, DI viruses used in the protection experiments had 
heterogeneous properties and support the earlier views presented in Chapter 5 that DI 
virus generated in the same series may have heterogenous properties.
The mechanism(s) by which an attenuated variant of virus was generated in 
mice is not understood. One possibility could be that DI virus might have exerted 
selective pressure during their propagation in mice to evolve an attenuated variant of 
STD virus. This result is unprecedented in that no such variant so far has been 
identified in any other virus system that has been studied for DI virus-mediated 
protection. Viral persistence studies with DI WN virus in murine cell culture have 
demonstrated the generation of ts and replication efficient mutants during persistent 
infections (Brinton, 1981, 1982, 1983). However, none of these mutants were studied 
for their virulence properties in any animal model. Studies with DI VSV (Fultz et 
û/,1982), and DI reovirus (for review see Fields and Green, 1982) have demonstrated 
the generation of ts mutants in DI virus protected animal hosts.
Interestingly, the virulence studies also indicated a relationship between the 
the level of protection achieved by different DI viruses and the virulence of the 
viruses isolated from the mice treated with those DI viruses. For example, all the
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virus isolates derived from the mice treated with DI virus p3 were found to be highly 
attenuated and this particular DI virus demonstrated the highest protective ability in 
mice against a challenge by STD WN virus (Table 6.10). On the other hand, DI virus 
p6 and p8 demonstrated a low level of protection and the virus isolates from the mice 
treated with these DI viruses were either as virulent as the parent virus or their 
virulence depended on the route of inoculation (Table 6.10). With this evidence it is 
tempting to speculate that protection by DI WN virus is not only a result of DI virus 
virus interference with STD virus but also the ability of DI virus to modulate the 
biological properties of STD virus used as a challenge virus. The question remains 
how those mice receiving the DI viruses which have not modulated the STD virus 
properties to become attenuated survived with such a high level of infectious virus in 
their brains without showing any clinical signs of disease. One possible explanation 
for this situation could be that the infectious viruses localized to a specific area of the 
brain, possibly in equilibrium with DI virus.
In conclusion, prevention of acute viral disease by DI WN virus was found to 
lead to a phase of persistent infection which eventually ceased without showing any 
clinical disease between 19 to 90 days post infection. Evidence for the propagation 
of DI virus in mouse brain serves to postulate that viral interference was involved in 
the protection mechanism. However, modulation of the biological properties of STD 
virus to become attenuated in infected mice may also be contributing to protection. 
On the basis of the results presented it is quite difficult to assess the relative role of 
DI virus in the generation of attenuated variants of STD virus but further studies on 
WN virus-mouse model utilizing the well-defined mutants of the virus should give
183
more insight into understanding this phenomenon.
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CHAPTER 7 
Heterotypic Interference by DI WN virus
185
7.1. INTRODUCTION
The definition of DI particles given by Huang and Baltimore (1970) embodied 
the specificity of interference caused by DI particles as homotypic, i.e. DI particles 
interfere with the STD virus from which they are derived. Contrary to this general 
opinion, heterotypic interference (i.e. interference between different strains of the 
same virus) by DI particles has been demonstrated in several virus systems (Huang 
and Wagner, 1966; Schnitzlein and Reichmann, 1976; Prevec and Kang, 1970; Nayak 
et al, 1981; Barrett and Dimmock, 1984)
Historically, typing viruses has sometimes depended on interference. Closely 
related viruses were thought to be able to interfere with each other, but not distantly 
related viruses (Huang, 1973). Huang (1977) has recapitulated the important features 
of DI particle-mediated interference in animal viruses illustrating the striking 
specificity of interference which is strongest against the STD virus from which the 
DI particles were derived, less strong against related viruses or strains of the same 
STD virus and nonexistent against unrelated viruses. It is likely that the degree of 
interference by DI particles of one serotype against STD virus of another serotype 
measures the degree of relatedness between the two. However, deviation from this 
concept of specificity of interference has also been observed with one particular type 
of VSV DI particles of the Indiana serotype (HR DI 0.46) where STD VSV of both 
Indiana and New Jersey serotypes were equally inhibited (Prevec and Kang, 1970). 
The mechanism involved in DI particle-mediated interference is still poorly
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understood. It has remained even more intriguing to establish whether heterotypic 
interference occurs through a mechanism similar to that homotypic interference. In 
comparison with homotypic interference relatively few studies that have dealt with 
the nature of heterotypic interference (Huang, 1977) either in vitro or in vivo.
Therefore, in this chapter, attempts were made to investigate the heterotypic 
nature of DI particle-mediated interference both in vitro and in vivo using DI viruses 
derived from three different strains of STD WN virus. Flaviviruses of different 
serogroups were used as STD viruses for determining the spectrum of heterotypic 
interference. Also, a comparative study was undertaken to show the nature of 
relatedness of the STD viruses based on both serology and the basis of cross 
interference.
7.2. EXPERIMENTAL PROTOCOL
7.2.1. STD Viruses
Five isolates of WN virus, from India (G-2266), Malaysia (Sarawak), Uganda 
(B 956), Madagascar (Madagascar) and Egypt (Egypt 101) were used. Other viruses 
used in this study were mosquito-bome flaviviruses Japanese encephalitis (JE) strains 
Sarawak (Malaysian isolate), 782219 (Indian isolate) and SA 14-5-3 (a vaccine strain). 
Saint Louis encephalitis (SLE) strain TBH-28, Murray Vally encepalitis (MVE) strain 
original and yellow fever (YF) vaccine strain 17DD, the tick-borne flaviviruses 
Langat (LGT) strain TP21 (Malaysian isolate) and a central European encephalitis
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(CEE) strain from Turkey and a non-vector borne flavivirus Dakar bat strain IPDA 
249. The ts^ strain of alphavirus Semliki Forest virus (SFV) was also used as control 
(Sources and other detail information on these viruses are shown in Table 2.2).
7.2.2. DI viruses
Three types of DI viruses derived from three strains of STD WN virus were 
used. Generation and interference properties of DI viruses derived from WN virus 
strain Sarawak and India were described in Chapter 3 and the same DI virus stocks 
were used in this study. DI virus derived from WN virus strain Egypt 101 were 
generated in Vero cells following the same procedure as described in Chapter 3 for 
generating DI virus from WN virus strain India and Sarawak (data not shown).
7.3. RESULTS
7.3.1. Interference between DI and STD viruses of different strains of WN virus
DI viruses derived from WN virus strains Sarawak, India and Egypt were 
assayed for their interfering abilities against STD WN virus of five different strains 
(Sarawak, India, Egypt, Madagascar and Uganda). Table 7.1 shows that although 
heterologous interference between strains of STD WN virus was demonstrable, 
interference titres as measured by the OIA were variable: strong, moderate, marginal 
or no interference was observed depending upon the combination of STD and DI 
viruses used. For example, although DI WN virus strain Sarawak interfered
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efficiently with the replication of STD WN virus strains Sarawak, Egypt and Uganda, 
moderately with strain Madagascar, only very marginal interference was demonstrated 
with STD WN virus strain India. Similarly, while DI WN virus strain India interfered 
very efficiently (10  ^ DIU/ml) with WN virus strain India and moderately with WN 
virus strain Uganda, there was only marginal or no detectable interference with STD 
virus strains Egypt, Sarawak and Madagascar. DI WN virus Egypt interfered equally 
well with the replication of STD WN virus strains Sarawak, Egypt, Madagascar and 
Uganda but only marginally with STD WN virus strain India. These results indicated 
that the patterns of interference demonstrated by different DI WN viruses were 
variable depending upon the strains of WN virus examined.
7.3.2. Heterotypic interference between DI WN viruses and other flaviviruses
The observations made on the DI WN virus-mediated interference against 
different strains of STD WN virus were extended by investigating the range of 
interference activities against other flaviviruses. STD viruses used for interference 
assays could be categorised into three groups on the basis of their serological 
relationship and mode of transmission: a) Viruses from the WN subgroup of the 
Flaviviridae were represented by MVE, SLE and three different strains (wild-type and 
vaccine) of JE viruses, b) Flaviviruses more distantly related to the WN subgroup 
were represented by mosquito-bome (YF virus 17DD), tick-bome (LGT virus TP-21 
and CEE virus Turkey) and non-vector-bome (Dakar bat virus) viruses, c) The 
alphavirus SF was included as a control to represent a STD virus unrelated to 
flaviviruses. Boardly speaking, the results of DI WN virus-mediated interference
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against these viruses demonstrated two clear patterns (Table 7.2). Firstly, interference 
could be observed against flaviviruses of the WN subgroup. Secondly, none of the 
DI viruses used showed any detectable interference against flaviviruses outside the 
WN subgroup or the alphavirus SFV. While heterotypic interference was limited to 
viruses within the WN subgroup, interference titres as measured by the OIA were 
variable: strong, moderate, marginal or no detectable interference was observed. 
Although DI WN virus strain Sarawak interfered efficiently with STD MVE virus and 
moderately with different strains of IE virus, only a marginal level of interference 
was exhibited against STD SLE virus. Similarly, DI WN virus strain India interfered 
efficiently with the vaccine strain (SA 14-5-3) of IE virus and moderately against two 
wild-types (Sarawak and India) of IE virus but poorly against MVE virus and showed 
no detectable interference against SLE virus. DI WN virus Egypt interfered well with 
wild-type JE and MVE viruses but poorly against SLE and the vaccine strain of JE 
virus. Interference did not take place between DI WN virus and any other STD 
flaviviruses irrespective of their serological relationship and mode of transmission 
suggesting that DI WN viruses mediated interference could occur only between 
members of the WN subgroup. Similarly, no interference was detected against SFV.
7.3.3. Antigenic analysis of the flaviviruses of WN subgroup
Since the spectrum of DI WN virus-mediated interference was extended to 
flaviviruses within the WN subgroup of the Flaviviridae, it was interesting to examine 
the serological relatedness of those viruses which exhibited interference by DI WN 
virus using a panel of MAbs. Thirty-nine envelope protein reactive MAbs generated
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from a fusion using JE virus strain G8924 as the immunogen (Sil et al. , 1992) were 
examined in haemagglutination inhibition (HAI) assays to determine the antigenic 
relationship between the members of the WN subgroup. With the exception of two 
MAbs (K ll and K39), all the MAbs used elicited HAI activity (95%) (Table 7.3). 
Five strains of WN virus, MVE and SLE viruses all had HAI titres which were lower 
than those against three strains of JE virus used (India 782219, Sarawak and SA14-5- 
3). The wild-type specific MAbs (KIO, K13 and K43) only reacted with the wild- 
type JE viruses examined (strain Sarawak and India 782219) and MAb K39 which is 
wild-type specific remained non-reactive against all the viruses used (Sil, 1991). 
Comparatively, JE virus strain India 782219 elicited higher HAI titres than any of the 
other viruses used in this study. Only 9 MAbs (23%) reacted against SLE virus, the 
lowest number of MAbs that reacted against one particular virus indicating its distant 
relatedness with the other viruses used in this study. There was a wide-range of 
differences in HAI reactivities among the different strains of WN virus suggesting 
antigenic variation between the isolates. HAI reactivity patterns against MVE 
virus,although not identical, were very close to that of WN viruses.
7.3.4. Degree of similarity between viruses
Results obtained from interference and HAI assays showed a wide range of 
variation between viruses and even between strains of viruses. An analysis of these 
variations may be able to show the significance between antigenic relatedness and 
cross interference between the viruses as demonstrated by different DI WN viruses. 
Therefore, interference and HAI results were assayed separately in cluster analyses
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to illustrate the degree of similarity between viruses.
7.3.4.1. Cluster analysis and construction of dendrogram
HAI and interference titres were expressed as logjo values. The data generated 
from HAI and interference assays were used separately to calculate a similarity co­
efficient called the similarity ratio, with a range from -1 to 4-1 using a formula 
applied to continuous variables (Sneath and Sokal, 1973; Wishart, 1987).
The similarity co-efficients were sorted by an unweighted pair group method 
of cluster analysis to classify the viruses, using the results of HAI and interference 
assays as numerical attributes of the viruses. Dendrograms were constructed on the 
basis of the results obtained by cluster analysis to illustrate the degree of similarity 
between viruses. Calculations of similarity co-efficients, cluster analysis and 
construction of dendrogram were performed using Clustan version 3.2. running on 
a Prime mainframe computer (Wishart, 1987).
7.3.4.2. Degree of similarity between viruses on the basis of interference
Figure 7.1 shows that on the basis of interference by DI viruses three major 
clusters of viruses were formed. One cluster (A) included four strains of WN virus 
(Sarawak, Egypt, Madagascar and Uganda), MVE virus and two strains of JE virus 
(Sarawak and India-782219). Another cluster (B) included WN virus strain India and 
JE virus strain SA14-5-3. These two clusters of viruses differentiated strains of WN
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virus into two groups or subtypes, one consisting of Sarawak, Egypt, Uganda and 
Madagascar which could be refered to as an African-Middle Eastern subtype, and the 
other containing strain India, referred to as an Indian subtype. Furthermore, JE 
viruses distributed between these two clusters showed differences between wild-type 
(Sarawak and India-782219) that grouped with the African-Middle Eastern subtype 
of WN virus, and the vaccine strain (SA-14-5-3) which formed a group with the 
Indian subtype of WN virus. WN viruses in the African-Middle Eastern subtype also 
showed close relatedness with MVE virus. SLE virus alone formed the third cluster 
(C), showing that it is only distantly related to the other clusters.
7.3.4.3. Degree of similarity between viruses on the basis of HAI tests
Those STD viruses that interfered heterotypically were examined in HAI tests 
(Table 7.3.) and the data analysed using the numerical taxonomy technique to 
demonstrate serological relatedness among them (Figure 7.2).
Four major clusters of viruses were formed: one (A) consisting of three strains 
of JE virus (Sarawak, India 782219 and SA 14-5-3), a second (B) with three strains 
of WN virus (India, Sarawak and Egypt) together with MVE virus, another (C) with 
WN virus strains from Uganda and Madagascar, and the remaining one (D) with SLE 
virus alone. However, within individual clusters several smaller groups were formed. 
Similarity between two wild-type strains (Sarawak and India-782219) and one vaccine 
strain (SA 14-5-3) of JE virus were demonstrable. Similarly, WN viruses clustered
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into three groups on the basis of HAI data: strain India formed one group, strains 
Sarawak and Egypt formed another group and strains Madagascar and Uganda formed 
a third group. MVE virus was found to be closely related serologically to the strains 
of WN virus examined (Egypt, Sarawak and India) (Figure 7.2.). SEE virus was 
distantly related to MVE and WN viruses. Thus, the relationship of the viruses 
studied varied whether interference or HAI was used to compare them.
7.3.5. Effects of DI virus on challenge of mice with heterologous strains of WN 
virus
DI viruses derived from WN virus strains Sarawak, India and Egypt had been 
shown to have heterologous interference properties in vitro against different 
flaviviruses (Table 7.1.). It was of interest to test the effectiveness of DI virus- 
mediated interference in mice against challenge by heterologous strains of WN virus. 
The in vivo interfering properties of DI viruses derived from WN virus strain India 
(DI virus plO derived from LLC-MK2 cells), Sarawak (DI virus p3 derived from 
LLC-MK2 cells) and Egypt (DI virus plO derived from Vero cells) were examined 
in adult mice by treating them with DI viruses and challenging with all combinations 
of their STD viruses. Mice were challenged with STD virus of the same infectivity 
titre as that of the DI virus preparation. Also, it was possible that the large quantity 
of WN virus antigen in the preparation might contribute to the protective effect of the 
DI virus preparations. Therefore, mice were treated with BPL-inactivated DI virus 
as described previously in Chapter 2 and considered as controls to compare the 
protective effect of DI virus on challenge by STD viruses.
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In order to determine the protective effects of the DI viruses on challenge of 
mice with STD virus, mice were infected with either STD virus alone, DI virus plus 
STD virus, BPL-treated DI virus plus STD virus or DI virus alone. Following 
inoculation of viruses by the intraperitoneal route, mice were observed daily up to 21 
days post infection to record their health status including sickness, half paralysis and 
complete paralysis leading to death. Protection rates were calculated from the 
differences between survival rates of mice receiving live DI virus plus STD virus and 
BPL-treated DI virus plus STD virus.
Table 7.4. shows the summary results of protection studies indicating that all 
the DI viruses used showed protective abilities against challenges with STD WN virus 
of homologous and heterologous strains. However, protection rates varied according 
to the combination of DI and STD viruses used.
Table 7.5 shows variable protection rates of mice by administration of DI WN 
virus strain India against challenges by homologous and heterologous strains of WN 
virus. The survival rates of mice receiving DI WN virus strain India plus STD WN 
virus strain India (87.5%) were significantly higher than those of the mice infected 
with STD virus alone or BPL-treated DI virus plus STD virus (37.5%) indicating that 
live DI WN virus strain India was responsible for protection mice against challenge 
by STD virus. Similar survival rates by DI WN virus strain India could be achieved 
against WN virus strain Egypt. However, this protective ability of DI WN virus strain 
decreased by 50% when mice were challenged with STD WN virus strain Sarawak 
suggesting that DI WN virus strain India was less effective in protecting mice from
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challenge by STD WN strain Sarawak. Similarly, the protection rate of mice treated 
with DI WN virus strain Sarawak plus STD WN virus strain Sarawak was 75%, 
whereas mice treated with DI WN virus strain Sarawak plus STD WN virus strain 
India was 25% (Table 7.6). In comparison, mice treated with DI WN virus strain 
Egypt gave a protection rate of 62.5% against a challenge by homologous strain of 
STD WN virus but challenge by STD WN virus strain India decreased the protection 
rate to 25 % (Table 7.7). Thus, although protection against a challenge by homologous 
strain of STD virus was effective, it was less effective against a challenge by STD 
WN virus strain India. All the DI virus preparations used in these studies contained 
10^  ^ to 10^  ^pfu of STD viruses and survival rates of mice receiving DI virus alone 
varied between 80 to 100% whereas mice inoculated with those doses of STD virus 
only had 37.5% or fewer survivors. This would indicate that mice were protected 
from the challenge of that amount of STD virus by their respective DI viruses. These 
results demonstrated two specific patterns of protection mediated by different DI 
viruses: a) protection against a challenge of homologous strains of WN virus was 
effective; b) challenge by heterologous strains of STD WN virus decreased the level 
of protection depending upon the DI viruses used; a greater variation in protection 
rate was oberved with DI WN virus against challenge by heterologous strains of WN 
virus or with DI WN virus strains Sarawak and Egypt against a challenge by STD 
WN virus strain India. This variation of DI virus-mediated protection between WN 
virus strain India and WN virus strains Sarawak and Egypt may be explained in part 
by the differences observed in their similarity coefficient (see above).
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7.3.6. Comparison of in vivo and in vitro heterologous interferences
A comparison of interference data generated in vitro and in vivo by DI viruses 
(Table 7.8.) revealed that there was little or no correlation between the degree of 
interference in these two systems. For example, in vitro interference demonstrated by 
DI WN virus strain Sarawak against STD WN virus strain India was 200-times less 
than that against homologous STD virus, whereas in vivo systems protection rates 
between homologous and heterologous ( STD WN virus strain India) differed by 3- 
fold. Similarly, DI WN virus strain India did not show any detectable interference 
against STD virus strain Sarawak in vitro but in vivo DI WN virus strain India gave 
a low level of protection (25%) against a challenge of WN virus strain Sarawak. DI 
WN virus strain India protected mice against a challenge by STD WN virus strain 
Egypt half as much than that of against a challenge by homologous strain of STD 
virus whereas in vitro heterologous interference was 1000-fold less than that of 
homologous interference. With DI WN virus strain Egypt, in vitro interference 
against STD WN virus Sarawak was 12-fold less than that of against homologous 
STD virus whereas in vivo this difference was only marginal (1.5-fold). However, it 
can be seen that the variation in the degree of protection of mice by different DI 
viruses against challenge by different strains of STD WN virus differentiated the STD 
viruses into two groups as had been shown in vitro. For example, DI viruses derived 
from WN virus strains Sarawak and Egypt interfered efficiently against each other 
both in vitro and in vivo (Table 7.8.), whereas WN virus strain India interfered 
efficiently against the homologous strain of STD virus but showed poor interference
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with strain Sarawak.
7.4. DISCUSSION
The results described in this chapter demonstrates two specific aspects of DI 
WN virus-mediated interference:
a) DI WN virus derived from STD WN virus strains Sarawak, India and Egypt
have the ability to interfere homotypically and heterotypically in vitro.
b) The use of DI viruses to modulate the affect of STD virus infection in adult 
mice through the intraperitoneal route of inoculation has shown that DI WN 
virus strains Sarawak, India and Egypt can protect mice against challenges by 
homologous and heterologous strains of STD WN virus.
While limited in vitro heterotypic interference has been reported for Sindbis 
virus (Weiss and Schlesinger, 1981), SFV (Barrett and Dimmock, 1984), influenza 
virus (Nayak et al., 1981) and VSV (Holland et al., 1976), the spectrum of 
heterotypic exhibited by different DI WN viruses signifies the nature of DI virus- 
mediated interference in the context of relatedness of viruses.
One important charateristic of DI virus activities is the strong preferential 
interference observed with homologous STD virus (Huang and Baltimore, 1970). DI 
virus derived from Sindbis virus was reported to interfere with homologous virus 
about 100-fold better than with Easter equine encephalitis virus (Shenk and Stollar, 
1973). The results presented here also show that DI viruses derived from different
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strains of STD WN virus interfered very effectively against STD viruses from which 
they were derived. They did, however, interfere with related viruses showing variable 
degrees of interference against different viruses. A number of flaviviruses were used 
in the heterotypic interference assays based on the fact that flaviviruses have been 
subdivided into subgroups and complexes on the basis of their serological cross 
reactivities and type of arthropod vector they utilize (Calisher et a l ,  1989; Brinton, 
1986). Interestingly, interference by different DI WN viruses was limited with various 
strains of WN virus and the members of the WN subgroup which includes IE, MVE, 
SEE and WN viruses. These viruses have been shown to be antigenically related to 
each other (Calisher et a l ,  1989). Interference mediated by DI viruses was 
completely abrogated when mosquito-bome YF fever strain 17DD was used as STD 
virus indicating that although both WN and YF viruses are mosquito-bome, 
interference by DI WN virus does not depend on the similarities of vector rather on 
the antigenic relatedness as YF virus is known to be relatively distantly related to WN 
virus. Similar observations were made with tick-bome and non-vector-bome 
flaviviruses showing that interference by DI WN virus does not take place against 
these viruses. It is worth mentioning that these viruses are antigenically also distantly 
related from WN virus. It is not surprising that no interference was seen against the 
alphavirus SFV which is unrelated to flaviviruses. Thus, interference demonstrated 
by DI WN viruses is a very specific event and appears limited to viruses of the same 
antigenic subgroup.
The results of variable degrees of interference shown against different 
heterologous viruses were examined using a computer-based cluster analysis
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programme (Wishart, 1987) with a view to determine whether there was any specific 
pattern of interference. These analyses showed that on the basis of cross-interference 
the strains of WN viruses were differentiated into two subtypes: African-Middle 
Eastern and Indian (Figure 7.1). Strains of JE virus were found to group as either 
wild-type or vaccine; MVE virus was closely related to African-Middle Eastern 
subtype of WN virus and SEE virus, also a member of WN virus subgroup, was 
distantly related to WN and MVE viruses. Differentiation of strains of WN virus into 
two groups favourably compares with the findings that isolates of WN virus from 
different geographical locations differentiates into African-Middle Eastern and Indian 
subtype or groups based on the use of polyclonal antisera in HAI assays (Hammam 
et al. , 1965). When the pattern of relatedness of these viruses based on interference 
activity was compared to that determined from serological data based on HAI assays 
with a panel of MAbs, similar relationships could be obtained, showing that 
serologically related flaviviruses of the WN subgroup can interfere heterotypically 
with DI WN viruses. Thus, the degree of heterotypic interference exhibited by DI 
WN virus may depend on the genetic relatedness of the STD viruses used. However, 
the virus grouping based on HAI data did show some differences to that based on 
interference. For example, although the degree of relatedness of WN virus with MVE 
and SEE viruses as determined by HAI and interference assays is similar, the 
relationship between strains of JE virus and the above mentioned viruses is different 
in the two assays. This may in part be attributable to the specificity of anti-JE virus 
MAbs for particular epitopes of WN virus. DI MVE virus have been reported to 
interfere heterotypically with Kunjin and WN virus (Poidinger et al., 1991). This 
observation taken together with the findings presented here provide evidence that
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heterotypic interference can occur, and that interference between different members 
of flavivirus subgroup can occur.
The use of DI virus-mediated interference property to examine the relatedness 
of viruses has been documented in VSV virus systems and are found to be consistent 
with and partially confirm the serological classifications of VSV (Crick and Brown, 
1973; Reichmann et al., 1978). In this study the nature of heterotypic interference 
demonstrated by DI WN virus are also found to be consistent with the antigenic 
classification. The pattern of heterotypic interference shown in this study agrees with 
the general hypothesis that interference by DI virus is strongest against the STD virus 
from which it is derived, less strong with related viruses and nonexistent with 
unrelated viruses (Huang, 1977). Thus, interference by flavivirus DI particles may 
be useful in the classification of flaviviruses.
The findings that DI WN virus can protect mice against challenge by 
homologous and heterologous strains of WN virus indicates that interference by DI 
WN virus can also take place in vivo. Earlier (see chapter 5), the influence of DI 
WN virus strain Sarawak in protecting mice against a lethal challenge by homologous 
strain of WN virus has been described. Here, in addition to the WN virus strain 
Sarawak, strains Egypt and India also showed their ability to protect mice against a 
challenge by homologous strains of WN virus suggesting that DI WN virus-mediated 
protection is not limited only to WN virus strain Sarawak; similar protection can be 
obtained by DI WN virus strains India and Egypt. Furthermore, DI WN viruses 
derived from the above mentioned strains were also capable of modulating protection
212
against heterologous strains of WN virus although the level of protection was 
dependent on the combination of DI virus and strains of STD virus used. Therefore, 
it could be suggested that as observed in cell culture, protection by DI WN virus 
against a challenge by STD virus may also depend on the genetic relatedness of the 
viruses.
A comparison between in vitro interference and in vivo protection by DI WN 
virus (Table 7.8) shows that the degree of interference observed in these two systems 
varies significantly. In vitro interference shown by DI WN virus strain Sarawak 
against STD WN virus strain India was 200-times less than that of against 
homologous strain, whereas in vivo protection rates against homologous and 
heterologous strains differed by three folds. Similar variation between two systems 
could be seen with strains of WN virus. It has also been observed that DI WN virus 
strains India interfered with its homologous STD virus very efficiently (10  ^ DIU/ml) 
whereas in vivo protection by DI WN virus strain India against a challenge by 
homologous strains of WN virus was only moderate (50%). Studies with DI SFV 
derived from strain ts"^  would protect mice from infection by homologous strain of 
SFV, but not of the LIO strain of SFV. However, the same DI virus preparation 
interfered with replication of both ts'  ^ and LIO strains of STD SFV in vitro (Barrett 
and Dimmock, 1986).
There are as yet no unifying hypotheses which can explain the interference 
mechanism by DI of all RNA viruses and it is not surprising since different RNA
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virus groups display quite different strategies of replication. The biological differences 
and similarities of viruses of the WN subgroup determined by HAI and interference 
assays show significant similarities as described above. It is now known that the 
major antigenic determinant of flavivirus is the virion glycoprotein, which gives rise 
to and reacts with neutralizing antibodies (Barrett, 1991). But the mechanisms 
involved in DI flavivirus-mediated interference have not been determined yet. An 
understanding of the mechanism of DI virus-mediated interference should come from 
the study of the structural and functional differences in STD and DI viruses. While 
some of the functional evidence associated with the effect of DI WN virus on STD 
virus both in vitro and in vivo has been made available in this study, the structural 
basis of homotypic and heterotypic interference is yet to be determined. However, all 
models for the mechanism of interference associated with DI RNA viruses have 
suggested that the replication advantage of DI virus over STD virus would be an 
important cause of interference and this may be due to some structural features of 
their RNAs (Reichmann and Schnitzlein, 1979; Perrault, 1981; Schlesinger, 1988). 
Evidence for structural significance of DI RNA for SFV and Sindbis virus has shown 
that DI RNA has extensive deletions of STD virus genome with subsequent 
rearrangement and duplication (Monroe et al. , 1982; Petersson, 1981). The variation 
of interfering abilities by DI viruses was found to be consistent with variations in 
sequence of DI virus genome (Kaarianen et û/. ,1981; Barrett and Dimmock, 1984). 
It has been suggested that changes in the terminal regions which serve as recognition 
sites for replicase binding will reflect the degree of interference (Weiss and 
Schlesinger, 1981). Heterotypic interference by DI Sindbis virus with SFV has been 
explained on the basis that in the 3^  end of these two viruses exhibit strong homology
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over the first 20 nucleotides. The mechanism involved with heterologous interference 
described with DI WN virus might have a similar structural basis. A comparative 
sequence and secondary structure analysis of the 5^  terminal regions of different 
flavivirus genome RNAs has shown that there is a significant sequence homology of 
the 5^-noncoding region among members of the same flavivirus subgroup and almost 
complete conservation was observed between different strains of the same virus 
(Brinton and Dispoto 1988). Therefore it can be postulated that if the STD viruses 
used in this study have similar polymerase recognition site(s) their DI viruses will 
cross interfere. However, before making any conclusion the sequence of the DI RNA 
needs to be determined.
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CHAPTER 8
General Discussion
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Since the discovery of an auto-interfering activity of an influenza virus 
preparation by von Magnus (1954), a large body of information has accumulated on 
DI virus derived from different viruses. The interest in DI viruses largely stems from 
their characteristic interfering properties and their role in the establishment of 
persistent infection. Another aspect is the use of the DI genome as a tool to identify 
and explore the nucleotide sequences responsible for such functions as replication and 
encapsidation which DI virus and STD virus have in common. Their abundant 
appearance in vitro and ability in animal model systems to profoundly alter the normal 
course of disease suggests that their role in natural infection, although largely 
unexplored, is likely to be significant. DI virus can be considered as a natural 
antiviral product which is highly specific, strongly antiviral, readily produced in the 
proper system and which can be non-toxic at levels well beyond the effective 
concentration (Kennedy and Holland, 1978).
Over the years, a great amount of work has been undertaken to understand 
both the functional and structural properties of different DI RNA viruses. However, 
little definitive information has been available concerning the nature of DI 
flaviviruses. Flaviviruses are considered to be one of the most important groups of 
RNA viruses. Of the 68 currently registered flaviviruses, over 50% have been 
associated with human and veterinary diseases and many of them are fatal for humans 
and animals (Karabatsos, 1985). To date, the only studies on DI flaviviruses have 
involved WN (Brinton, 1986), Banzi (Smith, 1981), MVE (Poidinger et al. , 1991) and 
JE (Schmaljohn and Blair, 1977) viruses. None of these studies have investigated the 
nature of DI flavivirus either in vitro or in vivo in any detail. This limited progress
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in understanding the nature of DI flavivirus may partly be responsible for the failure 
to identify an appropriate cell-virus system for growing high titre DI flavivirus and 
the lack of a suitable assay for quantifying DI viruses (Chambers et al. , 1990).
WN virus, an important member of the Flaviviridae, was used in this thesis 
to identify a cell-virus system that will readily generate DI virus and démontrâtes its 
interfering activities, and to investigate the functional properties of a DI flavivirus. 
The major aims of this thesis were to generate a number of DI WN viruses and to 
characterize their properties both in vitro and in vivo.
Initial studies were directed towards developing an assay that would reliably 
measure DI WN virus present in a virus preparation. This was achieved and was 
designated as the "optimised interference assay" (OIA) for DI WN virus. The assay 
followed the basic design of the yield reduction assay described by Bellett and Cooper 
(1959) who measured biological activity (interference) of DI VSV.In order to adapt 
this approach for DI WN virus, several important parameters were identified that 
could greatly influence DI WN virus interference in vitro. These include: a) 
identification of sensitive cell types that support DI WN virus-mediated interference;
b) influence of the quantity of STD virus and DI virus on the assay; c) interference 
as a function of time.
While some of these parameters were found to act in a very similar way to 
those reported for other DI viruses, cell-types that were found to be sensitive to 
support DI WN virus-mediated interference were different to those of other virus
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systems. However, this finding does support the general proposition that 
demonstration of DI virus-mediated interference depends on the cell type used. In this 
thesis it has been clearly demonstrated that cell types displayed a gradient of 
sensitivity to interference by DI WN virus. LLC-MK2 cells appeared to be the most 
sensitive cell line among those examined while no detectable interference could be 
demonstrated in BHK-21 and SW13 cells. In addition, evidence was produced that the 
interference measured by the OIA has the property of DI virus-mediated interference 
as described in Chapter 1 and the possibility that it was caused by some other form 
of interference has been excluded.
Identification of a sensitive cell type which could readily show the interference 
activity of DI virus would have great value in investigating the role of DI virus in 
flavivirus pathogenesis and facilitate the use of DI virus as a tool for the study of 
flavivirus RNA replication. However, it should be noted that since the assay measures 
interference, it detects only biologically active DI virus rather than a physical 
property of the virus and its sensitivity is limited by the number of cells on the tissue 
culture plates since the number of DI particles is calculated from the proportion of 
cells that do not yield STD virus. As far as sensitivity is concerned, however, this 
assay can be favourably compared with the focus-forming assay (Popescu et ah, 
1976) and the YRA of Barrett et ah (1984).
In order to characterise the in vitro generation, amplification and propagation 
of DI WN virus, studies were conducted in different cell types with different strains 
of WN virus. Initial studies clearly demonstrated that serial undiluted passage of WN
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vims in Vero and LLC-MK2 cells resulted in the production of DI WN vims after 
2-4 passages. Generation of DI vims is an initial event by which a DI vims is 
produced but only DI vimses which are capable of being amplified can be studied. 
In order to amplify DI WN vims, an approach was made by maintaining a high moi 
of STD vims in every serial passage in cell culture so that cells infected with DI vims 
can be co-infected with STD vims to replicate more DI vims (termed amplification). 
A similar approach has been made to amplify DI vims for other vims systems 
(Holland et a l ,  1976; Janda et a l ,  1979).
Another approach which may be closely related to amplification but is distinct 
experimentally is the propagation of DI vims by inoculating different cell lines with 
pre-formed DI vims. In this way a cell line was identified which would permit the 
multiplication of STD vims but not detectable DI vims. From these experiments it 
appeared that SW13 cells would be the most suitable cell line among the cell lines 
examined to propagate STD WN vims. These findings taken together with the 
observation of sensitivity of cell types to support interference strongly support the 
hypothesis that both replication and interference of DI vims are quantitatively 
dependent on host cells. How can the cell influence the generation and interference 
of DI vims? As yet this question for DI vims biology has remained unanswered. 
While little experimental evidence has been produced on this problem either in this 
thesis or studies on other vims systems, it has been proposed that generation depends 
on the replicase detaching from the template. The replicase enzyme, which probably 
consists of viral replicase protein in association with cellular factors, detaches from 
the template at a rate determined by the cell proteins (Dimmock, 1991).
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The majority of studies on DI virus have involved tissue culture systems as a 
model. These have led to the suggestion that DI viruses have a role in modulating 
both acute and persistent infection in nature (Huang and Baltimore, 1970). 
Unfortunately, relatively few studies have been carried-out to investigate this 
proposal. In this thesis, it has been shown that DI WN virus preparations can prevent 
the lethal encephalitis caused by i.p. inoculation of STD WN virus in mice. Not only 
was death prevented, but mice remained clinically healthy (i.e. they were "protected" 
from disease). These experiments were carefully controlled and it was shown that the 
immunogenic load of virus was not the cause of protection. In protection experiments 
mice were challenged with 40 to 400 LD5 0  of STD virus. Even though such large 
doses of STD virus were used, DI virus was still capable of eliciting protection. 
Accordingly, the protection studies reported in this thesis compare very favourably 
with previous studies where DI virus mediated lower protection rates and a lower 
challenge dose of STD virus was used (Barrett et a h , 1984; Dimmock and Kennedy, 
1978; Jones and Holland, 1980). Also, it is important to note that challenge of mice 
by the i.p. route is a severe test of protection against a neurotropic virus, none the 
less good protection rates were observed. Again, this compares very favourably with 
previous studies (Barrett and Dimmock, 1984; Fultz et ah, 1982). The protection 
studies were carried out using DI viruses from unconcentrated tissue culture fluids 
which also contrasts with the studies using purified, enriched DI VSV (Jones and 
Holland, 1980) and lymphocytic choriomeningitis (LCM) virus (Welsh et a l ,  1977).
Studies on the ability of different DI viruses to modulate an otherwise lethal 
STD WN virus infection in mice revealed some characteristic features of DI WN
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vims activities in vivo. Firstly, the multiplication of STD vims in mice treated with 
live DI vims showed that the quantity of vims infectivity in the brain was reduced by 
several orders of magnitude in comparison to those treated with BPL-inactivated DI 
vims plus STD vims. Thus, live DI vims is involved either directly or indirectly in 
inhibiting the multiplication of STD vims. Variable protection rates in the 
heterologous interference experiments would indicate that the interfering activity of 
DI vims is directly responsible for protection. Evidence has also been produced to 
show that DI vims has been propagated in the brains of mice protected by DI vims. 
It is therefore suggested that viral interference seems the more plausible explanation 
for the protection effect.
Secondly, the lack of large quantities of neutralizing antibodies in most of the 
protected mice suggests that the humoral immune response plays at best a minor role 
in protection. However, short-lived IgM and interferon levels have not been 
measured in protected mice, so a humoral immune response or non-specific protection 
can not be completely mled out. The variable protection rates in heterologous 
protection studies in mice would tend to suggest that a non-specific immune response 
is not involved in protection of mice.
The prevention of acute WN vims infection in mice by DI WN vims supports 
the suggestion that DI vims plays a role in modulating vims infections in nature. 
Possibly DI vimses are involved in recovery from vims infections since they would 
cause a reduction in levels of STD vims in the infected hosts. Alternatively, the 
presence of DI vims may cause a vims infection to become sub-clinical rather than
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manifesting signs of disease. The detection of infectious virus in the brains of a 
minority (24%) of the protected mice examined at 19 days post infection suggests that 
DI virus is modulating the acute infection and causing it to become persistent. Prior 
to these experiments, STD WN virus was considered only to cause an acute virus 
infection in mice and there is no evidence that the virus can persist in natural 
infections. However, other flaviviruses such as tick-bome encephalitis can persist in 
their host and it is possible that DI virus plays a role in persistence. DI VSV- 
protected hamsters (Fultz et al:, 1982) and DI SFV-protected mice (Atkinson et a l., 
1986) also cause persistent infection. However, STD VSV was only recovered only 
after co-cultivation of brains while WN virus can be directly isolated from brains. 
Clearly, further studies are required to fully evaluate the nature of DI WN virus- 
mediated persistent infection. In particular, the evidence presented in this thesis 
suggests that the DI WN virus system will provide an excellent model for studying 
the role of DI viruses in persistent infection.
The data presented in this thesis do not establish the role of DI virus in 
maintaining a persistent infection. However, evidence that some of the infectious 
viruses isolated from the brains of protected mice demonstrated a greatly reduced 
virulence in mice compared to their parent virus provides an indication that DI virus 
might have exerted selective pressure during their propagation in mice to evolve an 
attenuated variant of STD WN virus. Further studies on the DI and STD virus 
isolated from the brains of mice are required to assess the relative role of these 
viruses in initiating and maintaining the persistent infection. However, it is tempting 
to speculate that protection of mice by DI virus may not be only a result of DI virus-
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mediated interference with STD virus but also due to the ability of DI virus to 
modulate the biological properties of STD virus used as challenge virus.
Evidence has also been presented that DI virus preparations can cause 
heterotypic interference with different members of the WN subgroup of the 
Flaviviridae. This nature of heterotypic interference was found to be consistent with 
the antigenic classification of flavivirus since no interference was demonstrated with 
STD viruses from outside the WN subgroup. This pattern of heterotypic interference 
agrees with the general hypothesis that interference is strongest against the STD virus 
from which it was derived, less strong against related viruses and non-existent with 
unrelated viruses (Huang, 1977). Determination of the molecular basis of this 
heterotypic interference may be valuable in understanding the replication strategy of 
flaviviruses.
The DI WN virus-mediated protection studies presented in this thesis have also 
demonstrated that DI virus preparations are heterogeneous in their ability to protect 
mice. Some DI virus preparations provided strong protection, while others were 
either moderate or weak in protecting mice against challenge with STD WN virus. 
This variability of DI WN virus activities in vivo was not consistent with the 
interfering properties of these DI virus in vitro. Furthermore, virus isolates collected 
from the brains of the protected mice also showed variable degrees of virulence in 
mice: from as virulent as STD virus inoculated into the mice to attenuation of the 
virus isolates. The virulence appeared related to which DI viruses were administered 
to the mice. On the basis of these data it could be concluded that DI WN virus
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preparations are biologically heterogeneous and have different interfering properties 
however the origin(s) of these variations have not been determined. The lack of 
correlations between in vitro and in vivo interference may also be explained by a 
minority of DI RNA species in the population being able to interfere in vivo. At the 
moment this is speculation and will only be fully resolved by future studies on DI 
RNA.
The important features of the modulation of RNA virus infection by DI virus 
both in vivo and in vitro have been uncovered by using VSV, SFV and influenza virus 
as prototype systems for studies (Dimmock, 1991; Roux et al., 1991, Holland, 1990, 
Nayak et al., 1989; Barrett and Dimmock, 1986). An extrapolation of the 
characteristic biological features of DI viruses derived from these viruses and those 
of the DI WN virus presented in this thesis demonstrates patterns of similarities and 
differences in their biological affects (Chapter 5). On the basis of these differences 
and similarities it is tempting to propose a conceptual basis of mechanisms by which 
DI virus acts in vivo. That is, since SFV, VSV and WN virus are all neurotropic and 
cytolytic in mice and demonstrate similarities in many of their important biological 
characteristics, the mechanism(s) by which DI viruses derived from these viruses act 
may be similar. In contrast, DI influenza virus interferes with the abortive infection 
of lymphocytes which otherwise results in the immune pathology (Dimmock, 1991; 
Morgan and Dimmock, 1992). Therefore, the mechanism(s) by which DI influenza 
virus acts may be different to that of neurotropic viruses.
The conformity of function of DI viruses derived from these three neurotropic
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viruses, despite the differences in the structure and replicative strategy of the STD 
viruses, suggests that DI virus may play an important role in virus infections. The 
studies performed in this thesis have added to this body of knowledge and may 
facilitate future studies in this area.
In conclusion, the work presented in this thesis is the first detailed biological 
study of DI WN virus and as such describes some of the important biological 
characteristics of the DI virus. However, a number of details remain to be elucidated, 
particularly those associated with the structural basis of DI WN virus activities. 
Specifically, the DI RNA species synthesised in cell culture and in mice need to be 
identified and at least one DI RNA sequenced. Comparison of the nucleotide sequence 
of the DI RNA with that of STD WN virus RNA should elucidate important 
information on the molecular basis of interference. Also, STD and DI WN virus 
cDNA probes will prove important in analysing the events involved in DI virus 
mediated protection of mice.
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Appendix
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I. Calculation of the average survival time (AST), standard error of the mean 
(SEM) and confidence limit.
1) AST = X =
n
2) SEM = —
f n
TAx- xŸ
ft — \
4) AST ± SEM ~ X ± ^
f n
Where x is the individual observation, x is the mean , n is the sample size and 
s is the standard deviation.
Therefore the reliability of a sample mean in indicating the true mean of the 
whole population can be described. It is useful to attach confidence limits at 
a certain level of probality. Thus, for any normal distribution 95% of 
measurements will be 1.96 standard deviations either side of the mean (i.e. the 
mean has a probability of 95 % of being between these limits or:
251
X  ± 1.96 —
fn
II. Calculation of pfu/LD^o
The LD 5 0  titre was caculated by the Reed-Muench method. The formula are 
as follows:
The proportinate distance of the 50% mortality endpoint=:
( % mortalityatdilutionnextabove 50% ) -  50%
( % mortalityatdilutionnextabove 50% ) -  ( % mortalityatdilutionnextbelow )
Where % mortality is calculated by the accumulated values: i.e. the number 
of dead at each dilution is taken as the accumulated value from the higher 
dilutions, whereas the number of survivals is taken as accumulated value from 
the lower dilutions.
LD5 0  endpoint titre=:
Negative logarithm of the lowere dilution (next above 
50% mortality) plus (Proportionate distance x dilution 
factor (logio 1 0 )
252
pfu/LD5o=:
Volume of virus inoculum (ml) x virus infectivity titre 
(logio pfu/ml) X 10^°^°
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